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Résumé  
 
Les progrès dans le domaine de la neuroimagerie cérébrale ont permis une certaine 
compréhension des maladies mentales comme la schizophrénie. Cependant, peu de résultats sont 
cohérents et ils sont souvent contradictoires, ce qui rend difficile de tirer des conclusions concrètes 
par rapport à la maladie. 
Plusieurs facteurs jouent un rôle dans les résultats divergents et convergents : Les 
différentes techniques d'imagerie et les analyses, le nombre de patients inclus dans les études, l'âge 
des patients, l'âge de l’'apparition de la maladie, les critères de diagnostic, les effets du traitement 
antipsychotique, le statut social, ainsi que les comorbidités, font partie de ces facteurs. Bien que 
les différences cérébrales entre femmes et hommes « normaux » sont bien établies, ce n’est que ces 
dernières années que des études en neuroimagerie de la schizophrénie ont abordé les différences 
homme-femme comme une explication potentielle des résultats discordants de l’imagerie 
cérébrale. 
L'objectif de cette thèse est de comprendre le rôle du sexe (genre féminin et masculin) dans les 
anomalies anatomiques observées dans la schizophrénie; ceci, en réalisant des études qui 
contrôlent, autant que possible, l'effet de différentes variables confondantes et en utilisant des 
analyses d’IRM automatisées chez des patients et des sujets sains de même âge et du même sexe.  
Une brève revue globale des résultats actuels dans le domaine de la schizophrénie ainsi que 
des résultats liés aux différences entre les sexes dans la schizophrénie vont être présentés. 
La première étude visait à étudier l'influence des différences de sexe sur des mesures de la 
gyrification corticale de la schizophrénie. Étant donné que la schizophrénie est une maladie dont 
les «symptômes cliniques » ont un impact négatif sur la qualité de vie des patients qui en souffrent, 
nous avons exploré la relation entre la gyrification corticale et les différents symptômes de la 
schizophrénie chez les hommes et les femmes atteints de ce trouble psychiatrique. Le rôle du sexe 
sur la gyrification corticale et son association aux symptômes a été à peine étudié chez les patients 
atteints de schizophrénie ; c’est pour cette raison que, nous croyons que cette étude est d’une 
importante valeur.  
Dans cette première étude, des images 3T T1 ont été acquises auprès de 48 patients atteints 
de schizophrénie (24 hommes [SZ-M] et 24 femmes [SZ-F]) et 48 volontaires sains (24 hommes 
[NC-M] et 24 femmes [NC-F]), appariés en fonction de l'âge et du sexe. Des mesures d’indice de 
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gyrification (IG) pour chaque hémisphère et les quatre lobes cérébraux (frontaux, temporal, 
pariétal, et occipital) ont été effectuées en utilisant le pipeline de CIVET, lequel est entièrement 
automatisé. Plusieurs résultats intéressants ont émergé: les patients avaient des valeurs inférieures 
importantes de l’IG global par rapport aux témoins; SZ-M avaient des valeurs d'IG hémisphériques 
significativement inférieurs par rapport à NC-M, cela n'a pas été observé dans les groupes de 
femmes. Aucune différence entre les sexes dans les valeurs de diminution de l’IG avec l'âge n’a 
été observés chez les témoins sains par contre, une diminution de la valeur de l’IG avec l’âge chez 
les patients était plus importante chez les patients homme que les patients femmes. Une 
détérioration plus progressive dans l'hémisphère droit dans les deux groupes de patients a été 
observée, tout comme des réductions significatives des valeurs d’IG en relation avec la durée de la 
maladie chez SZ-M, mais pas chez SZ-F. 
Dans les groupes de patients, on observe des diminutions des valeurs d’IG dans les lobes 
frontaux bilatéraux et, le lobe occipital droit; le groupe SZ-M a montré une valeur d’IG 
significativement plus élevée par rapport à NC-M dans le lobe temporal droit; SZ-F a montré des 
valeurs d’IG significativement plus faibles dans les lobes bilatéraux frontaux, temporaux, pariétaux 
et le lobe occipital droit, par rapport à NC-F. Aucune corrélation significative n'a été trouvée entre 
les valeurs de l'IG et le profil de la symptomatologique dans les deux groupes de patients. 
Etant donné que l’IG reflète, en partie, des altérations dans le développement et la connectivité 
cérébrale, la diminution de l’IG observée chez les patients est en accord avec le modèle de 
développement neurobiologique de disconnectivité dans la schizophrénie. De plus, nous 
soulignons l'importance de l'âge ainsi que la durée de la maladie lorsque nous comparons les 
hommes et les femmes atteints de schizophrénie. Cependant, nous n'avons pas observé de 
corrélation significative n'a été trouvée entre les valeurs de l'IG et les symptômes, ce qui est d'un 
intérêt particulier et inattendu compte tenu des résultats de la neuroimagerie montrant par exemple 
certaines corrélations entre les symptômes positifs et certaines anomalies du lobe temporal dans la 
schizophrénie. 
Considérant ces résultats, nous avons décidé d'investiguer, dans notre deuxième étude, 
l'association entre les symptômes et les densités de matière grise (DMG) et de matière blanche 
(DMB) à la place des mesures de gyrification corticale. Nous avons utilisé la morphométrie basée 
sur le voxel "Voxel Based Morphometry (VBM8.0 with Diffeomorphic Anatomical Registration 
(Through Exponentiated Lie Algebra [DARTEL])" et la modélisation linéaire automatique 
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(SPSS21.0 ALM) sur les images 3T T1 MPRAGE acquises auprès de 40 patients atteints de 
schizophrénie (SZ) et 41 témoins sains (NC). 
Nous avons trouvé que les patients atteints de schizophrénie avaient une DMG réduite dans le 
cortex cingulaire antérieur, le cortex temporal médian gauche et une DMG plus élevée dans le 
cortex cingulaire postérieur gauche par rapport aux sujets sains. Une diminution significative de 
DMB dans la région fronto-rectal inférieure gauche et la région pariétale postérieure gauche a été 
observée chez les patients comparés aux sujets sains. 
Nous avons trouvé des corrélations positives entre les symptômes positifs et la DMG dans l'insula 
gauche et le noyau caudé droit; et entre les symptômes négatifs et la DMG dans le cortex frontal 
médian droite et le lobe postérieur de cervelet droit. Nous avons aussi trouvé des corrélations 
négatives de DMG dans la région pariétale droite (précuneus), le lobe postérieur du cervelet gauche 
et les symptômes positifs; ainsi qu'entre la DMG du lobe antérieur du cervelet gauche et les 
symptômes négatifs. En outre, des corrélations positives ont été trouvées entre la DMB dans le 
cortex frontal médian droit et les symptômes positifs et entre le DMB dans la région frontale 
supérieure droite et les symptômes négatifs. Des corrélations négatives ont été trouvées entre les 
symptômes positifs et la DMB dans la région occipitale inférieure droite et le cunéus occipital droit, 
tandis que des corrélations négatives ont été trouvées entre la DMB et la région frontale supérieure 
gauche. 
Il est intéressant de noter que lorsque les symptômes ont été analysés par regroupement, 
nous avons trouvé que le symptôme de la désorganisation conceptuelle corrélait positivement avec 
la DMG totale et la DMB totale. L’augmentation de DMG a été associée à une diminution de la 
gravité des hallucinations et du manque de spontanéité; tandis que l'augmentation de DMB totale 
a été associée à la diminution de la sévérité de l'hostilité et des idées de grandeur. Une comparaison 
entre les groupes d'hommes a montré une diminution de la DMG chez les patients schizophrènes, 
tandis qu’aucune différences n’a été observée dans les groupes de femmes. Nous n’avons trouvé 
aucune corrélation entre la DMG, la DMB, le liquide cérébro-spinal, le volume total du cerveau, 
les symptômes individuels et la schizophrénie chez les sujets féminins. Chez les hommes atteints 
de schizophrénie, on observe des corrélations négatives importantes entre les idées de grandeur et 
la DMB; des corrélations positives entre la désorientation et la DMB. De plus on observe des 
corrélations entre et les déficits d'attention et de DMG et DMB. Nos résultats montrent que ces 
associations sont différentes chez les hommes et les femmes atteints de la schizophrénie. 
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La symptomatologie de schizophrénie est un mélange de déficits cognitifs et socio-affectifs. Dans 
ce contexte, le but de notre troisième étude est d'étudier chez les patients atteints de la schizophrénie 
des DMG et DMB et leur relation avec l’acuité mnésique avec des contenus émotionnelles 
(négatives, positives et neutres) ainsi que étudier l'effet des différences de sexe sur nos résultats. 
Quarante et un patients droitiers, traités par antipsychotique, souffrant de schizophrénie (SZ) et 40 
témoins sains (NC), tous droitiers, ont participé à l’étude. Nous avons utilisé des images de 
l'International Affective Picture System (IAPS), une banque d'images émotionnelles, et de l’IRM. 
On observe chez les témoins sains des corrélations entre les valeurs élevées de DMG du cortex 
pariétal postérieur, du lentiform, du putamen, noyau caudé, le cortex orbitofrontal inférieur gauche 
et la reconnaissance des images négatives. On observe des corrélations entre la DMG dans la région 
temporale gauche, fusiforme et la reconnaissance des images positives ; et également dans le 
cervelet antérieur gauche et l’acuité des images neutres. Chez les patients on observe des valeurs 
élevées des DMG dans le cortex occipital inférieur gauche et la reconnaissance des images 
négatives, mais aucune corrélation entre la capacité de reconnaissance des images positives ou 
neutres. 
Nous avons observé chez les témoins sains: des relations significatives entre la DMB dans le cortex 
pariétal postcentral gauche et la capacité de reconnaître des images négatives; dans le cortex 
temporal inferieur gauche, le cortex pariétal gauche (précuneus), le cortex frontal gauche et la 
capacité de reconnaissance des images positives; des valeurs de DMB du cortex temporel médian 
et l’acuité des images neutres. 
Les patients atteints de schizophrénie ont montré des relations significatives entre de DMB dans le 
cortex occipito-lingual gauche et la reconnaissance des images négatives ; dans le cortex pariétal 
angulaire gauche et la reconnaissance des images positives ; et dans le cortex temporal supérieur 
droit et les images neutres. Les différences de sexe dans la schizophrénie ont été observées : chez 
les patients de sexe masculin, des corrélations négatives ont été trouvées entre les DMB et la 
capacité de reconnaître des images négatives et positives. Chez les hommes sains, nous avons 
trouvé des corrélations positives entre des valeurs totales de DMG et la capacité de reconnaître des 
images négatives. Nous n’avons pas observé de corrélations dans les groupes de femmes. Ces 
résultats soutiennent l'hypothèse de l'atrophie fronto-temporale régionale chez les patients 
schizophrènes. Toutefois, nous notons qu’ils ont des augmentations relatives des valeurs de DMB 
dans le cortex occipito-pariétal. 
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Nous avançons l'hypothèse que les déficits mnésiques chez les patients sont liés à des perturbations 
dans la coordination des réseaux cérébraux, ce qui peut être affecté par des déficits structuraux plus 
évidents chez les patients masculins. Par conséquent, nous préconisons que les futures études 
devraient utiliser le connectome ou l’approche « réseaux cérébraux » pour étudier l’impact du sexe 
(genre masculin-féminin) sur les déficits cognitifs et symptomatologiques dans la schizophrénie. 
Nos résultats globaux soulignent l'importance de la différence entre homme et femme dans la 
modulation de manifestations cliniques et fonctionnelles de la schizophrénie. Ainsi, nous croyons 
que le contrôle des covariables comme l'âge, la durée de la maladie et le statut social est insuffisant 
et que les études futures sur la schizophrénie devraient systématiquement séparer les hommes des 
femmes, afin de mieux  comprendre cette maladie mentale complexe et dévastatrice. 
 
Mots-clés: Schizophrénie, les différences de sexe, l'imagerie par résonance magnétique, les 
symptômes, les déficits cognitivo-affectifs, indice de gyrification, substance grise, la substance 
blanche. 
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Abstract 
 Advances in cerebral neuroimaging techniques have helped our understanding of mental 
illnesses, such as schizophrenia. Few findings remain consistent and are often contradictory, 
making it difficult to draw informative conclusions about the disease. Several factors play a role in 
both diverging and converging results. Imaging technique and analyses, number of patients 
involved, age of patients, age at onset of the disease, diagnostic criteria, antipsychotic treatment 
effects, social status, comorbidities, are among some of the reasons. Despite well established 
cerebral sex differences in healthy population, it is only in recent years that neuroimaging studies 
in schizophrenia have addressed sex differences as a major possible explanation for discrepant 
neuroimaging finding.  
The aim of this thesis is to help understand the role of sex on brain structures in 
schizophrenia, by conducting studies that control as much as possible for other variables and by 
using MRI automated analyses for patients and controls matched for age and sex. This work will 
briefly present findings in schizophrenia in general, and then an extensive review of the literature 
on sex differences in schizophrenia will be presented. From it, we are able to conclude that sex 
differences have been reported with rare exception in almost all aspects involved in the life of 
patients with schizophrenia.  
 
Chapters 
1. The first study investigated sex differences in cortical gyrification in schizophrenia patients 
(SZ). In addition, considering that schizophrenia is a disease of “clinical symptoms” that determine 
the quality of life of patients afflicted by it, we explored the relation between cortical gyrification 
and symptoms in males and females with schizophrenia. The role of sex on cortical gyrification 
and its association with symptoms has been scarcely investigated in patients with schizophrenia. 
In this study, 3T T1 images were acquired from 48 schizophrenia patients (24 males [SZ-M] and 
24 females [SZ-F]) and 48 normal controls [NC] (24 males [NC-M] and 24 females [NC-F]) 
matched for age, sex, and handedness. Gyrification Index (GI) analyses for each hemisphere and 
four cerebral regions (frontal, temporal, parietal, and occipital) were performed using the fully 
automated CIVET pipeline. Patients had significant lower values of the overall GI relative to 
normal controls and SZ-M had significant lower right hemispheric GI values compared to NC-M. 
This was not observed in either NC-F or in SZ. No gender difference in GI values decreases with 
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age were observed in NC. In patients, GI decreases with age were greater in SZ-M than SZ-F, with 
a more progressive deterioration in the right hemisphere in both patient groups. Significant GI 
value reductions in association with duration of illness were observed in SZ-M but not in SZ-F. 
Patient groups had lower GI in bilateral frontal, temporal, and parietal lobes than controls. SZ-F 
had significant lower GI values in left frontal, bilateral temporal and left parietal lobe compared to 
NC-F. No significant correlations were found between GI values and symptom scores in either 
group of patients. Since GI reflects, in part, alterations in cerebral development and connectivity, 
the decrease in GI observed in patients is in agreement with the neurodevelopmental model of 
disconnectivity in schizophrenia, and may explain the worse prognosis and social outcome 
observed in male patients. Furthermore, we emphasize the importance of age and duration of illness 
when comparing males and females with schizophrenia. Observed differences between male and 
female patients may reflect a more diffuse and generalized cortical loss in males. Female patients 
had cortical loss in specific regions, while preserving cortical gyrification in compensatory regions. 
Our latter finding -no significant correlation between GI values and symptom scores- was of 
particular interest and was unexpected in view of neuroimaging findings of correlations between 
positive symptoms and temporal lobe abnormalities. 
2.  In the second study, we examined the association between symptoms and brain structure 
using gray (GMD) and white matter (WMD) densities. Voxel-based morphometry (VBM8.0 with 
Diffeomorphic Anatomical Registration Through Exponentiated Lie Algebra [DARTEL]) and 
Automatic Linear Modeling (SPSS21.0 ALM) were used on 3T T1 MPRAGE images acquired 
from 40 schizophrenia patients (SZ) and 41 normal controls (NC). We found that SZ had lower 
GMD in the anterior cingulate cortex and left middle temporal gyrus, and higher GMD in the left 
posterior cingulate in comparison to NC. SZ had significantly lower WMD in the left inferior 
fronto-rectal and the left posterior parietal regions in comparison to NC. Significant positive 
correlations were found between positive symptoms and GMD in the left insula and right caudate, 
and between negative symptoms and GMD in the right middle frontal and the posterior lobe of the 
right cerebellum (uvula). Inverse relationships between GMD in the right parietal (precuneus), the 
left posterior lobe of the cerebellum (uvula) and positive symptoms, and between GMD in the left 
anterior lobe of the cerebellum and negative symptoms were observed in SZ. In addition, positive 
correlations were found between WMD in the right middle frontal lobe, and between positive 
symptoms and WMD in the right superior frontal region with negative symptoms. Negative 
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correlations were found between positive symptoms and WMD in the right inferior occipital and 
the right occipital cuneus, while negative symptoms correlated negatively with the WMD of the 
left superior frontal.  
 When symptom clusters were analyzed, conceptual disorganization symptom positively 
correlated with both total GMD and WMD. While increases in GMD were associated with 
decreased severity of lack of spontaneity and hallucinations symptom, increases in total WMD 
were associated with decreased severity of hostility and grandiosity symptoms. Comparison 
between male subjects revealed decreased GMD in male schizophrenia patients, while no 
differences were observed between females across groups. No correlations were found in female 
groups between GMD, WMD, CSF, or total brain volume and individual symptoms. In males with 
schizophrenia, significant negative correlation between ideas of grandiosity and WMD, a positive 
correlation between disorientation and WMD, and attention deficits and GMD and WMD were 
found. The current data suggest region-specific GMD and WMD association with negative and 
positive symptoms. In addition, it reveals that such associations are different in male and female 
schizophrenia patients.  
3. The third study investigated the relationships of GMD and WMD with memory accuracy 
for emotionally negative, positive, and neutral pictures in schizophrenia patients relative to normal 
controls. Schizophrenia is characterized by an amalgam of cognitivo-socio-emotional deficits. The 
relationship between emotion processing on cognition and neurobiological underpinnings merit 
more attention than it has received so far. Memory deficits are among the most common deficits in 
schizophrenia and have a widespread impact on cognition in general. Additionally, consistently 
with the major theme of the present thesis, we investigated the effect of gender on the observed 
effect. Forty one, right-handed medicated patients with schizophrenia (SZ) and 40 right-handed 
normal controls (NC) matched by age and sex were assessed for memory accuracy using negative, 
positive and neutral pictures taken from the International Affective Picture System (IAPS). 
Imaging methods and analyses were similar to our second study. Fifteen minutes after presentation 
of selected IAPS images (incidental encoding), subjects were asked to recognize the previously 
seen images among other images. We found higher GMD in NC in the right posterior parietal 
cortex, lentiform, putamen, and caudate, as well as the left inferior orbitofrontal cortex, in relation 
with the negative images accuracy. NC had higher GMD in the left temporal and fusiform regions 
in relation with the positive images accuracy, and higher GMD in the left anterior cerebellum in 
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relation with neutral images. Schizophrenia subjects had higher GMD in the left inferior occipital 
cortex in relation with the negative images accuracy, but GMD was not correlated with positive or 
neutral images accuracy in this group. WMDs correlations were higher in NC in the left postcentral 
parietal region for negative images; in the left inferior temporal, left precuneus parietal, and left 
frontal regions for positive images; and in the left middle temporal region for neutral images. 
Schizophrenia patients had higher WMD in the left lingual occipital for negative images; in the left 
angular parietal for positive images; and in the right superior temporal region for neutral images. 
While examining the two sexes separately, we observed inverse correlations between WMD and 
both negative and positive pictures in male patients. In addition, only in male controls, GMD 
positively correlated with negative pictures and this correlation was absent in female SZ subjects 
and NC females. These findings support the hypothesis of fronto-temporal regional atrophy in 
schizophrenia. Schizophrenia patients have relatively increased occipito-parietal WMD, advancing 
the hypothesis that the core pathophysiological problem underlying recall memory in SZ may be 
related to disruptive alterations in the coordination of large-scale brain networks, and this may be 
affected by structural deficits that are more evident in male patients. It is recommended that future 
studies should use the connectomes or the brain networks approach to investigate the effect of sex 
on memory deficits in schizophrenia. 
 Our overall findings point out to the importance of sex in modulating the clinical and 
functional manifestations of schizophrenia. We believe that controlling for covariates as age, 
duration of illness, social status, etc. is insufficient and that future studies in schizophrenia should 
systematically separate male and female findings, if we wish to understand this complex and 
devastating mental illness. 
 
Keywords: Schizophrenia, sex differences, magnetic resonance imaging, positive and negative 
symptoms, cognitivo-emotion deficits, gyrification index, voxel based morphometry, gray matter 
densities, white matter densities.
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1 Introduction 
 
1.1 History of schizophrenia 
 
 The term schizophrenia, which literally means “split mind or mind torn apart” was first used 
by Euegen Bleuler (1911). Bleuler defined schizophrenia as essentially a splitting of thoughts 
(cognition) from feelings (emotion). Bleuler considered symptoms such as loose associations, 
blunted affect, ambivalence, and autism as the core psychopathologies of the illness. Bleuler 
defined a set of basic symptoms considered to be unique to the disorder and present in all patients 
with the disorder. The pathogenesis and prognosis were considered to be variable where patients 
may present a stable, deteriorating, or improving clinical tableau after the first onset (1). Kraepelin 
(1919) used the term dementia praecox to describe schizophrenia; he believed it was a disease with 
a single etiology and a distinct pathogenesis (2). More specifically, Kraepelin described the disease 
as neurodegenerative with a dementia-like characteristics that started in adolescence or early 
adulthood. Symptoms described were catatonia, hebephrenia, and paranoid dementia. Positive 
symptomatology in schizophrenia was conceptualized by Schneider (1959) who described primary 
symptoms of schizophrenia like hallucinations as disease specific (3). Since then several authors 
have reported these symptoms in other somatic/physical (4, 5), neurological (6), genetic (7-9) and 
psychiatric pathologies (10). 
 
1.2  Overview 
 
Schizophrenia is a severe, chronic and complex psychiatric disorder characterized by a 
significant functional decline impacting cognitive, affective and social domains (11). Its 
complexity is reflected in the heterogeneous clinical presentation with symptoms ranging from 
hallucinations and delusions, disorganized speech and behavior, to flat affect, lack of motivation, 
and cognitive deficits linked to areas of attention, memory and executive functions (12, 13). In 
addition, schizophrenia heterogeneity is further complicated by the presence of important sex 
differences with respect to age at disease onset, symptomatology, medication responsiveness, 
prognosis, social outcomes, comorbidities, premorbid functioning, and structural brain 
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abnormalities (14-21). Schizophrenia typically manifests during late adolescence or early 
adulthood between the ages of 16 and 30 years. It usually has a progressive and insidious onset 
over several years. Approximately 10-15% of schizophrenia patients commit suicide (22, 23) and 
almost half of the patients will have attempted suicide during their lifetime (24-26). Mortality in 
schizophrenia population for all causes, has been shown to be two to threefold higher than in the 
normal population (27). 
Schizophrenia is characterized by a large array of symptoms that can be seen in other mental 
diseases. Symptoms are classified under three broad types: I- Positive symptoms (i.e., conceptual 
disorganization, delusional ideation, altered perceptual experiences as acoustic- verbal, tactile, and 
gustatory hallucinations, hostility, grandiosity, and paranoid ideation). II- Negative symptoms (i.e. 
blunted affect, emotional withdrawal, passive/apathetic social withdrawal, anhedonia, 
avolition/apathy, and poverty of speech). III- Cognitive symptoms (i.e. poor attention, lack of 
judgment and insight, unusual thought content, difficulties in abstract thinking, disorientation in 
time and space, alteration in the perception of self and one’s situation, and concentration and 
memory deficits. 
 Criterion-based systems have been developed to decrease the complexity and improve the 
reliability of diagnosis. These systems include the International Classification of Diseases, tenth 
edition (ICD-10) (1994), used mostly in European countries, the Diagnostic and Statistical Manual 
of Mental Disorders, fourth edition (DSM-IV) (1994), and more recently the Diagnostic and 
Statistical Manual of Mental Disorders, fifth edition (DSM-V) (2013) which describe characteristic 
symptoms of schizophrenia (28). The two systems have some fundamental differences (for details 
please see table Y) (29). The release of the DSM-V introduced two changes to DSM-IV Criterion 
A for schizophrenia: (1) bizarre delusions and special auditory hallucinations (Schneiderian first-
rank symptoms) are not considered as schizophrenia specific and (2) that the individual must have 
at least one of the core “positive symptoms”: delusions, hallucinations, and disorganized speech 
for a reliable diagnosis of schizophrenia. Both DSM-IV and V criteria require the presence of social 
and occupational dysfunction (30). Subtypes of schizophrenia were removed because of lack of 
diagnostic and course stability. Since the release of DSM-V several clinicians and researchers 
questioned, criticized, and debated the coherence of its criteria for schizophrenia (29, 31-34). 
Overall, diagnostic criteria improve reliability and improve clinical communication.  
Thèse de doctorat Adham Mancini Marïe August 2016 
 
 
3 
 The emphasis on psychotic symptoms (delusions and hallucinations) in the diagnosis of 
schizophrenia has overshadowed the importance of other symptoms that are less acute, particularly 
those symptoms that have a great negative impact on social and interpersonal relations. Symptoms 
of social and cognitive deterioration are usually present before and persist after remission of the 
acute phase of positive symptoms. Interestingly, a recent meta-analysis demonstrated that contrary 
to the current belief, negative symptoms were found to decrease in almost all schizophrenia 
outpatient samples (35). These findings suggest that negative symptoms may improve over time to 
a greater extent than what has previously been assumed (36-38). Blanchard & Cohen (2006) 
examined the structure of negative symptoms in schizophrenia and whether they represent an 
independent group of symptoms. They also investigated if negative symptoms are themselves 
subtyped. They consistently found across studies that negative symptoms seemed to be independent 
from positive, affective, depression, anxiety, or disorganization symptoms. Two separate clusters 
of negative symptoms were consistently identified in the literature: diminished expression and 
anhedonia-asociality (39). 
 The relation between negative symptoms (e.g. apathy, avolition, blunted affect) and loss of 
social and interpersonal abilities are now well documented in the literature (40, 41). Patients 
suffering from schizophrenia are typically unable to continue their education or maintain their 
employment (42). Tsang et al, (2010) found that cognitive functioning, negative symptoms, social, 
community, and mental health support were significant predictors of employment outcome Positive 
symptoms, substance abuse, gender and hospitalization history were found to be non-significant 
predictors (43). Negative symptoms may be the best symptomatic predictor of functioning in 
individuals with early psychosis is an important treatment target to improve remission (44, 45) 
 A cornerstone theory to explain schizophrenia symptoms is the ‘dopamine hypothesis’ (46) 
It was posited that positive symptoms were related to dopamine neuron overactivity in the 
mesolimbic pathway, and that the negative symptoms were related to underactivity of dopamine 
neurons in the prefrontal cortex (47-49). 
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1.3 Epidemiology of schizophrenia 
 
 Schizophrenia is a severe mental disease with a combined economic and social burden (50) 
ranking among the world’s top causes of disability in life-years (51, 52). Lifetime prevalence is 
between 0.7 and 1% worldwide (53-55). More recent studies suggest that the rate of 1% could be 
an overestimate and that arguably, the prevalence of the disorder is typically higher in developed 
than in developing countries, and higher in migrant groups than in native-born populations (56, 
57). Additionally, a higher prevalence of schizophrenia among lower socio-economic classes 
within communities has been steadily reported over the past century (58-60). Incidence, which 
represents the annual number of newly diagnosed patients in the population varies significantly in 
the literature (61, 62). McGrath and colleagues (2008) have reported that the median incidence of 
schizophrenia was 15.2/100,000 persons and that the central 80% of estimates varied significantly 
between 7.7 and 43/100,000 persons. In addition, the authors found urbanity, migration, and male 
gender to be associated with higher developing of the disorder. The changeability in incidence rates 
might be attributed to changes in diagnostic approaches (27). 
 
1.4 Etiology of schizophrenia 
 
 Factors that may play a role in the development of schizophrenia include , perinatal/prenatal 
viral infections (63, 64), obstetric complications, hypoxia at birth, Rh incompatibility, famine and 
malnutrition, severe environmental stresses, urbanity, winter births, and heritability as 
demonstrated by twin and adoption studies. To date the etiology of schizophrenia remains unclear. 
Several theories on the origin of schizophrenia have been proposed. One central hypothesis is the 
neurodevelopmental theory, which posits that neurodevelopmental changes in utero through young 
adulthood play a role (65-70). Neurodevelopmental factors are influenced by the combined impact 
of genetics and prenatal events triggering pathological processes during adolescence (71-73). The 
mechanism by which these factors lead to schizophrenia remains unknown. Neurodevelopmental 
anomalies during uterine development in the 1st and 2nd trimesters have been proposed to result in 
pathological neural circuitry during critical development in adolescence (74) especially if the 
adolescent is exposed to stress or abused drugs (65, 71, 75-80). 
Thèse de doctorat Adham Mancini Marïe August 2016 
 
 
5 
 Recent advances in neuroimaging, genetics, and neuropharmacology have indicted the 
pivotal role played by abnormalities in key neurotransmitters (i.e. dopamine, serotonin, glutamate, 
GABA, acetylcholine, and noradrenaline) in development of schizophrenia (81-91). 
 The risk of developing schizophrenia is considerably higher in individuals with an affected 
family member. This risk increases with the degree of genetic proximity: it is higher in persons 
with first-degree relative with the disorder (92, 93). Twin and adoption studies of schizophrenia 
consistently show higher concordance rates in monozygotic of approximately 50 to 80% in 
comparison with approximately 17% in dizygotic twins(94-99). Approximately 20 to 50% of 
monozygotic twins are discordant for schizophrenia, suggesting a role for the environmental factors 
(100, 101). There is little evidence available to isolate one specific or group of genes in 
schizophrenia (60), although it is likely to be a polygenic/multifactorial disease (60, 102, 103). 
Additionally, both pre- and perinatal complications (e.g. maternal influenza, fetal hypoxia), 
comorbidities as obsessive-compulsive disorder and other environmental elements (e.g. season of 
birth, cannabis use) have been linked to a substantial increase in risk for schizophrenia (60, 104-
108). Lastly, subjects with a family history of schizophrenia were found to have a lower average 
age at onset (109) 
 
1.5 Cognition in schizophrenia 
 
Schizophrenia was a term created by Bleuler in 1911 to characterize the fragmentation and 
disintegration of the mind and behavior of this disorder (1). Since then, research has intensively 
investigated the splitting of thoughts, feelings, and actions in schizophrenia (110-114). 
Specifically, studies have addressed how and why these functions are dissociated (115-117). 
Despite the robust evidence for the influence of emotion on cognition and vice versa, the nature of 
these interactions and their role in psychotic symptoms are not yet clearly understood (118-120).  
A meta-analysis by Reichenberg (2010) revealed that schizophrenia patients manifest a 
wide range of cognitive deficits, including reduced capacity in executive function, declarative 
memory, and processing speed. Other cognitive deficits encompass working memory, motor speed, 
language and perception deficits (121). Chronic schizophrenia patients have disturbances in both 
selective attention and maintaining attention (122-124). Neuroimaging studies show that these 
deficits are associated with a diminished activation in superior temporal and frontal gyri, cingulate, 
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thalamus, and basal ganglia. Abnormal activation correlated with positive and negative symptoms 
(125). Increased activation in other prefrontal areas in patients is thought to be compensatory (126). 
A meta-analyses by Fioravanti et al., (2012) reported that executive functions are severely 
affected in patients with schizophrenia (127). Functional neuroimaging studies on executive 
function show that schizophrenia patients activate a similar neural network when compared with 
healthy subjects; however, patients had altered activity with deficits in the dorsolateral prefrontal 
cortex, anterior cingulate and mediodorsal nucleus of the thalamus. 
Memory deficits are among the most common deficits in schizophrenia with widespread 
impacts on other cognitive problems, ranging from attentional and visuo-spatial deficits to 
problems in higher cognitive functions such as reasoning, planning and problem solving (124, 128-
137). Deficits in working memory have been associated with hypoactivation in the medial temporal 
lobe (137). A meta-analysis of episodic memory in patients with schizophrenia showed a robust 
pattern of decreased cerebral activations in the prefrontal cortex, cerebellum and temporal regions 
(138). Temporal lobe neuroanatomical abnormalities, contributing to memory deficits, observed in 
structural neuroimaging studies remain among the most robust findings (139-142). 
Overall, memory impairments in schizophrenia are considered to be core endophenotypes 
because they are common, are relatively stable across the course of the illness, are present 
regardless of psychotic symptoms, and are found to a lesser degree in unaffected relatives (143). 
 
1.6 Emotion in schizophrenia 
 
 Affective deficits are characteristics of schizophrenia and can be summarized in three 
general domains: perception, expression, and experiencing of emotions (144-154). Habel et al., 
(2000) assessed discrimination and experience of emotion (mood induction) in three different 
ethnic groups of patients with schizophrenia (American, German, and Indian) using happy, sad, 
and neutral facial expressions of Caucasian actors. Face discrimination performance was impaired 
across the three patient groups in comparison with healthy controls. This finding is consistent with 
the literature on schizophrenia features being stable across cultures (155, 156). A recent meta-
analysis by Barkl and colleagues (2014), found that deficits in facial emotion identification were 
already present in patients at the onset of psychosis, and that emotion identification impairment 
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represents a trait susceptibility marker, rather than a consequence of the disease (144). Impairments 
in perception of facial emotions vary from moderate to severe in schizophrenia (146), and appear 
to be influenced by clinical and demographic factors (151). Collectively, these studies provide 
substantial support for a socio-emotional deficit in schizophrenia (147, 149, 157-162). 
Disturbances in socio-emotional cognition observed in patients with schizophrenia may represent 
an abnormal interaction between frontal lobe and its functionally connected cortical and subcortical 
areas (163). Significant variations in deficits are not explained by age, education, or gender. 
Severity of clinical symptoms and duration of illness were associated with greater deficits in 
emotion processing (164). 
Inconsistent findings of emotional valence and arousal deficits are reported in schizophrenia 
patients. Patients with anhedonia show deficits in valence but not in arousal compared to controls. 
Reduced valence experience was associated with increased degree of anhedonia in patients and 
controls (165). Schizophrenia patients with flat affect seemed to rate emotional valence similarly 
to healthy controls however they have reduced neural activity in the anterior cingulate, right 
parahippocampal gyrus and multiple visual areas (166). Foucher et al, (2011) showed that coupling 
arousal with cognitive tasks improve cerebral activity in hypoactive regions in patients with 
schizophrenia (167). In healthy population, a weak but consistent V-shaped relation between 
arousal and valence was reported. This relation showed a large variation at the individual level 
depending on person or circumstances (Kuppens et al., 2013). 
Many studies have identified structural and functional abnormalities in the medial 
prefrontal cortex, orbitofrontal and anterior cingulate gyrus regions pivotal to the regulation of 
affective states and emotional behavior in schizophrenia (168). Additionally, abnormalities of the 
amygdala have been reported during processing of emotions in patients with schizophrenia (153). 
Gur and colleagues (2004) (169) found that schizophrenia patients had no activation of the limbic 
regions during emotional valence discrimination tasks. Conversely, a study by Kosaka et al., (2002) 
found that schizophrenia patients activated their amygdala bilaterally during negative face 
discrimination tasks in comparison to healthy controls who activated the right amygdala alone 
(170). Interestingly, studies comparing subgroups of schizophrenia patients show varying degrees 
of emotional impairments (108, 171-184). Impairment in emotional functioning is closely 
associated with to poor clinical and social outcomes including unemployment, social dysfunction, 
Thèse de doctorat Adham Mancini Marïe August 2016 
 
 
8 
and worse prognosis (42, 185-188).Cognitive and affective deficits in schizophrenia have been 
associated with altered multisensory integration also termed perceptual incoherence (189). Postmes 
et al., (2014) theorize that perceptual incoherence in schizophrenia may evoke incoherent self-
experiences including depersonalization, ambivalence, diminished sense of agency, and 'loosening 
of associations' between thoughts, feelings and actions. Thus patients with schizophrenia are unable 
to apprehend the world in holistic manner or to experience the unity of his/her self, thoughts and 
feelings (190) 
1.7 Pathogenesis of schizophrenia 
 
 The combined effects of gene and environment have been associated with brain 
morphometric abnormalities in schizophrenia. These abnormalities are suggestive of alterations in 
synaptic, dendritic, and axonal organization, resulting in abnormalities in connectivity between 
cerebral neural circuitry (141, 191-198). Environmental and developmental processes further 
impact these abnormalities (22, 77, 199). 
It has been postulated that schizophrenia is a result of disturbances in the later phases of 
cerebral cortical development especially in the last phases of neuronal migration and pruning of 
cortical connections (e.g. Jones, EG, 1995, 1997)(200, 201). A disturbance of migration or 
preprogrammed pruning in the white matter immediately below layer VI of the cortex causing a 
failure to establish normal patterns of connections in the overlying cortex was proposed as an 
explanation. This vulnerable circuitry is associated with altered gene expression for 
neurotransmitter and receptor-related molecules, which in turn could lead to schizophrenia (200, 
201). Based on studies showing altered neuronal density, Selemon and Goldman-Rakic (1999) 
proposed that reduction in prefrontal cortex interneuronal neuropil compromised cell structure, and 
impoverished neuronal connectivity caused deficits in functional communication between neurons. 
They reported that the increased neuronal density seen on histological examination as reduced 
neuropil without neuronal loss, indicated a subtle loss of connections between neurons with 
devastating consequences on cortical function in patients with schizophrenia (202). Andreasen et 
al., (1998) proposed a connectivity model in schizophrenia that leads to what the authors termed 
cognitive dysmetria. This model implicates dysfunction of the cortico-cerebellar-thalamic-cortical 
circuit (CCTCC) connectivity in schizophrenia (203). 
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McGlashan and Hoffman (2000) proposed that schizophrenia resulted from 
developmentally reduced synaptic connectivity (DRSC). The model suggests that schizophrenia 
arises from critically reduced synaptic connectedness because of developmental disturbances of 
synaptogenesis during gestation and early childhood and/or synaptic pruning during adolescence. 
The DRSC model describes reduced synaptic density in prefrontal and other areas of association 
cortex as the “final common pathway” to the symptoms and course of schizophrenia (198). Buckley 
et al., (2007) found that disturbances in brain-derived neurotrophic factor (BDNF) and nerve 
growth factor (NFG) might contribute to the pathogenesis of schizophrenia. These disturbances 
were found in first-episode patients. The preceding findings point to the presence of altered 
connectivity patterns in schizophrenia. These alterations may manifest as micro (i.e. the 
synaptic/neural level) or macro (i.e. white matter wiring/cabling level) circuit anomalies (204). 
 
1.8 Treatment of schizophrenia 
 
Schizophrenia remains an incurable mental illness partly due to the heterogeneity of 
symptoms and the limited efficacy of current treatments (205-209). Existing treatments aim at 
managing the symptoms in their acute phase and attaining a clinical stability over time using 
multidisciplinary approaches such as medication, cognitive remediation, individual and group 
psychotherapy, social enforcement and integration, appropriate housing, adapted employment and 
financial aid, and supportive family education (210). These approaches are recommended 
guidelines in North America by The Schizophrenia Patient Outcomes Research Team (PORT) 
(2009) and The National Institute for Health and Care Excellence (NICE) in UK (2009). 
 In general, typical antipsychotics, also termed first generation antipsychotic drugs have 
been shown to be effective in improving positive symptoms and in decreasing relapses of 
schizophrenia, while having little therapeutic effects on negative symptoms, mood symptoms and 
cognitive deficits (11, 211-215). Atypical antipsychotics are characterized by fewer extrapyramidal 
side-effects (i.e. pseudo Parkinson’s-like symptoms), better efficacy in treatment of negative 
symptoms, fewer prolactin disturbances, and additional benefits on cognitive deficits (216). It 
should be noted however, that recent data regarding efficacy of atypical versus typical 
antipsychotics does not support the greater benefit of atypicals for management of negative 
symptoms or for cognitive amelioration (217-222). Clozapine, an atypical antipsychotic, has also 
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shown more efficacy in some non-respondent patients (223-227). A multicenter randomized double 
blind controlled study demonstrated that olanzapine had the lowest rates of discontinuation and 
was most strongly associated with metabolic syndrome and weight gain. The efficacy of the first 
generation antipsychotic perphenazine appears similar to that of the second generation 
antipsychotics quetiapine, risperidone, and ziprasidone (219, 228-231). Observational and 
naturalistic studies report that: patients treated with olanzapine and clozapine had somewhat better 
outcomes than patients treated with other atypical or typical antipsychotics in terms of response, 
relapse, remission and treatment discontinuation. Additionally, atypical antipsychotics had also a 
lower frequency of extrapyramidal symptoms and anticholinergic use compared to typical 
antipsychotics (e.g. haloperidol, flupenthixol, fluphenazine, perazin and zuclopenthixol). Weight 
gain was associated with all antipsychotics, however it was greater with olanzapine and clozapine 
(229). 
 Other treatment interventions are gaining momentum in the management of schizophrenia, 
including cognitive training, psychoeducation, social skills training, cognitive behavior therapy and 
cognitive remediation therapy (232-248) The lack of consensus on assessment methods of efficacy 
of alternative therapies, such as cognitive behavioral and remediation therapy remains problematic 
(249). Cognitive remediation therapy show a neurobiological enhancing effect in patients with 
schizophrenia by increasing activations in several cerebral regions, specifically the frontal. 
Improved working memory and executive tasks in these patients was suggested to be in relation 
with post therapeutic neuroplasticity (250, 251). FMRI and PET studies comparing pre to post 
cognitive remediation therapy found increased brain activation in the frontal and parietal lobes, 
including the left medial frontal gyrus, the left inferior frontal gyrus, the right middle frontal gyrus, 
the right postcentral gyrus, and the inferior parietal lobule in patients with schizophrenia after 
therapy. Increased brain activity in medial and middle frontal gyrus in patients after therapy was 
related to the improvement in working memory performance (251). Cognitive remediation therapy 
has a significant association with improvement of psychosis symptoms and these effects remain at 
follow-up (252). Combined approaches using both computerized cognitive training and group 
therapy in schizophrenia patients show significant improvements in verbal memory and in 
symptom intensity (253). Cognitive training programs have shown little or non-significant effects 
on positive and negative symptoms in schizophrenia (254). Psychoeducation has been reported to 
reduce relapse and length of hospital stay. Additionally, it encourages medication compliance 
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(232). Cognitive behavior therapy has beneficial effect on positive symptoms (255). Additionally, 
it may attenuate brain responses to threatening stimuli and thus mediate symptom reduction in 
patients with schizophrenia (256). More evidence is needed to support other approaches such as 
social skills training (257). 
Recently, consensus about the combination of pharmacological and psychosocial/cognitive 
therapies having more benefits for schizophrenia patients than one or the other individually has 
been reached (258, 259). 
  
1.9 Neuroimaging findings 
 
 One of the most robust neuroanatomical findings in schizophrenia is enlargement of 
ventricles and related decreases in total brain volume and in cortical and subcortical tissue, which 
appear to be particularly pronounced in the prefrontal cortex, superior temporal cortex and 
hippocampal formation (260-264). 
 Schizophrenia is thought to be underpinned by neurodevelopmental abnormalities of brain 
gray matter and white matter function, structure and connectivity (191, 192, 265-268). Numerous 
brain regions have been implicated in the pathophysiology of this genetically and behaviorally 
complex disorder, suggesting that schizophrenia is not caused by any focal brain abnormality, but 
results from disturbed interactions between brain regions. In this regard, Friston and Frith (1995) 
have advanced that the core pathology of schizophrenia is an impaired neuromodulation of synaptic 
plasticity, leading to abnormal functional integration of neural systems (269). 
Research evidence repeatedly demonstrated functional and structural alterations in cerebral 
gray matter (GM) and white matter (WM) in schizophrenia, particularly in the prefrontal cortex 
(including the anterior cingulate), the superior temporal gyrus, the limbic system (medial temporal 
lobe, hippocampus, entorhinal cortex, amygdala) as well as in the striatum, the insula, the thalamus 
and the cerebellum (50, 270-280).  
Imaging studies demonstrate a large spectrum of inconsistent alterations associated with 
schizophrenia symptoms. GM losses in the orbitofrontal, medial prefrontal, lateral prefrontal and 
temporal cortices, thalamus, as well as limbic and subcortical structures were associated with 
negative symptoms. Conversely, positive symptoms were linked to the perisylvian regions and 
extended thalamic, superior temporal cortex GM losses. GM reductions in the temporal, insular 
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and medial prefrontal cortices, medial temporal and cerebellar regions was correlated with 
disorganized symptoms  
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2 Sex differences in schizophrenia 
2.1 Epidemiology 
 
 Sex differences in schizophrenia have been reported in almost all facets of the disease: onset 
and course of the illness, clinical manifestation, treatment response, side effects of medication, 
cognitive and emotion deficits, social outcome, prognosis, comorbidities, genetics, in addition to 
cerebro-functional and morphological differences. Lewine’s hypothesis stating the presence of sex 
differences in schizophrenia has been tested (281-285). A recent review of the literature by Van 
der werf and colleagues (2014) reported that overall males had a 1.15-fold greater risk of 
schizophrenia than females. Specifically, males had higher risk up until the age of 39, while females 
had higher risks between the ages of 50-70 (286). In addition, females had two incidence peaks of 
age, the first between 20 and 29 years, the second between 30 and 39 years; compared to males 
who had one incidence peak between the ages of 20-29 years. These finding suggest that sex 
differences are present in both incidence and risk of schizophrenia (27, 287). Okkels et al., (2013) 
found similar findings in a recent study on early onset schizophrenia; however, they report that 
higher male incidence than females in the periods 1971-1993 and 1971-2010. In the period 1994-
2010 incidence rates were higher for females than males. They propose that changes in the 
diagnostic tools in recent years account for this finding (288). Anderson (2013) argued that, these 
time-periods coincided with a change in availability of data, with data from outpatient services 
only available in the latter time-period. These additional data may have partially contributed to the 
observed increase in incidence, and may have led to the narrowing of the sex differential, as males 
are more likely to be treated in an in-patient setting than females (289). Vanasse et al., (2012) 
conducted a population-based cohort study in Quebec using a population health services database 
between January 1996 and December 2006. They found that males were diagnosed at early ages 
while diagnosis in females was distributed in a uniform manner over age (290). This difference in 
prevalence was not reported in other studies (27, 291-293). In contrast, few studies have found 
higher incidences in females or no significant gender differences (294, 295) and no sex difference 
in terms of rates of mortality (26, 27). 
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2.2 Age of onset 
 
 Earlier age of onset in males compared to females is one of the most consistent finding in 
schizophrenia and later onset schizophrenia is reported in females (283, 286, 296-307). Meesters 
et al., (2012) performed a study on 100 males and 100 females unequivocally meeting DSM-III 
criteria for schizophrenia. The mean age at onset was about five years younger in males than in 
females. Approximately 9/10 males were diagnosed with schizophrenia before the age of 30 
compared to only 2/3 of females. Late onset after the age of 35 years occurred in 17% of females 
and in only 2% of males (308). Several studies show that males usually develop the illness at age 
18–25, while in females, the mean age of onset is 25–35 (301, 303). Similar to finding by Van der 
werf and colleagues (2014), females were found to have two periods during their life in which they 
may manifest a first onset: after menarche and after 40 years old (286, 291, 299, 300, 309, 310). 
These findings have also been replicated in first episode psychosis patients (311-313). Hafner et 
al., (1993), found that females at first onset were 3.2 to 4.1 years older than males (310). This sex 
difference disappears in the presence of family history (109, 299, 314).  
Reduced estrogens after menopause may explain the increased prevalence in females over 
40 (310, 315). In contrast, studies showing no sex difference in the age of onset were explained by 
the use of diagnostic criteria of DSM-III limiting the age to 45 and/or positive family history 
influencing the age of onset in both males and females equally (301, 305, 309, 310, 316-321). 
Several reports have found that even though age of onset is significantly earlier in males, no sex 
differences in the time from onset of symptoms to first hospitalization were found, suggesting that 
age of onset is related to biological rather than psychosocial factors (299, 322-324). 
 
2.3 Premorbid history 
 
 Retrospective studies of patients and follow-up data of females with schizophrenia and their 
children show great premorbid deficits and more pronounced decline in males than females on 
several aspects of the illness. (303, 313, 325-335). 
 Males are more frequently diagnosed with substance abuse and antisocial behavior than 
females, while females have superior family and occupational function and superior clinical 
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responses (326). Males with schizophrenia have poorer premorbid functioning and more rapid 
deterioration than females especially when closer to the disease onset. Additionally male have 
significantly longer duration of untreated psychosis (DUP). Poor premorbid function was related 
to a more insidious onset and presence of negative symptoms, especially among males. Positive 
symptoms do not necessarily precede the onset (313). Males appear to have more severe negative 
symptoms and lower functioning than females and these differences are stable overtime (336). 
Poorer premorbid social adjustment is more common in male patients with primary persisting 
negative symptoms.(337). Males exhibit more severe premorbid impairment than females, however 
no sex differences were found in the decline of academic adjustment. Social dysfunctioning is 
spared in females until late adolescence (332, 338, 339). Several authors have suggested that these 
differences are due to the neuroprotective effects of estrogen (339-341) which might explain other 
sex differences, such as older age of onset, milder negative symptoms, and better response to 
antipsychotics (325, 342, 343). 
 Subgroups of patients with a good prognosis were characterized by: female sex, absence of 
premorbid deviant behavior and a high education level at first admission (344). These findings are 
consistent with findings that females with schizophrenia are more likely to be married and to have 
started a family at the time of first hospitalization compared to males schizophrenia (345). Males 
were reported to be more socially isolated, withdrawn, more likely to be single, have lower levels 
of education and work capacities (328, 346). It is suggested that enhanced premorbid functioning 
in females is due to later onset allowing them to complete their education, form personal 
relationships, marry and work before the manifestation of the illness (42, 301, 347). For example, 
Skokou and Gourzis (2014) found that earlier onset patients were characterized by significantly 
more single status, more avoidant premorbid personality disorder traits, and less passive-aggressive 
premorbid personality disorder traits, than late onset patients. Additionally, earlier age of onset 
seems to be associated with increased social inhibition and worse psychosocial adaptation in the 
premorbid period of paranoid schizophrenia (347). Males presented more schizoid-schizotypal 
traits before the first onset (348). 
In summary, most studies show that females have better premorbid functioning than males 
(301, 313, 329, 344, 349-351). Few studies have reported no sex differences in premorbid function 
specifically at early stages of schizophrenia (352, 353). Worse premorbid functioning depended on 
age of onset and the presence of negative symptoms (352). 
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2.4 Birth complications 
 
Obstetric complications (OCs) have been reported to appear more frequently in patients 
with schizophrenia relative to the general population. For example, O'Callaghan et al., (1992) 
reported that OCs were significantly more likely in patients with schizophrenia than in controls, in 
terms of number and severity. These finding were more significant in males that in females with 
schizophrenia, and were associated with a younger age at onset of their disease (354). These finding 
were also consistent with a subsequent study by Byrne et al., (2000) where males with earlier onset 
(before the age of 30) had a greater frequency and more severe OCs than the matched control group 
(355). In the same vein, Preti et al., (2000) found that severe obstetric complications were noted 
more often among males (41%) than among females (15%) (356). In addition, early-onset males 
were found to present more labor and delivery complications relative to controls and to female 
patients (357). The risk of schizophrenia following OCs was higher in males than in females, and 
OCs were more frequently associated with an early age at onset of schizophrenia in males (358-
364). 
The evidence that OCs increase the risk of subsequently developing schizophrenia is 
compelling, but we are still unclear about the antecedents of these OC. One hypothesis proposes 
that at least some OCs stem from the prenatal exposure to influenza. Thus, lower birth weight in 
patients with schizophrenia has been associated with exposure to influenza virus during the second 
trimester; patients’ mothers were five times more likely to experience at least one definite OC in 
these cases (365-370). Nevertheless, the exact mechanism implicated in the relation between 
influenza, birth weight, and schizophrenia remains unclear (371). In addition to influenza, some 
authors propose that the maternal inflammatory response may be associated with fetal brain injury 
(372, 373). Others propose a maternal-fetal chronobiological dysfunction hypothesis to explain the 
relation between birth seasonality and schizophrenia, i.e. seasonal lack of sunlight is related to 
several thermo-chemical disturbances during the prenatal stage, that in turn affects the 
dopaminergic system in the fetal brain (hippocampus and striatum), leading to later development 
of schizophrenia (369, 374). Additionally, viral infections up to age 14 years were associated with 
higher risk of schizophrenia specifically in males (375). Some previous studies have reported that 
females exposed to influenza virus prenatally were more susceptible to developing schizophrenia 
than affective psychosis, however this relation was not observed in males, and the ratio of female: 
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male with schizophrenia increased with influenza exposure during the 5 months prior to birth (370, 
376-378). Finally, maternal age at birth seems to plays a role in subsequent development of 
schizophrenia. A significant increase in risk of schizophrenia in males was related to mothers older 
than 39 years, and conversely in females with mothers younger than 19 years at the time of birth 
(358). Overall, despite the fact that numerous studies have investigated the relationship between 
OCs and schizophrenia, the findings remain somewhat inconsistent, mainly because of the 
variability of the reported birth complications, retrospective limitations, and small sample sizes 
(379). 
 
2.5 Psychosocial factors 
 
Psycho-socio-cultural factors play an important role in the perception and social outcomes 
of schizophrenia. Attempts to understand the implication of psycho-socio-cultural factors on 
schizophrenia patients’ identity and role remain largely insufficient, specifically in relation with 
sex differences. Le Torre (1976) proposed gender identity and/or role problems as leading stressors 
in the diathesis-stress theory of schizophrenia, and that it is the only theory that accounts for the 
early onset of schizophrenia (380). 
 The role of each person is typically determined by her/his biological sex and depends on 
the cultural norms of each society. The use of the term “gender” interchangeably with term “sex” 
is a cause of important confusion. While “sex” refers to the biological and physical characteristics, 
“gender” on the other hand refers to masculine or feminine traits, behaviors, or beliefs as a psycho-
socio-cultural attribution. Lewine (2004) found that sex, but not gender, was a significant predictor 
of age at first hospitalization, even when controlling for illness severity, Both sex and gender 
significantly contributed to the prediction of neuropsychological performance, beyond the 
contributions of education, age, and illness severity. (281). 
A separate study examined sex and gender effects on seven domains of neuropsychological 
functioning in schizophrenia/schizoaffective patients and healthy individuals (284). The authors 
found main effects of sex on two neuropsychological domains and main effects of gender on five 
neuropsychological domains. Interestingly, executive functioning was unaffected by sex or gender, 
supporting its role as a behavioral marker of schizophrenia. Sajatovic et al., (2005), hypothesized 
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that subjectively, gender may affect the experience of illness in patients with schizophrenia in a 
way that may influence treatment and recovery, and that males and females with schizophrenia 
would have less identification with their traditional gender role characteristics. Their findings 
reveal that patients with schizophrenia experience their gender identity differently from what is 
expected by cultural norms. Both males and females with schizophrenia had lower masculine and 
feminine descriptive measures respectively in comparison to healthy controls. This has important 
implications on clinical recovery, as female patients tend to accept assistance from their families, 
a factor that improves schizophrenia outcomes; dependence on family is more gender-role-
appropriate for females (381). The onset of schizophrenia typically occurs during late adolescence 
or young adulthood, coinciding with the period during which multiple levels of identity 
development normally occur. Because males may often develop the illness earlier in life compared 
with females, effects on gender identity among males with schizophrenia may be more profound 
than those among females (381). Several studies reported reversed gender role and identity in 
patients with schizophrenia (382-384). 
 Parrott and Lewine (2005) reported that higher parental socioeconomic status is associated 
with decreased symptom severity in female patients, but with increased symptom severity and 
decreased global functioning in males (385). This suggests that females from higher socioeconomic 
backgrounds are under less stress, and exhibit fewer and less severe symptoms of schizophrenia 
than those from lower socioeconomic standing. In contrast, in male patients, the higher the parental 
socioeconomic status, the more severely ill the patient is as judged by age at first hospital 
admission, symptoms, and global functioning. It seems that higher social status of origin may serve 
as a significant source of stress for males predisposed to schizophrenia. Males with schizophrenia 
from higher socioeconomic status face higher job expectations and greater stress due to difficulty 
fulfilling their high vocational expectations, while higher socioeconomic status appears to be a 
source of support for predisposed females. Similarly, Leung and Chue (2000), reported that 
families of males with schizophrenia were more critical, and expressed more emotion, and this had 
a greater negative impact on males in comparison to female patients (301). The most robust 
findings have been that males who presented an earlier onset of the disease were much less likely 
to be or had been married. In terms of social functioning, males with schizophrenia fared worse 
than females in several domains including self-care, daily activity, and work performance. The 
negative syndrome was correlated with greater role impairment, regardless of sex. Only females 
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presented a positive correlation positive symptoms and social role performance (386). Overall, 
psychosocial implications in schizophrenia remain relatively unexplored. A majority of studies 
show better social functioning in females with schizophrenia in comparison to males, but the issue 
of gender merits further investigation (387). 
 
2.6 Clinical expression 
 
 The presence of negative symptoms in males with schizophrenia compared to females is a 
consistent finding in the literature, and is typically twice as severe in males than in females (338, 
388-396). Schizophrenia first presents with negative symptoms in 70% of cases, occurring two to 
six years before admission (309). Andreasen et al., (1990), found that schizophrenia patients with 
positive symptoms were mostly female, while patients who presented mixed and negative 
symptoms were predominantly males (89%) (389). Similarly Fenton & McGlashan (1991), found 
that male patients accounted for 60% of patients with high negative symptoms and female patients 
for 56% of those with low negative symptoms (388). Interestingly, no sex differences were found 
in positive or negative symptoms at hospital admission, however at follow-up, males had 
significantly more flat affect and anhedonia compared to female patients (36). Mayer et al., (1993) 
performed a retrospective study evaluating symptoms at admission and at discharge in patients 
with schizophrenia during the first manifestation of symptoms (397). Males were more apathetic 
at admission and discharge than females, and had higher depressive and psycho-organic syndrome 
scores at discharge. 
 Positive symptoms, have often been found equally in males and females with schizophrenia 
(398-401), more frequent in males (402) or more frequent in females (389, 403-409) who present 
more often affective symptoms, such as behavioral and sexual disinhibition, impulsivity, and other 
atypical psychotic symptoms (399, 403, 408). While negative symptoms seem to appear two to six 
years before admission, positive symptoms appear up to two years before (309). Marneros (1984) 
investigated the frequency of first rank symptoms (FRS) among schizophrenia patients at first 
hospitalization; females presented more thought insertion and hallucination symptoms relative to 
males who had other delusions of being influenced. Furthermore, females had more FRS at first 
hospitalization compared to males. Contrary to findings on the severity of negative symptoms in 
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males, no significant sex differences were found in the severity of positive symptoms (390, 407). 
In terms of frequency of positive symptoms, Morgan et al., (2008) investigated lifetime and current 
symptom profiles in males and females with schizophrenia. Their findings show that females were 
significantly less likely than males to report having hallucinations, delusions or poor concentration 
currently and more likely to report at least one serious episode of dysphoria over a lifetime (393).  
In accordance to previous findings in the literature, Beratis et al., (1994) have found that 
mean age at onset was significantly higher in all female patients compared to males; this was 
especially true for the paranoid subtype (410). These findings were consistent with a subsequent 
report in Finnish schizophrenia patients who presented no sex differences in age of first admission, 
except for the paranoid schizophrenia where males had a significantly younger age at onset. In 
addition, females diagnosed with paranoid schizophrenia seemed to manifest the illness at an older 
age than males and females with other subtypes of schizophrenia (411). Other subtypes, such as 
disorganized schizophrenia have been shown in a few rare studies to appear earlier in females 
(410). The stability of positive and negative symptoms has been also shown to be affected by the 
sex of patients. Mancevski and colleagues (2007) reported significant decreases in positive 
symptoms and increases in negative symptoms over the course of the illness which was particularly 
pronounces in males.(412). 
Very few studies have addressed sex differences and subjective experiences of illness in 
schizophrenia. Thornicroft et al., (2002) found that males expressed more total needs and more 
unmet needs for 'accommodation', 'substance misuse', 'psychotic symptoms', 'harm to others', and 
'sexual expression. In contrast, females expressed more total needs and more unmet needs in the 
domains of 'childcare' and 'harm to self' (413). Males seem to have a greater biological vulnerability 
to worse symptoms, consequent social disability in the face of psychosis and poorer prognosis, 
while females have either a biological or a psychosocial resilience to the illness (390). 
Several hypotheses have been offered to explain sex differences in symptom presentation 
in schizophrenia. One of the most widely accepted is the estrogen neuro-protective hypothesis, 
where estrogens, directly or indirectly, modulate symptom expression in males and females with 
schizophrenia. Organizational and activational effects have been attributed to sex hormones. 
Organizational effects occur in the brain during the prenatal fetal phase and are fixed, while 
activational effects fluctuate depending on the level of circulating hormones (311, 312, 315, 414-
421). Seeman and Lang (1990) put forward several arguments in favor of the estrogen neuro-
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protective hypothesis: The modulatory relation between the dopaminergic system and estrogens, 
delayed onset of illness of 4-6 years in females, males exhibiting one main peak of schizophrenia 
onset in their late teens and early twenties, females having an additional onset peak at age 40 to 45 
years when estrogen levels decrease, less debilitating symptoms in females during the first decade 
following onset that thereafter approximates that of males particularly after menopause, lower 
doses of antipsychotic treatment effective premenopausally perhaps due to the potentiating effect 
of the antidopaminergic action of estrogen, and higher doses needed postmenopausally (417). 
Rendering further support to this hypothesis is the effectiveness of estrogen therapy in improving 
symptoms of schizophrenia (422, 423), the observed worsening of symptoms when estrogen levels 
drop sharply after pregnancy or during the follicular phase of the menstrual cycle (424, 425), and 
symptom improvement in females with schizophrenia during mid-luteal phase when estrogen 
levels are higher (426-429). 
 
2.7 Course of illness  
 
The course of illness is bound with the outcome. The term “outcome” refers to several 
domains in the life of a patient that go beyond the symptoms of the disease and considers the patient 
in a holistic manner. It includes quality of life, daily activities, severity of medication side effects, 
global functioning, employment, etc. (430-432). Morgan et al., (2008) investigated sex differences 
in outcomes and found that females were significantly more likely to be in long-term relationships 
and to have children, had better premorbid social functioning were more likely than males to be 
engaged in meaningful although not necessarily paid employment in the past twelve months, and 
were less likely to be on social aid (393). These findings are in agreement with those found 
previously (301, 325, 330, 403, 433, 434). 
Generally, sex differences in outcome were found for both patients with schizophrenia and 
those with other psychotic disorders, with females consistently showing better functioning over 
time, recurrent episodes of remission, better global functioning, and fewer and shorter re-
hospitalizations (330, 433, 435-437). No sex differences were reported when the duration of the 
illness exceeded 10 years (400, 438, 439). The sex differences in outcome for patients with 
schizophrenia are consistent over time (435). Grossman et al., (2008) analyzed their data 20 years 
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later, and found less psychotic symptoms for females during the course of illness and more 
improvement following 20 years; however, these trends were not observed in male patients. Not 
only females had a better clinical picture, but also they outperformed males in global functioning. 
In terms of recovery, 61% of females had a period of recovery compared to 41% of males during 
the course of 20 years (440).  
The more favorable course of illness observed in females becomes lost with substance abuse 
(301, 441). Additionally, females are more likely to commit suicide during an acute exacerbation 
of the illness, although the rate of suicide is overall higher in males than in females (442, 443). 
This is likely due to the presence of more affective liability and affective symptoms in females than 
in males with schizophrenia (399, 403, 408, 442). Comorbid alcoholism and drug abuse may 
adversely influence the course of illness and is more prevalent among males than females with 
schizophrenia (292, 301, 442, 444). Schizophrenia patients have poorer outcomes compared to 
patients having other psychotic disorders additionally poorer outcomes are associated with longer 
follow-up periods (445).Male sex and pronounced negative symptoms were predictors for poorer 
outcomes (446). Lindamer et al., (2003) found that females with schizophrenia were older, many 
of them married and had medical insurance and presented less comorbidity with substance abuse 
than males. More females were living independently. In contrast, more male patients either were 
homeless or lived in assisted living establishments (447). 
 
2.8 Cognition 
 
Several studies have reported sex differences in cognitive performances in normal 
populations (448-452). These sex differences seem to be more prominent in schizophrenia patients. 
Cognitive impairments are present in both males and females with schizophrenia, but in varying 
degrees depending on the duration of the illness and the age of onset. Thus, some studies reported 
comparable cognitive deficits in male and female first episode patients (326, 453), but greater 
deficits in especially on verbal tasks, once the illness dated more than 5 years. Similar results were 
found for social cognition, Wisconsin Card Sorting Test, and verbal processing (454, 455). 
Schizophrenia patients performed worse than healthy subjects after matching for age and sex, and 
within patients, males performed worse than females (124, 455-458). Superior cognitive 
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performance in females seems to be consistent across other mental disorders, including bipolar 
disorder and schizotypal personality disorder (459, 460). 
 High quality studies have indicated that males and females with schizophrenia both have 
cognitive impairments but in different cognitive domains (453, 455, 459-463). Differential 
cognitive impairments were observed in female patients who had a significantly worse performance 
than female controls on attention, executive functions, visual memory, and motor functions, but 
not in language, verbal memory and visuospatial memory (455). More recent studies are in 
agreement reporting that females with schizophrenia have better performances in processing speed 
and episodic memory relative to male patients, while male patients perform better on visuospatial 
working memory (455, 461, 462). These differences in cognitive impairments may be a result of 
sex differences in age of onset or illness severity, and may become insignificant once these 
variables are controlled for (37, 403, 464-471). 
 Our group have investigated sexual dimorphism in 17 males and 17 female with 
schizophrenia during a task of episodic memory using event related potentials (ERP) (472). The 
two groups were matched for age, social economic status, education, and intelligence. In males, 
reaction times were modulated by valence, but in females, reaction times were mainly modulated 
by arousal. Accuracy was affected by both emotional valence and arousal in females, but not in 
males (472). Another study by our group addressed sexual dimorphism in strategic cognitive 
approaches (473). In this study, error types were analyzed during spatial working memory tests. 
No differences in number of errors were found, however, differences emerged in error and strategy 
profiles based on sex (473). 
 In 2007, our group started a series of studies investigating sex differences in schizophrenia. 
We presented preliminary behavioral data collected from 17 males and 13 females with 
schizophrenia during performance of a mental rotation task and from healthy subjects matched for 
age and sex (474). This task was specifically used for its already validated sensitivity to sex 
differences in healthy controls (451, 475-481). We found no significant difference between the two 
groups of females. In contrast, males with schizophrenia had a significantly longer reaction time 
and lower percentage of correct answers compared to male healthy controls. Thus, in schizophrenia 
female patients outperformed male patients in both reaction time and percentage for correct 
answers, while the opposite pattern is typically observed in the general population. Another recent 
study used the jittered orientation visual integration (JOVI) task - test of contour integration, which 
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activates orientation-selective feature detectors in the primary visual cortex and is used to evaluate 
early visual processing (482). Females demonstrated higher contour integration scores but lower 
performance on the context sensitivity index of presented shapes compared to males with 
schizophrenia. The findings suggest greater neurodevelopmental deficits in males with 
schizophrenia (483). 
 Few studies have reported better cognitive performance in males with schizophrenia (282, 
285, 484). Lewine et al., (1996) found greater deficits on visual processing, verbal and spatial 
memory in females compared to males with schizophrenia (285). To date, cognitive impairments 
and their relation with sex differences in patients with schizophrenia remain inconclusive and merit 
further investigation (301, 485). A review by Mesholam-Gately et al., (2009) concluded that most 
studies addressing sex differences and cognition were not adequately designed to examine sex 
effects, contributing to the heterogeneity of cognitive performance reported in the literature (486). 
For more details please see our review paper in the appendix (487). 
 
2.9 Treatment  
 
Males and females with schizophrenia respond differently to treatment. Sex differences that 
affect drug response in schizophrenia include the following: delayed diagnosis in females, males 
presenting more deficit symptoms, stronger therapeutic alliance in females, males having more 
substance abuse and higher rates of smoking; females more often prescribed concomitant 
medications to treat comorbid problems, such as sleep disturbances, mood problems, endocrine 
disturbances, eating disorders, personality disorders (325, 434). Szymanski et al., (1995) found that 
females with first onset and chronic schizophrenia had similar response to treatments and that 
females had greater pharmacologic responsivity than males (405). In contrast, chronically ill males 
require twice as high a dose of psychotropic medication than females for effective maintenance 
(405, 488). Overall, males generally receive more neuroleptics compared to females, and have poor 
adherence to treatment (298, 489, 490). 
 Females with schizophrenia respond more quickly and show a greater degree of 
improvement on antipsychotic medications in comparison to males (405, 436, 491, 492). In 
addition, females have higher antipsychotic plasma levels in comparison to males after receiving 
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the same dose of drug, which may explain superior neuroleptic response and the need for lower 
doses of antipsychotics in females (493-496). 
 After menopause, females may require higher neuroleptic doses than males, and in turn may 
be more at risk for severe tardive dyskinesia, parkinsonian symptoms, and dystonia (301, 497, 498). 
In addition, females with schizophrenia are more likely to be prescribed antidepressants in 
comparison to male patients and more likely to change their antipsychotic treatment (499, 500). 
Rubin et al., (2008), also demonstrated better responsiveness to antipsychotic medication in 
females in relation to cognitive functions. The authors used cognitive tests that demonstrate sex 
differences in the general population, i.e. cognitive tests with scores that in normative studies favor 
males over females, such as visuo-spatial abilities, or favor females over males, such as verbal 
abilities. Their results revealed that females with schizophrenia had selective improvement on 
cognitive tests favoring females and decreased performances on cognitive tasks favoring males. In 
comparison, males seemed to have a worse performance than female patients on both types of tests 
(501). 
  Sex differences in treatment responses have been attributed to role of estrogen as a 
protective hormone against the illness in females and enhancing antipsychotic efficacy (417, 423, 
502-505). Very few studies have investigated sex differences in relation to other therapeutic 
approaches, such as cognitive and behavioral therapy (CBT), cognitive remediation, 
psychoeducation and pharmacoeducation, social skill training and supported employment. To date, 
females with schizophrenia have shown more reductions in overall symptoms and increased insight 
using CBT in comparison to male patients, however more studies are needed to confirm these 
findings and to evaluate other approaches (506). 
 
2.10 Structural neuroimaging findings 
 
Sexual dimorphism has been observed in several brain regions in the general population 
(507-510). For example, regionally specific sex differences have been reported in regions 
associated with languages functions. Specially, females show larger volumes of the superior 
temporal cortex in proportion to the cerebrum (509). Moreover, age-related volume loss is greater 
in males than in females in the whole brain, specifically frontal and temporal lobes, whereas it is 
greater in females than males in the hippocampus and parietal lobes (510). 
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Gur et al., (2004) investigated sexual dimorphisms using MRI and automated tissue 
segmentation procedure to examine the orbitofrontal cortex and amygdala ratio (OAR) in males 
and females with schizophrenia (511). Male patients had reversed sexual dimorphism (increased 
OAR relative to healthy males) reflecting reduced amygdala volumes. The reverse pattern was 
found in female patients, where the decrease in OAR reflected reduced orbitofrontal volumes in 
comparison to female controls (511). A more recent study by Savadjiev et al., (2014) investigated 
normal brain pattern asymmetry referred to as torque in adolescent-onset patients with 
schizophrenia, using white matter geometry computation in diffusion tensor imaging data (512). 
This group observed a reversal of normal sexual dimorphism in white matter tissue in patients. 
These abnormalities were correlated with the severity of symptoms (512). 
 
General Overview of Parenchymal Findings 
 It is now well established that morphological sex-related differences in the brain in healthy 
populations exist (510, 513-516). Imaging studies on sex–dependent brain abnormalities have 
consistently reported more severe disturbance in males than females with schizophrenia: reduced 
prefrontal volumes, reduced anterior temporal horn and medial temporal lobe volumes, more 
specifically amygdala, hippocampus, superior temporal and larger ventricular-brain ratios (VBR) 
(292, 301, 517-524). For example, Andreason et al., (1990) found that male patients had a smaller 
brain volume compared to controls in all four cortical regions, but not in the cerebellum; their CSF 
measures were higher than the controls' in relatively more anterior (rostral) regions, but not in 
occipital or cerebellar regions. The female patients, had a specific deficit in frontal lobe tissue only, 
as well as higher CSF measures in comparison with the controls in frontal and temporal regions 
and in the cerebellum (517). However, some studies have reported no sex differences (525-527). 
Gur et al., (1999) measured gray matter volumes (GMV) using the MRI scans of 130 patients (51 
neuroleptic naive, 79 previously treated) and 130 healthy controls (75 males, 55 females in each 
group). They found that GMV displayed sex–dependent reductions, where male patients had a 6% 
reduction compared to 2% reduction in female patients. Results survived correction for age and 
total intracranial volume. In this study, only females with schizophrenia had a correlation between 
higher parenchymal volume and better premorbid functioning in females (513). 
 
Subregional Findings 
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a) Brain volume, ventricular dilation, and cerebrospinal fluid 
 Ventricular dilation remains the most replicated and consistent in-vivo morphometric 
deficit observed in schizophrenia (528, 529). Clear relationships between ventricular dilation and 
clinical symptoms remain uncertain. Frontal and temporal lobe volume reductions have been the 
most frequently reported volumetric deficits (530). Sex differences in volume deficits have been 
equivocal, with some data suggesting that ventricular dilation is more prominent in male patients 
(518, 528). Nopoulos and colleagues (1997) reported a significant sex-by-diagnosis interaction for 
ventricular volume, such that males with schizophrenia had larger ventricles than healthy males, 
while no differences were observed between female groups (531). 
 Even when structural brain abnormalities are similar in males and females with 
schizophrenia, these abnormalities are generally more prominent in male patients. Molina and 
colleagues (2005) reported that only males with schizophrenia had significantly more CSF in the 
left prefrontal area, due to probable gray matter loss. Positive correlations between CSF values in 
the prefrontal and temporal regions and illness duration were found in males, but not in females 
with schizophrenia. These findings were observed only in the frontal and temporal regions and not 
in the whole hemisphere (532). Specific increases in sulcal and subarachnoid CSF appear 
prematurely in males with schizophrenia, while females with schizophrenia have aging effects 
similar to healthy subjects. Male patients, however, exhibited increased CSF even in young 
adulthood (533). Haijma et al., (2013) reported no sex differences with one major exception; the 
presence of reduced intracranial volume and significantly reduced white matter tissue volume in 
males with schizophrenia compared to healthy males. Intracranial volume reaches approximately 
90% of its final volume at the age of 5 years and no further changes occur to its final volume after 
the age of 14. The more pronounced intracranial reductions in male patients may be attributed to a 
more severe or earlier neurodevelopmental derailment (534). Yotsutsuji et al., (2003) reported 
significant volume increases in the left temporal horn, the bilateral anterior horns, and the right 
ventricular body in male patients. Female patients had similar patterns of volume changes, but they 
were less significant (535). These findings suggest larger temporal gray matter reductions in males 
than females with schizophrenia. 
Collinson et al., (2003) investigated hemispheric brain volume, asymmetry (torque) and IQ 
in early-onset schizophrenia patients. The authors found that total brain volume was significantly 
smaller in the group with early-onset disease relative to the control group (4.5%), especially in the 
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left hemisphere of female patients (6.0%). In addition a significant sex by diagnosis interaction was 
observed such that female patients had significantly reduced right more than left asymmetry 
relative to the female control group, while the male patients had decreased left more than right 
asymmetry relative to the female control group. In patients, these reductions in volume correlated 
with lower IQ measures (536). 
 
b) Subcortical Temporal Lobe Deficits – Amygdala, Hippocampus, Hypothalamus 
 Bryant et al., (1999) reported smaller volumes in the superior temporal gyrus and the 
amygdala/hippocampal complex in patients compared to controls when male and female patients 
were grouped together. When patients were analyzed separately by sex, the left temporal lobe 
volume was significantly smaller in male patients compared to healthy males. In contrast, no 
significant differences were observed in the female groups (537).  
 Abnormalities of hippocampal morphology are another common observation in patients 
with schizophrenia (538, 539). With respect to sex effects on hippocampal volume, Irle et al., 
(2011) reported that only males with schizophrenia had hippocampal volume reduction in 
comparison with male controls. The authors also reported a correlation between smaller 
hippocampal sizes with longer duration of illness only in female patients. Female patients had 
normal hippocampal size at the onset of disorder, but after a few years, females and males with 
schizophrenia had similarly sized hippocampi (540). Additionally, female but not male first episode 
patients had significantly larger hippocampal volumes compared to female and male chronic 
patients (540). In contrast, Gur et al., (1998), Arciniegas et al., (1999), and others, reported that in 
minimally treated first-episode schizophrenia patients, significant sex by diagnosis effects were 
observed, with female patients having significantly smaller anterior and right hippocampal volumes 
than healthy control females. This effect was not observed in male patients suggesting that smaller 
hippocampal volumes are present even in early stages of the illness (541-543). Niu et al., (2004), 
found significantly, smaller volumes in the bilateral amygdala in males with schizophrenia 
compared to male controls. No differences in amygdala volume were observed between female 
groups. Between patient groups, females had a significant reduction in the right amygdala 
compared to males. A significant left-smaller-than-right volumetric asymmetry of the amygdala 
was detected only in male patients with schizophrenia (544). A left-right difference was only seen 
in the male patients, in whom significantly smaller left amygdala volume was observed (544). 
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c) Cortical and Gyral Deficits 
 Cortical gray matter volumes are frequently found to be reduced in schizophrenia (513, 
545). Normal cortical patterns of sexual dimorphisms are disrupted in schizophrenia, in the 
frontomedial cortex, basal forebrain, cingulate and paracingulate gyri, posterior supramarginal 
gyrus, and temporal lobe (511, 546). Perturbation of normal gray matter volume asymmetry, has 
been observed in the left inferior parietal lobes in male patients, but not in female patients (547). 
No significant differences in gray matter asymmetry of volume were observed by Frederikse and 
colleagues (2000) in female patients compared to female controls, even when they had significantly 
smaller total brain volumes than healthy females (547). A recent study be Takayanagi et al., (2011) 
applied both volumetric and cortical thickness measures in MRI images. Consistent with the 
majority of structural findings in schizophrenia, patients in this study had gray matter volume 
reductions and cortical thinning in prefrontal and temporal cortices compared with controls. Sex 
differences were found in the bilateral amygdala, with more reductions in males than females with 
schizophrenia (548). Nesvag et al., (2008), found no significant effect of gender on variation in 
cortical thickness in their large-scale study (549). Sex differences in insular volume were reported 
by Duggal et al., (2005) in previously untreated patients with first-episode schizophrenia (550). 
The authors found that females with schizophrenia had significantly reduced right insular and 
anterior cingulate volume relative to healthy females. No difference between males with and 
without the diagnosis has been reported (551). 
 Takahashi, et al., (2002) investigated the anterior cingulate, a region anatomically 
associated with the corpus callosum. The authors found no significant group differences in the 
anterior cingulate volume in males; however, right anterior cingulate GMV was significantly 
reduced in the females with schizophrenia when compared with the healthy females. In addition, 
they lacked the normal structural asymmetry- right larger than left- in anterior cingulate gray and 
white matter volumes typically observed in female controls (552). Subsequently, Takahashi, et al., 
(2003) measured the volume of the perigenual cingulate gyrus in patients with schizophrenia and 
age and gender matched controls using MRI. Significant gender differences were found in the total 
gray and white matter volumes of the perigenual cingulate gyrus in control subjects where females 
had larger gray matter volumes than males (552). These gender differences were not significant in 
the patient group. Female patients also had significant decreased volumes of bilateral perigenual 
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cingulate gray matter compared with female controls, while no significant differences were 
observed between male groups (552). Male patients had volumetric reductions in prefrontal cortex, 
inferior parietal lobule, parahippocampus, and hippocampus (553). Significant differences in the 
covariance matrices in females and males with schizophrenia compared with healthy controls were 
observed in relationship with the inferior parietal and anterior cingulate gyri, the hippocampus and 
prefrontal cortex (553). The latter covariance was significantly associated with better verbal 
memory performance in females. In male patients, who had poorer performance compared to 
female patients, hippocampus and prefrontal cortex volumes were significantly correlated with 
memory performance (553). In healthy females, but not in males, the anterior cingulate was 
significantly correlated with memory performance. The authors suggested that females with 
schizophrenia compensate volumetric loss in the anterior cingulate by engaging alternative patterns 
between the inferior parietal and the prefrontal cortex (553). These findings were congruent with 
their previous study and with other reports (553, 554).  
 Narr et al., (2004) used MRI to measure 3D gyral complexity to investigate five cerebral 
regions in each hemisphere in patients with schizophrenia. The authors found a significant increase 
in cortical folding in the right superior frontal cortex in male patients compared to male controls. 
This difference was not observed in female groups, suggesting that these abnormalities predate 
illness onset and are of neurodevelopmental origin. These finding also suggest sexually dimorphic 
developmental processes that influence the organization of cortical folding probably during gyral 
formation in utero (555). In a subsequent investigation of the cingulate and occipital cortex, female 
patients had cortical thinning in cingulate and occipital regions bilaterally compared to healthy 
control females, while male patients had more cortical thinning in the left caudal anterior cingulate 
cortices, and in the paracentral lobule and posterior occipital regions bilaterally compared to male 
controls (554). In addition, male patients had small regional thickness increases in the gyrus rectus 
compared to male controls (554). Reports of reduction in the anterior cingulate volume in females 
with schizophrenia compared to control females contrasted with the absence of differences between 
male patients and comparison subjects (551). 
 Few studies have investigated the effect of sex on gyrification in schizophrenia (556-558). 
Only the study by Vogeley et al., (2000) found an effect of sex and diagnosis on the degree of gyral 
folding as assessed by gyrification index (GI). The study was conducted on postmortem brains of 
patients with schizophrenia and healthy controls using gyrification measures specifically in the 
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prefrontal region. The authors found a significant effect of diagnosis-by-sex interaction on the GI 
in the right prefrontal, where male patients had higher gyrification indices in comparison to healthy 
males, while no significant difference was observed in the female groups (558). The finding of sex 
differences in the GI in schizophrenia is consistent with several reports of more neuroanatomical 
abnormalities in males relative to female patients. For example, Narr et al. (2001) found a sex-by-
diagnosis interaction in males with schizophrenia showing a greater loss of superior temporal sulcal 
slope asymmetry in the right hemisphere than females with schizophrenia. In addition, the authors 
found greater variability in the longitudinal fissure, reflecting both larger sulci and larger CSF 
space in male relative to female patients (559). In a different study, Bullmore et al., (1995), showed 
a global reduction in the right hemisphere radius of gyrification in males but not in females with 
schizophrenia (560). Similar structural sex differences have been found in volumetric and cortical 
thickness studies (20, 561-564). Highley et al., (2003) performed gyrification measures on frontal, 
temporal, parietal, and occipital regions in schizophrenia patients and age and sex-matched 
controls. The authors found no effect of diagnosis or sex on the degree of folding (565). In the 
present thesis, we investigate this issue further while considering sex, age, and illness duration 
effects. 
 
d) Deep Brain Subcortical Gray Matter Deficits – Basal Ganglia, Thalamus 
  Sex effects on subcortical volumes remain equivocal. Arciniegas et al., (1999) found no 
significant diagnosis, hemisphere, or gender differences in thalamic volumes (543). Similarly, Gur 
et al., (1998) investigated basal ganglia and thalamus volumes in patients with schizophrenia and 
their relation to antipsychotic medication and severity of symptoms in patients with schizophrenia 
and healthy controls (542). The authors found that antipsychotic naïve male and female patients 
had lower thalamic volume, with no correlation between volumes and severity of negative 
symptoms, however higher volumes in the thalamus and the putamen were associated with more 
severe positive symptoms (542). Increased subcortical volumes in the putamen and globus pallidus 
were found equally in males and females with schizophrenia treated with antipsychotics (542). 
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e) Deep White Matter Deficits – Corpus Callosum 
 Abnormalities of the deep white matter, particularly in the callosal morphology, have been 
observed in schizophrenia. Narr and colleagues (2000, 2003, 2004, 2005, 2006, 2009) have 
conducted a series of studies investigating sex-dependent morphological abnormalities in 
schizophrenia (533, 554, 555, 566-568). Significant increases in maximum widths in anterior and 
posterior callosal regions in males with schizophrenia compared to male controls and increased 
patterns of callosal variability in female patients, without effects of diagnosis between female 
groups have been observed from imaging (567). Displacement and curvature increases were highly 
correlated with structural differences in surrounding neuroanatomical regions, including increased 
volume of the lateral ventricles (567). The authors suggest that females with schizophrenia are less 
vulnerable to ventricular enlargement and to alterations in surrounding neuroanatomic regions 
compared to male patients (567). Other less investigated regions is the cerebellum. Okugawa et al., 
(2003) found a significant cerebellar reduction in schizophrenia patients compared to controls, 
however no sex differences were found (569). 
 Sex-dependent structural differences and their relation with cognitive deficits have been 
addressed in few studies. For example Abbs et al., (2011) aimed at understanding why verbal 
memory processes seemed to be more preserved in females than males with schizophrenia by 
studying structural differences in prefrontal cortex, inferior parietal lobule, anterior cingulate gyrus, 
parahippocampus, and hippocampus (553). 
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3.0  Summary 
 
 Several hypotheses have been proposed to explain sex differences in the brain in 
schizophrenia. Crow (2008) suggested that sex differences related to psychosis are attributed to a 
genetic species-specific variation related to a locus on the X and Y chromosomes (570). Gene 
expression in this region is influenced by the degree of X and Y chromosomes pairing in male 
meiosis. This process is referred to as MSUC “meiotic suppression of unpaired chromosomes" 
which normally would lead to a more rapid mean rate of lateralization in females than in males and 
this in turn would relate to the higher incidence rate of language delays and dyslexias in males. 
This complex theory posits that language disturbances are integral to psychosis. Cerebral torque 
(in which the right frontal lobe is larger than the left, while the left occipito-temporo-parietal is 
larger than the right) is due to the development of neural connections associated with language. 
Disturbance in this neural development was proposed as the basis of the genetic predisposition to 
psychosis, and schizophrenia was proposed to be is a result of an abnormal cerebral lateralization 
associated with the emergence of language in humans (571). When this hypothesis is considered 
in the context of brain structures, it may explain the higher levels of anomalies found in male 
compared to female patients and the differences in the development of schizophrenia in males and 
females in general (572). 
The influence of sex steroid hormones have also been suggested, particularly with respect 
to a putative neuroprotective effect of estrogen (573, 574). Estrogen is thought to influence sexual 
characteristics, the development of the brain aminergic networks, and the ability to adapt to 
stressful events, and to enhance the vulnerability threshold for psychosis by the downward 
regulation of dopamine. This model may explain the later onset and the more positive course of 
illness in females with schizophrenia. Increased levels of estrogen in females with schizophrenia 
with normal menstrual cycles were significantly associated with lower severity of schizophrenia 
symptoms suggesting that that estrogen had "a weak neuroleptic-like effect on schizophrenia 
symptoms" (325). 
 The accumulative body of neuroimaging findings remains, somewhat inconsistent and 
sometimes contradictory. Whether some of the inconsistencies with respect to sex differences in 
the published literature are associated with confounding factors, including duration of illness, age 
at onset of illness, ethnicity, IQ, and social status, methodological issues, imaging analyses 
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techniques remains unclear. Table X in the fourth article in the annex presents a summary of studies 
investigating sex differences in brain structure of schizophrenia patients. Given the variable 
findings in schizophrenia, it is evident that potential sex differences in this extremely complex 
mental illness are yet to be fully understood. In concordance with Dr. Shon Lewis’ (1992) in his 
visionary paper “Vive la Différence” on the inherent difficulties in interpreting subtyping 
schizophrenia, we posit that “the advantage of using gender as the sub dividing variable by which 
to look for heterogeneity is that it is completely reliable, stable and valid- an immutable 
sociodemographic variable” (360).  
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4  Hypotheses and rationale 
 
Hypotheses 
 
We hypothesized to find significant sex differences in individuals diagnosed with 
schizophrenia in their morphology, symptoms, cognition, and emotion. In addition to the 
experimental work to test these hypotheses, a complete review of the literature was undertaken. 
The review led us to conclude that sex differences have been reported in almost all aspects of life 
of patients with schizophrenia. Given this state of affair, we performed a series of studies to shed 
light on several unresolved or unexplored areas in this field. Thus, in the first study we 
hypothesized that female patients will show less deficit than male patients (relative to the same-
sex controls), that the gyrification index will show deterioration with age and duration of illness, 
and will be more pronounced in male schizophrenia patients. This hypothesis was based on several 
reports of more structural brain abnormalities in males than in females with a schizophrenia 
diagnosis. In the second study, we sought to assess the correlation between fronto-limbic volumes 
and schizophrenia symptoms. We hypothesized that correlations between symptoms, white and 
gray matter densities would show sex differences. In the final study, we predicted that male 
schizophrenia patients would show more cognitivo-emotional memory deficits, and that male 
patients would show more cerebral abnormalities in regions related to memory recall compared to 
female patients. 
 
Rationale 
 
The main goal of this thesis was to shed light on sex differences in schizophrenia. After a 
thorough review of the literature, we investigated the three cornerstones characterizing 
schizophrenia: symptoms, cognition, and emotion, using different morphological measures. 
Significant sex differences were revealed in all three domains no matter what methodological 
approach was used. 
 
The approach taken was:  
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1- Assessment of gyrification from high-field MRI in males and females with schizophrenia  
2- The investigation of the relationship between symptoms, cortical gray matter, deep brain 
white matter, and subcortical gray matter nuclei in males and females with schizophrenia. 
3- The investigation of the relationship between cognitive capacity and gray/white matter 
morphology in males and females with schizophrenia. 
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5 Article 1 
The following work has been accepted and published in Clinical Schizophrenia & Related 
Psychoses under the title: “Sex, age and illness duration affect gyrification index in schizophrenia” 
in Clin Schizophr Relat Psychoses. 2015 Jul 28. [Epub ahead of print] PubMed PMID: 26218234. 
 
Despite well established cerebral sex differences in healthy population, only in recent years 
neuroimaging studies have addressed sex differences in schizophrenia as a possible explanation for 
discrepant findings. To examine potential sex differences in neuroanatomy, cognition, emotion, 
and schizophrenia symptoms we conducted a series of studies using divers imaging techniques. 
Only a few studies have investigated sex differences in schizophrenia using cortical measures. The 
first study of this doctoral thesis was designed to fill in this gap in the existing literature and it is 
one of the first to investigate sex differences using gyrification index (GI). Furthermore, we 
examined GI in relation to age and illness duration. Sex differences were revealed, showing that 
males with schizophrenia had more cortical alterations than female patients. An important and 
unanticipated finding was the fact that symptoms correlated only with the GI of the occipital lobe, 
despite the fact that abnormalities in GI in our group of schizophrenia patients in comparison to 
healthy controls were found in several cerebral regions. 
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Abstract 
Introduction: The Gyrification Index (GI) represents the degree of cortical folding and is of 
special interest in schizophrenia, since alterations in cortical folding indirectly reflect white matter 
development and axonal connectivity underneath. To the best of our knowledge, only three studies 
have investigated the effect of sex on GI in schizophrenia. Differences in the GI between patients 
with schizophrenia and normal controls and the effects of sex, age, and duration of illness on the 
GI were investigated. Methods: T1 images were acquired from 48 schizophrenia patients (24 males 
[SZ-M] and 24 females [SZ-F]) and 48 healthy volunteers (24 males [NC-M] and 24 females [NC-
F]) matched for age, sex, and handedness. Gyrification index analyses were performed using the 
fully automated CIVET pipeline. Results: Significantly lower GI were found in schizophrenia 
patients relative to normal controls in bilateral frontal, bilateral temporal, and bilateral parietal. Sex 
differences were found: lower GI in the right hemisphere in SZ-M relative to NC-M (no difference 
between female groups); GI values decrease with age in normal controls (with no sex difference) 
and in patients (SZ-M> SZ-F), with a more progressive deterioration in the right hemisphere in 
schizophrenia. Negative correlations were found between the duration of illness and the right 
parietal GI and the right occipital GI in SZ-M, and in the left frontal and bilateral temporal GI in 
SZ-F. Patients, regardless of sex, had positive correlations between negative symptoms and GI in 
the right occipital. SZ-M had negative correlations between the left occipital GI and negative 
symptoms, while SZ-F had positive correlations between negative symptoms and the right occipital 
GI. NC-F had greater GI values than SZ-F and male groups in the left frontal; greater values than 
both patient groups in the bilateral temporal and right frontal; and greater values in the left parietal 
compared to SZ-F. Conclusion: Since GI reflects, in part, alterations in cerebral development and 
connectivity, the decrease in GI observed in patients is in agreement with the neurodevelopmental 
model of disconnectivity in schizophrenia, in addition, we emphasize the importance of sex 
differences in schizophrenia. 
 
Keywords: Schizophrenia, sex differences, magnetic resonance imaging, gyrification index, 
illness duration, age, symptoms. 
  
Thèse de doctorat Adham Mancini Marïe August 2016 
 
 
41 
1. Introduction 
 
The last couple of decades have witnessed a boom in the development of sophisticated 
methods of investigating brain structure and function, but a great deal of work still lies ahead in 
order to unravel the neurobiological mechanisms underlying schizophrenia (1-4). Numerous brain 
regions have been implicated in the pathophysiology of this genetically and behaviorally complex 
disorder, suggesting that schizophrenia is not caused by any focal brain abnormality, but results 
from disturbed interactions between brain regions. The core pathology of schizophrenia is thought 
to involve impaired neuromodulation of synaptic plasticity, leading to abnormal functional 
integration of neural systems (5). One way to assess this theory is to measure cortical folding, a 
marker of cortico–cortical connectivity, in addition to the intra-cortical organization (6). This 
cortical folding is measured through the gyrification index (GI). 
The Gyrification Index (GI) represents the degree of cortical folding by calculating the ratio 
of the entire inner cortical contour of the brain to that of the exposed outer surface contour. An 
increase in the GI index is thus correlated to an increase in the number and complexity of gyri (7). 
In 1991, Armstrong et al., (1995) stated that a change in this gyrification reflects aspects of the 
morphological development of the cortical layer (8). Developmentally, gyrification takes place 
following the completion of neuronal migration during the gestation period (9). The greatest 
increase in GI values occurs between 22 and 42 weeks of gestation (10). The gyrification index 
stabilizes shortly after birth and appears to be stable thereafter, even in the presence of atrophic 
processes affecting gray and white matter at a later age (10). 
The gyrification index is of special interest in schizophrenia, since alterations in cortical 
folding indirectly reflects white matter development and axonal connectivity underneath (10, 11). 
Results of gyral folding (using GI) in healthy population derive mainly from postmortem studies 
(7, 10, 12). For example, Zilles et al., (1988) measured the GI bilaterally in the brains of 25 males 
and 36 females without apparent neurological diseases. The GI was greatest in the prefrontal and 
parieto-temporal cortex and no significant sex differences in the GI were observed (7). 
Few studies have attempted to investigate GI in schizophrenia patients (13-16) and those that did, 
focused mainly on the frontal lobe. These studies reported both greater (15, 17) and lower gyral 
complexity (18, 19). A study by Sallet et al., (2003) and Palaniyappan et al., (2011) reported global 
reductions but with fluctuating regional increases in right anterior prefrontal cortex and bilateral 
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frontomarginal regions (20, 21). Harris et al., (2004) compared a larger sample (N=34) of first-
episode patients to healthy controls (N=36) and assessed the prefrontal, temporal, parietal, and 
occipital lobes. The authors found a trend toward reduction in the left prefrontal region but 
significant increases were observed in the right temporal regions (15). These structural 
abnormalities may provide insight into differences in schizophrenia symptoms (14, 20, 22). 
There is a paucity of investigating the effect of sex on GI measures in schizophrenia (20, 
23, 24). Only the study by Vogeley et al., (2000) found an effect of sex and diagnosis on the degree 
of gyral folding. Vogeley et al., (2000) conducted the study on postmortem brains of patients with 
schizophrenia (N=24) and healthy controls (N=24) using gyrification measures specifically in the 
prefrontal region. The authors found a significant effect of diagnosis-by-sex interaction on the GI 
in the right prefrontal, where male patients had higher gyrification indices in comparison to healthy 
men, while no significant differences were observed in the female groups (24). The second study 
by Highley et al., (2003), performed gyrification measures on frontal, temporal, parietal, and 
occipital regions in 61 patients with schizophrenia in comparison with 42 healthy controls (21 
females). The authors found no effect of diagnosis or sex on the degree of folding (25). Bonnici et 
al., (2007) used an automated gyrification measure in the frontal lobe to compare schizophrenia 
patients (14 males and 11 females) and patients with mental retardation and healthy controls. 
Schizophrenia patients had reduced gyrification; however, the authors report no significant effect 
of sex on gyrification index (13). Similarly Cachia et al., (2008) investigated local sulcal index in 
schizophrenia patients (10 females and 20 males) with hallucination in comparison with healthy 
controls. Reductions were significant in the superior temporal sulcus bilaterally, in the left middle 
frontal sulcus with no significant main effect of sex on the results (22). 
More recently Palaniyappan et Liddle (2012) performed gyrification analyses in a group of 
57 schizophrenia patients (50 males), and a second time after exclusion of the 7 female subjects. 
The authors report reductions in the left insula, the superior temporal gyrus, the caudal superior 
temporal and inferior parietal regions. Exclusion of the female subjects did not change the results. 
The authors recommended caution in the interpretation of these results and pointed out the need 
for studies with equal male/female ratios (26). 
The aim of the present study was three-fold: 1) to investigate differences in the GI between 
patients with schizophrenia and normal controls; 2) to investigate the main effects of sex on the GI 
in larger samples of patients; and 3) to investigate the main effects of age and duration of illness 
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on the GI. Based on previous studies, we hypothesized that: 1) patients would have lower GI than 
normal controls; and 2) female patients would show less GI deficit than male patients (relative to 
the same-sex controls). This hypothesis is based on several reports of more structural brain 
abnormalities in males than in females with a schizophrenia diagnosis (27-32). It is also expected 
that 1) the GI will show deterioration with age, which will be more pronounced in schizophrenia 
patients, and 2) the duration of illness will be associated with lower GI. 
 
2. METHODS 
 
2.1 Participants 
Ninety-six subjects were included in the present study. Inclusion criteria for the 
schizophrenia group were a DSM-IV (33) diagnosis of schizophrenia with no medical or 
neurological diseases and no concomitant axis-I or axis-II disorders. Forty-eight schizophrenia 
patients (24 males [SZ-M] and 24 females [SZ-F]) and 48 normal controls (24 males [NC-M] and 
24 females [NC-F]) participated in the study after signing a detailed informed consent approved by 
the local scientific and ethics committees. 
 SZ and NC were matched for age, sex, and handedness (34) (SZ-M: mean=31.25 years, 
SD=7.97; NC-M: 33.50 years, SD=8.69; p=.355; df=46 and SZ-F: mean=33.04 years, SD=8.38; 
NC-F: 29.92, SD=7.15, p=.171; df=46). No differences between groups were found in the parental 
socio-educational status (SZ-M: mean=2.82, SD=0.61; NC-M: mean=2.32, SD=1.12, df=46; SZ-
F: mean=2.63, SD=1.06; NC-F: mean=2.18, SD=1.13, p=.183; df=46) as assessed by the National 
Occupational Classification (NOC) (35) on a scale ranging from 1 to 4. There were no significant 
differences between male and female patients in either mean duration of illness or dose of 
antipsychotic medication in chlorpromazine equivalence. Patients were stabilized on one or more 
atypical antipsychotic. The effects of antipsychotic medications on GI were considered through 
estimation of chlorpromazine dose equivalents (36). Patients with DSM-IV (33) criteria of 
affective, schizoaffective and schizophreniform psychoses as well as patients with past or present 
neurological or Axis-I psychiatric disorder, alcoholism or drug abuse were excluded from the 
study. Control participants were screened with the non-patients edition of Clinical Interview for 
DSM-IV [SCID] (37). Symptoms severity was rated according to the positive and negative 
syndrome scale [PANSS] (38). Handedness was evaluated with the Edinburgh Inventory (34) 
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(Table 1). The date of illness onset was defined as the date of 1st psychiatric consultation, for lack 
of reliable information from family members and patients. Schizophrenia has common symptoms 
with other psychiatric disorders as bipolar disorder, personality disorder, etc.; therefore, a 
psychiatric consultation favors a better diagnosis. 
 
- Insert Table 1 just about here - 
 
2.2. Magnetic Resonance Imaging Acquisition. 
Individual high-resolution co-planar anatomical images were acquired using an 12channel 
headcoil (three-dimensional, spoiled gradient echo sequence; sagittal orientation, slices=176, scan 
time 9:38 min, slice thickness=0.98 mm, TR=19 ms, TE=4.92ms, flip angle=25°; matrix 256x256 
voxels, FOV:  256x256 mm, isotropic voxels 1.0 x 1.0 x 1.0mm) on a MRI Siemens TRIO-TIM 
system (Total Imaging Matrix) at 3.0 Tesla operating at the University of Montreal Geriatric 
Institute.  
 
2.3. Magnetic Resonance Imaging Analysis.  
2.3.1. Gyrification index preprocessing 
Gyrification index analyses were done using the fully automated CIVET pipeline. For 
details, please see following references (39-44) and the following link 
http://www.nitrc.org/plugins/mwiki/index.php/neurobureau:CIVETPipeline. 
 
2.3.2. Gyrification index measurement 
An intermediate cortical surface, halfway between the inner and outer CLASP (Constrained 
Laplacian Anatomic Segmentation using Proximity) surfaces, was used for measuring the surface 
morphometrics as it represents a relatively unbiased representation of both sulcal and gyral regions 
(45). The cortical area was calculated in the whole hemisphere and each lobar region by summing 
the Voronoi area based on geodesic distances over the folded topology of the surface (46). The 
middle cortical surface was divided into the sulcal and gyral regions by thresholding the depth map, 
i.e. 3D Euclidean distance from each vertex to the nearest voxel on the convex hull volume (47). 
The threshold of the depth map was determined from the fact that the human cerebral cortex is a 
highly folded sheet with 60–70% of its surface area buried within folds (7, 48). The mean GI was 
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defined as the ratio between the total surface area and the superficially exposed surface areas such 
as the gyral regions in each hemisphere and lobe (7). Please see figure 5 as an example. 
 
-----Insert Figure 5 around here ------- 
 
2.4. Statistical Methods and Analysis.  
The unified statistical approach to deformation-based morphometry was applied to the 
cortical surface (49), which is specifically performed when using age and gender as covariates. The 
cerebral cortex has the topology of a 2D highly convoluted sheet. As the brain develops over time, 
the cortical surface area, thickness, curvature, and total GM volume change. It is highly likely that 
such age-related surface changes are not uniform. By measuring how such surface metrics change 
over time, the regions of the most rapid structural changes can be localized. We avoided using 
surface flattening, which distorts the inherent geometry of the cortex in our analysis and is only 
used in visualization. To increase the signal to noise ratio (SNR), diffusion smoothing, which 
generalizes Gaussian kernel smoothing to an arbitrary curved cortical surface, has been developed 
and applied to surface data (2D smoothing). As an illustration, Evans and colleagues have 
demonstrated how this new surface-based morphometry can be applied in localizing the cortical 
regions of the gray matter tissue growth and loss in the brain images longitudinally collected in the 
group of children and adolescents. Further studies stated that each of the segmentation, thickness 
computation, and surface registration procedures are expected to introduce noise in the thickness 
measure (50, 51). To counteract this, data smoothing was used to increase the signal-to-noise ratio 
(SNR), and the sensitivity of statistical analysis. For analyzing data in 3D whole brain images, 
Gaussian kernel smoothing is widely used, which weights neighboring observations according to 
their 3D Euclidean distance. In the present study, however, the data lie on a 2D surface so the 
smoothing must be weighted according to distance along the surface. This method is adopted to 
reduce the noise in the thickness measure especially when co-varying with age and gender. 
Diffusion smoothing, that smooths data on an explicit 2D cortical surface representation, is based 
on the observation that, in Euclidean space, Gaussian kernel smoothing is equivalent to solving an 
isotropic diffusion equation. This diffusion equation can also be used on the surface manifold to 
increase the SNR. This is done to reduce noise and to overcome problems caused by neuroanatomic 
variability within the gender and age groups. In addition, mixed model regressions to account for 
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missing data, irregular intervals between measurements, and within-person correlation, were used 
to examine the developmental trajectories (52). The threshold for statistical significance was set at 
an α of 0.05. Correction for multiple comparisons was needed to control the false-positive rate. All 
statistical thresholds were determined by application of the false discovery rate (FDR) technique 
controlling procedure for multiple comparisons. This approach is reported to be effective for the 
analysis of neuroimaging data (53). 
A factor analysis (or ‘diagnostic group’) of diagnosis-x-gender was performed, for variables 
revealing significance for the GI. Then analysis of covariance with mean GI as the dependent 
variable with separate analyses for the left and right hemispheric, in addition to each lobe GI, were 
performed according to general linear model corrected for multiple comparisons. A series of 
univariate ANOVAs were subsequently performed according to the general linear model. 
Regression analyses were also performed, using GI as the dependent variable and age, symptoms 
scores and duration of illness as regressors. Potential interactions between regressors and diagnosis 
and sex were tested. Analyses were performed using the SPSS 17 software. Type I error was 
controlled by adopting Bonferroni corrections at p<0.05. 
 
3. Results 
 
3.1 Psychiatric assessments 
Independent t-tests revealed a significant difference in negative and total PANSS scores 
and age of onset between males and females with schizophrenia, but no differences were found in 
medication or illness duration (Table 1). 
 
---Insert Table 1 about here ----- 
 
3.2. Gyrification index 
3.2.1: Results by hemisphere 
The t-test revealed a significant main effect of group on the right hemisphere GI (t=2.723, 
p=.008) and the left hemisphere GI (t=2.127, p=.037), such that the patient group exhibited a lower 
GI compared to the control group. Based on previous findings, second level ANOVA was 
performed on the female and male groups separately. There was a significant main effect of group 
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in males on the right hemisphere GI (t=2.545, p=.018), and only a trend on the left hemisphere GI 
(t=1.947, p=.058), where SZ-M had a significantly lower GI compared to control males. No main 
effect of group was observed in females. 
 
3.2.2. Regression and general linear model Analyses with hemispheres 
General linear Model regression in SPSS revealed a Group-by-Age interaction in the GI of 
the right (F (1,95)=2.221, p0.019, df=94) and the left hemisphere (F (1,95)=2.239, p=0.018, df=94), 
such that the diagnosis of schizophrenia affected the rate of GI loss with age. The direction of this 
interaction was such that increased age correlated with lower GI in the right hemisphere and in the 
left hemisphere GI (Figure 1a and 1b) with more rapid decrease in GI bilaterally with progressive 
age in the patient group compared to controls. 
The examination of patients, revealed an Age x Sex interaction in the right and left 
hemisphere GI showing that males with schizophrenia had greater GI reductions bilaterally yet 
more pronounced in the right hemisphere with progressive age compared to females with 
schizophrenia (Figure 2a and 2b). Furthermore, an interaction was observed between duration of 
illness and sex demonstrating a greater decrease in GI in the right hemisphere with the duration of 
illness only in males with schizophrenia (Figure 4). There were no significant correlations found 
between hemispheric GI and symptoms in either group or patients. 
 
- Insert Figure 1a, and Figure 1b just about here - 
- Insert Figure 2a, and Figure 2b just about here - 
- Insert Figure 3 just about here – 
 
3.2.3 Results by Lobe 
The t-test performed between patients and controls revealed significant differences in the 
left frontal lobe GI (t=3.358, p=.001, df=94), the left temporal (t=2.902;p=0.005, df=94) and the 
left parietal GI (t=2.596; p=0.011, df=94), the right frontal lobe GI (t=2.886, p=0.005, df=94), the 
right temporal lobe GI (t=3.672; p=0.001, df=94) and the right parietal lobe GI (t=2.198; p=0.030, 
df=94), such that the patient group exhibited lower GI compared to the control group. ANOVAs 
were performed for the 4 groups NC-M, SZ-M, NC-F and SZ-F. Differences between groups were 
significant in the left frontal (F (1,95)=6.949; p=0.001, df=92) where NC-F had higher GI than NC-
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M (p=0.030), SZ-M (p=0.001) and SZ-F (p=0.004, df=92); and in the left temporal (F 
(1,95)=3.924; p=0.011, df=92) where NC-F had higher GI than SZ-M (p=0.034) and SZ-F 
(p=0.016); in the left parietal (F (1,95)=0.021; p=0.023, df=92), where NC-F had higher GI than 
SZ-F (p=0.023); in the right frontal (F (1,95)=5.165, p=0.002, df=92), where NC-F had higher GI 
compared to SZ-M (p=0.001) and SZ-F (p=0.046); in the right temporal (F (1,95)=6.263; p=0.001, 
df=92), where NC-F had higher GI than SZ-M (p=0.01) and SZ-F (p=0.001) (Figure 4). 
 
 ---------------Insert Table 2 and Figure 4 about here------------ 
 
3.2.4 Regression Analyses with lobes  
Regression analyses revealed a negative correlation between the duration of illness and the 
right parietal GI (r2=0.166; β=-0.407; t=-2.092; p=0.048, df=46) and the right occipital GI 
(r2=0.183; β=-0.427; t=-2.218; p=0.037, df=46) such that male patients show more rapid decrease 
in GI. While females had more rapid decrease in the left frontal GI (r2=0.306; β=-0.553; t=-3.115; 
p=0.005, df=46), the left temporal GI (r2=0.211; β=-0.459; t=-2.422; p=0.024, df=46) and the right 
temporal GI (r2=0.280; β=-0.529; t=-2.927; p=0.008, df=46). 
Regression analyses between symptoms and GI performed in patients regardless of sex 
revealed positive correlations between negative symptoms and the right occipital GI (r2=0.170; 
β=0.398; t=3.064; p=0.004, df=46). SZ-M had negative correlations in the left occipital GI with 
negative symptoms (r2=0.221; β=-0.470; t=-2.495; p=0.021, df=46), while SZ-F had positive 
correlations between negative symptoms and the right occipital GI (r2=0.230; β=0.479; t=2.561; 
p=0.018, df=46). 
 
4. Discussion 
 
The main findings of the present study are: (1) Significant lower values of the overall GI 
and in individual lobes in schizophrenia patients relative to normal controls; (2) Significant lower 
values of the GI in the right hemisphere in schizophrenia males relative to the same-sex controls 
(no difference between female groups); (3) GI values decrease with age in healthy controls (with 
no sex difference) and in patients (greater in males than in females), with a more progressive 
deterioration in the right hemisphere in schizophrenia; (4) Significant GI values decrease with the 
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duration of illness in schizophrenia males but not in schizophrenia females; (5) Patients having 
significantly lower GI in bilateral frontal, bilateral temporal and bilateral parietal compared to 
controls; (6) Female controls having greater GI values than schizophrenia females and both male 
groups in the left frontal; greater values than both patient groups in the bilateral temporal and right 
frontal; and greater values in the left parietal compared to females with schizophrenia. (7) An 
inverse correlation between the duration of illness and the right parietal GI and right occipital GI 
in male patients; (8) Female patients having a negative correlation between the duration of illness 
and the left frontal and bilateral temporal GI; (9) In all patients, positive correlations between 
negative symptoms and GI in the right occipital; (10) Male patients having inverse correlations in 
the left occipital GI with negative symptoms; (11) Female patients having positive correlations 
between negative symptoms and the right occipital GI. 
These findings point to abnormalities in the morphological development of the cortical layer 
in schizophrenia. These alterations were generalized bilaterally in the frontal, temporal, and parietal 
cortices, and were in concordance with previous structural findings in the literature (22, 54, 55). 
Taking into consideration two facts: (i) GI values reach their maximum during the first years of 
life and decrease gradually during childhood; (ii) the gyrification pattern is mostly completed at 
birth, yet, the sulco-gyral folds continue to develop until early adulthood (10), we advance that 
neurodevelopmental brain changes may be present at the onset of the illness (27, 32, 56-61) with 
further changes occurring during progression of schizophrenia (56, 62-65) specifically in males 
(56, 66). The finding of sex difference in the GI in schizophrenia is consistent with several reports 
of more neuroanatomical abnormalities in male relative to female patients. For example, Narr et 
al., (2001) found a Sex-by-Diagnosis interaction with schizophrenia males showing a greater loss 
of superior temporal sulcal slope asymmetry in the right hemisphere than schizophrenia females. 
In addition, the authors found greater variability in the longitudinal fissure, reflecting both larger 
sulci and larger CSF space in male relative to female patients (67). In a different study, Bullmore 
et al., (1995) showed a global reduction in the right hemisphere radius of gyrification in males but 
not in females with schizophrenia (30). Similar structural sex differences have been found in 
volumetric and cortical thickness studies (27-29, 31, 32). 
In addition to sex difference in the GI in schizophrenia, we have found a significant decrease 
in GI values with the duration of illness. Decreases were also seen in the right parietal and right 
occipital lobes in males. Female patients had decreases mostly in the left hemisphere (left frontal 
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and temporal and right temporal). Several studies have shown a progressive decrease in global 
brain measurements associated with illness duration (68, 69), specifically in frontal (70, 71) and 
temporal lobes (68, 70), however, the present study is, to the best of our knowledge, the first report 
of sex differences in GI taking into consideration the duration of illness. 
 The overt clinical expression of some psychiatric and neurodevelopmental disorders may 
be a reflection of an underlying abnormality in growth of cortical convolutions (72). It is plausible 
that the significant decrease in the GI observed in schizophrenia is related to the disease itself. 
Nevertheless, we found only an association between occipital GI and negative symptoms, in 
addition there were sex differences, where female patients with more negative symptoms also had 
greater GI in the right occipital cortex, and male patients who had greater negative symptoms had 
lower GI in the left occipital cortex. A study by Onitsuka et al., (2007) showed a relationship 
between reduced volumes in the visual association areas and hallucinations. Their study included 
only male schizophrenia patients (73). Bijanki et al., (2015) reported an association between 
increased white matter fractional anisotropy in the occipital lobe and increased score of Scale for 
the Assessment of Negative Symptoms (SANS) in schizophrenia patients. The authors did not 
report any sex differences (74). Of relevance is a study by Mitelman et al., (2003) showing that 
patients with negative symptoms and poorer outcomes had significantly lower gray matter volumes 
in the temporal and occipital lobes compared to better outcome patients and healthy controls (75). 
The abnormalities in GI in our group of schizophrenia patients in comparison to healthy 
controls were not the same regions that correlated with schizophrenia clinical symptoms as 
measured by the PANSS. We postulate that cognitive deficits play a role in such discrepancy. 
Several studies have shown abnormalities in these regions in relation with deficits in mental 
rotation abilities (76) IQ performance (77) language processing (78), and face recognition (79). 
Along this line of evidence, Jou et al., (2005) demonstrated abnormalities in cortical gyrification 
in individuals at increased genetic risk of schizophrenia (i.e., not presenting the full schizophrenia 
symptomatology) (80). 
Interestingly, female controls had greater GI values than schizophrenia females and both 
male groups in the left frontal; greater values than both patient groups in the bilateral temporal and 
right frontal; and greater values in the left parietal compared to females with schizophrenia. Luders 
et al., (2006) reported similar findings. In this study, the authors found increased gyrification in 
frontal, parietal, temporal, and occipital regions in healthy females compared to healthy males (81). 
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While previous findings investigating GI in schizophrenia (20, 23, 24) did not find any 
significant sex difference, in our study, decreased GI was observed in different regions in 
schizophrenia males relative to control males, and in females with schizophrenia compared to 
control females. Furthermore, sex differences were observed in regions showing lower GI in 
association age as well as illness duration, which in itself, suggest a differential neuropathological 
process implicated in male and female patients. Palaniyappan et al., (2011) showed a strong 
negative correlation between age and gyrification index in schizophrenia in general without 
reference to sex, suggesting a higher degree of age related morphometric changes in patients (26). 
Several hypotheses have been proposed to explain sex differences in the schizophrenia brain. Crow 
et al. (2008) suggested that sex differences related to psychosis are attributed to a genetic species-
specific variation related to a locus on the X and Y chromosomes (82). Gene expression in this 
region is influenced by the degree of X and Y chromosomes pairing in male meiosis. This process 
is referred to as MSUC “meiotic suppression of unpaired chromosomes" which normally would 
lead to a more rapid mean rate of lateralization in females than in males and would in turn, relate 
to the higher incidence rate of language delays and dyslexias in males (82). This complex theory 
posits that language disturbances are integral to psychosis. Cerebral torque (where the right frontal 
lobe is larger than the left, while the left occipito-temporo-parietal is larger than the right) is due to 
the development of neural connections associated with language: from right to left in relation to 
the motor speech output and from left to right in relation to speech perception. Disturbance in this 
neural development was proposed as the basis of the genetic predisposition to psychosis, i.e. the 
authors suggest that schizophrenia is a result of an abnormal cerebral lateralization associated with 
the emergence of language in humans. When this hypothesis is considered in the context of brain 
structures, it may explain the higher levels of anomalies found in male compared to female patients 
in our study and the differences in the development of schizophrenia in males and females in 
general (83). The influence of sex steroid hormones has also been considered in a few studies (84, 
85). These studies strongly suggest that the neuroprotective effects of estrogen (which influences 
sexual characteristics, development of the brain aminergic networks, and the ability to adapt to 
stressful events) enhance the vulnerability threshold for psychosis by the downward regulation of 
dopamine. Such mechanism may explain the later onset and the more positive course of female 
schizophrenia. In this vein, an amalgam of research has been proposed to explain the presence of 
significant brain structure abnormalities in schizophrenia males in comparison to normal control 
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males and schizophrenia females, such as greater enlargement of the lateral and third ventricles 
and decreased frontal and temporal lobe volumes (86, 87) and disease progression (88-90). With 
regards to the latter, Riecher-Rossler et al.,(1994) and Hafner (2003) found that increased levels of 
estrogen in females with schizophrenia with normal menstrual cycles were significantly associated 
with lower severity of schizophrenia symptoms suggesting that that estrogen had: "a weak 
neuroleptic-like effect on schizophrenia symptoms"(89, 91, 92). 
Because cortical gyrification is an important marker of cerebral development (10), we 
investigated the relationship between GI and age in our 96 subjects. We found a more pronounced 
decrease in GI with age in schizophrenia patients relative to healthy controls. Cortical convolution 
is influenced by the degree of thalamo-cortical connections (11). Hence, it is interesting to note the 
significant negative correlation between the GI and the duration of illness. Indeed, various studies 
have implicated thalamo-cortical connections in the pathophysiology of schizophrenia (93-95). 
Based on the preceding arguments, we suggest that the inverse correlations observed in the present 
study reflects the long-term instability in information processing and the failure of associative 
mental processes across the years of illness in schizophrenia.  
This study is limited by the use of the GI only. Further studies should investigate GI along 
with cortical thickness in order to have a better estimate of gray matter density. We emphasize that 
our results are preliminary and that larger studies are necessary to confirm our findings. 
Notwithstanding these limitations, there are two major differences between the present technique 
and other contemporary image analysis methods, which add to our confidence in interpreting the 
data: first, we used a completely automated method to assess GI. An advantage of an automated 
method is that rater error is not a factor and is corrected for multiple threshold. Second, we first 
used the MNI_AutoReg, which performs a 9-parameter, linear registration to the registration target 
model in order to later bring native (original raw) images into MNI-Talairach space. Then, during 
the 16th stage of the Civet pipeline 'non-linear surface registration' stages, where the cortical 
surfaces are produced, they need to be aligned with the surfaces of other brains in the data set so 
that cortical morphology data can compared across subjects. Following this Surfreg performs a 
non-linear registration of the surfaces to a pre-defined template surface. These steps are crucial to 
resampling in native space, which is essential when working with schizophrenia brains. Note that 
while the vertices have been aligned, the topological measurements associated with them (e.g. GI), 
remain unchanged in this process. Finally as gyrification decreases in both healthy controls and 
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patients, gyrification thus becomes a much more ambiguous marker as it is difficult to isolate 
factors of gyrification decline with healthy aging and even more so with disease (confounded by 
disease progression, different behavioural factors, and substance/medication exposure). For 
instance, future research capturing cortical folding measures prior to or at the time of disease onset 
may help clarify what brain effects are due to early development versus secondary effects of 
disease. 
In essence, we reported significant sex differences in GI decreases in schizophrenia, which 
correlated negatively with age and the duration of illness. Since alterations in cerebral development 
and connectivity may be observed by GI, we advance that this decrease is in accord with the agreed 
upon neurodevelopmental hypothesis of disconnectivity (5). In conclusion, we emphasize the 
importance of sex differences in schizophrenia. 
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Figure legends: 
Figure 1a and 1b: Figures show more rapid decrease in GI bilaterally with progressive age in the 
patient group compared to controls. (a) Represents Group-by-Age interaction in the right 
hemisphere regression GI (r2=.121; β=-.347; t=-3.592; p=.001, df=94). (b) Represents group-by-
Age interaction in the left hemisphere GI (r2=.104; β=-.323; t=-3.311; p=.001, df=94)  
Figure 2a and 2b: Figures show more showing that males with schizophrenia had greater GI 
reductions bilaterally yet more pronounced in the right hemisphere with progressive age compared 
to females with schizophrenia (a) represents Age x Sex interaction on the right hemisphere GI 
(r2=.212; β=-.461; t=-3.523; p=.001, df=94). (b) Represents Age x Sex interaction in the left 
hemisphere GI (r2=.121; β=-.348; t=-2.514; p=.016, df=94) 
Figure 3:. Represents interaction between duration of illness and sex (r2=.244; β=-.494; t=-3.856; 
p=.0001, df=46), demonstrating greater decrease in GI in the right hemisphere with the duration of 
illness only in males with schizophrenia. 
Figure 4: Represent higher GI in Female controls in comparison to Male controls and both groups 
of patients. 
Figure 5: Represents variation in GI, top image shows low gyrification index and bottom image 
show high gyrification index. 
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Table 1. Clinical assessments in schizophrenia patients 
 SZ-M Range SZ-F Range P value 
(df=46) 
 Mean (SD)  Mean (SD)   
Age (years) 31.25 (7.96)  20-49 33.04 (8.38) 21-51 0.452 
Duration of illness (years) 11.04 (10.63) 2-25 8.04 (7.55) 1-27 0.265 
Age of onset (years) 21.47 (4.78) 14-35 25.83 (7.37) 18-48 0.021 
PANSS positive score 17.083 (5.76) 8-29 19.62 (7.49) 9-34 0.194 
PANSS negative score 16.12 (4.45) 10-26 20.79 (7.69) 9-39 0.038** 
PANSS general score 36.96 (7.11) 25-54 42.41 (12.66) 24-72 0.072 
PANSS total score 70.92 (13.92) 46-107 82.83 (26.08) 41-140 0.05** 
Chlorpromazine equivalence (mg/day) 542.29 (372.09) 100-1500 438.71 (276.35) 66-1100 0.279 
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Table 2. Lobar GI measures 
 NC-M NC-F SZ-M SZ-F 
 Mean (SD) Mean (SD) Mean (SD) Mean (SD) 
Left       
Frontal  2.4366 (0.1137) 2.5341 (0.1060) 2.3904 (0.1302) 2.4139 (0.1181) 
Temporal 2.7597 (0.1817) 2.8517 (0.1777) 2.7055 (0.1782) 2.6929 (0.1769) 
Parietal   3.0085 (0.1717)  3.090 (0.1813) 2.9730 (0.1795) 2.9463 (0.1373) 
Occipital  2.0797 (0.1578)  2.117 (0.1702) 2.0565 (0.1511) 2.1097 (0.1607) 
Right       
Frontal  2.4473 (0.1261) 2.5287 (0.0978) 2.3986 (0.1135) 2.4355 (0.1324) 
Temporal  2.6461 (0.1639)  2.7402 (0.1581) 2.5912 (0.1372) 2.5525 (0.1758) 
Parietal   3.0525 (0.1375)  3.100 (0.1408) 3.0095 (0.1437) 3.0081 (0.1793) 
Occipital 2.2532 (0.1317) 2.3101 (0.1525) 2.1942 (0.1393) 2.2556 (0.1513) 
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Figure 1a. Representing Group x Age interaction in the right hemisphere 
 
  
 
 
  
Controls R2 Linear = 0.058 
Patients R2 Linear = 0.212 
Fit line for total R2 Linear = 0.121 
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Figure 1b. Representing Group x Age interaction in the left hemisphere 
 
 
  
Controls R2 Linear = 0.091 
Patients R2 Linear = 0.121 
Fit line for total R2 Linear = 0.104 
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Figure 2a. Representing Age x Sex interaction on the right hemisphere 
  
  
Males R2 Linear = 0.374 
Females R2 Linear = 0.098 
Fit line for total R2 Linear = 0.212 
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Figure 2b. Representing Age x Sex interaction on the left hemisphere 
  
 
 
  
Males R2 Linear = 0.217 
Females R2 Linear = 0.061 
Fit line for total R2 Linear = 0.121 
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Figure 3. Duration of illness and Sex interaction in right hemisphere 
  
men R2 Linear = 0446 
women R2 Linear = 0.059 
Fit line for total R2 Linear = 0.244 
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Figure 5 
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6 Article 2 
The following work has been re-submitted to Psychiatry Research Journal after including 
the reviewer’ corrections under the title: “Symptom based gray and white matter densities in 
schizophrenia”. We are awaiting the journal’s reply.  
 
In the first study, an important and unanticipated finding was the fact that symptoms 
correlated only with the GI of the occipital lobe, while, abnormalities in GI in our group of 
schizophrenia patients in comparison to normal controls were found in several cerebral regions. 
This intriguing finding lead to the work presented in the second paper, were we postulated that 
deeper structures and white matter are associated with symptoms of schizophrenia, and that this 
relation differs in male and female patients. Using voxel based morphometry, association between 
greater WMD and more severe symptom scores of conceptual disorganization and attention deficits 
were revealed. However, when considering the two sexes individually it became clear that there 
were no specific correlations between total GM, WM, CSF, or total brain densities and 
schizophrenia symptoms in female patients, while WMD in males correlated negatively with ideas 
of grandiosity, and positively with conceptual disorientation and attention deficits. To our 
knowledge, this is the first report of a direct relationship between white matter density and 
conceptual disorganization and attention deficits in schizophrenia and the first report of sex 
differences in correlation between symptoms and white matter densities. 
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Abstract 
We investigated the association between gray matter density (GMD) and white matter density 
(WMD) phenotypes and positive and negative symptoms in 40 schizophrenia patients (SZ). 
Additionally, cerebral volumes were compared with 41 normal controls (NC) matched for age and 
sex using voxel-based morphometry on T1-3T-MRI. We found decreased GMD in the anterior 
cingulate-temporal gyri and increased GMD in the posterior cingulate gyrus in SZ relative to NC. 
In addition, WMD reduction was found in the inferior frontal and posterior parietal regions in SZ 
relative to NC. GMD in the insula/caudate correlated with positive symptoms, while GMD in the 
middle frontal gyrus and cerebellum (uvula) correlated with negative symptoms. WMD in the 
middle frontal and superior frontal regions correlated with positive and negative symptoms 
respectively. Invers correlations were found between GMD in the parietal lobe and the uvula with 
positive symptoms. Additionally, an inverse correlation was found between GMD in the 
cerebellum (anterior lobe) and negative symptoms. Inverse correlation was also found in the WMD 
of the occipital region and superior frontal regions with positive and negative symptoms 
respectively. Comparison between male groups revealed decreased total GMD in SZ-M, while no 
differences were observed between female groups. Fronto-temporal reductions in patients support 
previous studies. These correlational findings suggest that symptom profiles in schizophrenia show 
unique GM/WM phenotypes. Our results reject the notion that all patients might share a core 
network of neuropathology. 
 
Keywords: schizophrenia, positive and negative symptoms, gray and white matter density, voxel 
based morphometry. 
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Introduction 
 
Schizophrenia is thought to be underpinned by neurodevelopmental abnormalities of brain 
gray matter and white matter function, structure and connectivity (1-4). To date, schizophrenia 
patients are mainly diagnosed using subjective criteria of psychiatric diagnostic manuals (DSM 
and ICD). These definitions emphasize the co-occurrence of positive symptoms (i.e., 
hallucinations, delusions, and paranoid ideation), and negative symptoms (i.e., poverty of thought 
and loss of motivation) (5-7). These definitions are markedly heterogeneous and patients diagnosed 
with schizophrenia do not necessarily share common symptoms. There is increasing clinical 
evidence that schizophrenia is a disorder of integration of information between specialized brain 
regions.  
Functional and structural alterations in cerebral gray matter (GM) and white matter (WM) 
in schizophrenia, particularly in the prefrontal cortex (including the anterior cingulate), the superior 
temporal gyrus, the limbic system (medial temporal lobe, hippocampus, entorhinal cortex, and 
amygdala) as well as in the basal ganglia, insula, the thalamus, and the cerebellum are well 
established (8-13). The heterogeneity of the findings do not easily allow for a parsimonious or 
singular anatomic substrate for schizophrenia phenotypes. 
 To date, among the most robust biological markers of pathology in schizophrenia are the 
alterations in brain structure correlated with symptoms detected using magnetic resonance imaging 
(MRI). An attempt to correlate each of these brain regions to specific symptoms might help advance 
our way to discovering true endophenotypes. Additionally, the identification of GM and WM 
structural correlates with symptomatology comparing between/within schizophrenia and other 
brain disorders might unveil the underlying genetic and pathophysiological bases and pinpoint 
better-tailored therapeutic targets. For example, the analysis of the National Institute of Mental 
Health, Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial, 
stated that negative symptoms have greater impact on global functioning than positive symptoms 
because of their undetermined etiology and resistance to treatment (14). Grouping patients by 
specific genetic, neuroanatomical and symptoms endophenotypes (15, 16) may yield more specific 
findings.  
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Sex differences have an important impact on symptoms in schizophrenia. The presence of 
negative symptoms in males with schizophrenia compared to females is a consistent finding in the 
literature, and is typically twice as severe in males than in females (17-26). The stability of positive 
and negative symptoms has been also shown to be affected by the sex of patients. Mancevski and 
colleagues (2007) reported significant decreases in positive symptoms and increases in negative 
symptoms over the course of the illness, which were particularly pronounced in males (27). 
Neurostructural differences in males and females with schizophrenia have also been reported. 
Imaging studies on sex–dependent brain abnormalities have consistently reported more severe 
disturbance in males than in females with schizophrenia: reduced prefrontal volumes, reduced 
anterior temporal horn and medial temporal lobe volumes, more specifically amygdala, 
hippocampus, superior temporal and larger ventricular-brain ratios (VBR)(28-37). Few studies 
address the relation between differences in brain structure and symptoms in males and females.  
Our group has studied the relation between cortical gyrification and symptoms in males and 
females with schizophrenia (38). Our results showed that male schizophrenia patients had inverse 
correlations between the cortical gyrification index (GI) in the left occipital cortex and negative 
symptoms, while female patients had positive correlations between GI in the right occipital cortex 
and negative symptoms. In addition, overall more sever cortical abnormalities were observed in 
male patients. An important and unanticipated finding was the fact that symptoms correlated only 
with the cortical gyrification of the occipital lobe, while abnormalities in cortical gyrification in 
our group of schizophrenia patients in comparison to normal controls were found in several other 
cerebral regions.  
The main purpose of the present study was to investigate the relation between schizophrenia 
symptoms and gray and white matter densities and the effect of sex on this relation using DARTEL- 
voxel-based morphometry. We hypothesized that deeper grey and white matter structures would 
be associated with symptoms of schizophrenia and that this relation would show sex differences. 
We expected changes in fronto-limbic structures to be differentially associated with PANSS scores. 
Particularly, we hypothesized that (1) gray and white matter densities in fronto-limbic region would 
differ between schizophrenia patients and normal controls, (2) these regions would differ in relation 
to the PANSS positive versus negative symptoms and that (3) males with schizophrenia would 
show more sever grey and white matter abnormalities than females with schizophrenia.  
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Methods 
Participants 
Eighty-one subjects were included in this study: 41 normal controls (NC) (22 males [NC-
M] and 19 females [NC-F]) and 40 individuals SZ diagnosed with schizophrenia (SZ) (20 males 
[SZ-M] and 20 females [SZ-F]) according to DSM-IV criteria (39) All patients were in a stable 
phase of their illness (defined as no relapse within the last two months and no change in their 
antipsychotic treatment within the last month). The groups were matched for age, sex, handedness 
(Edinburgh Inventory) (40) and parental socioeconomic status (National Occupational 
Classification (NOC). 
There was no significant difference in age between NC (mean age=31.51, SD=7.88) and 
SZ (mean age=32.08, SD=6.96), p=0.735. In addition, no significant differences were found 
between male groups or female groups. NC-M had a mean age of 30.50, SD=7.85 (p=0.677), NC-
F aged 32.68 SD=7.96 (p=0.988). 
Experienced psychiatrists reevaluated all patients before being assigned to the research 
group according to DSM-IV criteria. Affective, schizoaffective, and schizophreniform psychoses 
were excluded. Control participants were screened with the non-patients edition of the Clinical 
Interview for DSM-III (SCID) (41). The positive and negative syndrome scale (PANSS) was used 
to rate symptom severity (5, 7). The date of illness onset was defined as the date of 1st psychiatric 
consultation, for lack of reliable information from family members and patients. Schizophrenia has 
common symptoms with other psychiatric disorders, such as bipolar disorder, personality 
disorders, etc., therefore a psychiatric consultation favors a better diagnosis. All the patients 
received at least one atypical antipsychotic (chlorpromazine equivalence was calculated) (42). 
General exclusion criteria included: age below 18 or above 45 years, past or present 
neurological or Axis-I psychiatric disorder, alcoholism or drug abuse, noncompliance with testing 
procedures, abnormal uncorrected vision, or any contra-indication for MRI such as a cardiac 
pacemaker, an aneurysm clip, a metal prostheses or cardiac valve replacement, the presence of 
metal in an eye or any part of the body, certain dental work, or claustrophobia. 
In agreement with the Declaration of Helsinki, written informed consent was obtained prior 
to participation in the experiment. The ability of schizophrenia patients to give informed consent 
was established using the guidelines of the Canadian Psychiatric Association. The ethics 
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committees of the Fernand-Seguin Research Center of the Louis-H Lafontaine Hospital and the 
Regroupement Neuroimagerie Québec approved the study. Full details of subject characteristics 
are given in Table 1. All healthy participants were medication naïve, with no history of neurological 
or psychiatric disease. No abnormalities were observed on their brain structural MRIs. 
 
---------Insert table 1 around here------- 
 
Image acquisition  
 
Eighty-one individual high-resolution co-planar anatomical images were acquired using an 
12-channel headcoil (three-dimensional, spoiled gradient echo sequence; sagittal orientation, 
slices=176, scan time 9:38 min, slice thickness=0.98 mm, TR=19 ms, TE=4.92ms, flip angle=25°; 
matrix 256x256 voxels, FOV:  256x256 mm, isotropic voxels 1.0 x 1.0 x 1.0mm) on a MRI 
Siemens TRIO-TIM system (Total Imaging Matrix) at 3.0 Tesla operating at the University of 
Montreal Geriatric Institute.  
 
Image and statistical analyses 
Statistical Parametric Mapping (SPM8, Wellcome Department of Cognitive Neurology) 
implemented in MATLAB R2010a (Mathworks, Sherborn, MA) was used for image analyses. 
Images were converted to NIFTI format and processed using the latest version of SPM8. All 81 
subjects passed the SPM8 data quality control. Images were analyzed using the Diffeomorphic 
Anatomical Registration Through Exponentiated Lie Algebra (DARTEL) toolbox in the latest 
version of SPM8 used for voxel-based morphometry (VBM). We used VBM to assess the voxel-
wise comparison of the local concentration/volume of GM and WM between groups (NC and SZ), 
then within the SZ (multiple-regression with the PANSS). 
DARTEL toolbox uses a high dimensional warping process that increases the registration 
between individuals, which results in improved localization and increased sensitivity in analyses 
(43). Processing begins with the “import” step. This involves taking the parameter files produced 
by the segmentation, and writing out rigidly transformed versions of the tissue class images, such 
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that they are in as close alignment as possible with the tissue probability maps. The second step is 
the registration itself. It involves the simultaneous registration of GM with GM and WM with WM. 
This procedure begins by creating a mean of all the images, which is used as an initial template. 
Deformations from this template to each of the individual images are computed, and the template 
is then re-generated by applying the inverses of the deformations to the images and taking their 
average. Following this, warped versions of the images can be generated. These steps improve 
computational anatomy providing more easily interpreted voxel-based morphometry (VBM), and 
better parameterization of brain shapes. The normalized gray matter (GM) and white matter (WM) 
maps were then modulated with the resulting Jacobian determinant maps and smoothed with an 8-
mm FWHM Gaussian kernel. 
Total GMD, WMD and brain volume were obtained from calculated raw volumes in the 
VBM8 toolbox. The segmented images were visually inspected, then imported to DARTEL for 
warping procedure, and finally iteratively aligned to the average template. During DARTEL 
warping, the segmented images were modulated with Jacobian determinates to preserve volume 
changes. Expert users carefully evaluated each step to check for normalization or segmentation 
errors. For more details please refer to Ashburner et al., (2007, 2009) (43, 44) and 
http://www.fil.ion.ucl.ac.uk/spm/software/spm8/SPM8_Release_Notes.pdf 
In SPM8 VBM, all statistical analyses used the general linear model (GLM), which is used 
to identify regions of GM and WM concentration/volume that are significantly related to a specific 
variable (45). We conducted an exploratory whole-brain analysis. VBM is not biased to one 
particular structure, which permits an even-handed and comprehensive assessment of anatomical 
differences throughout the brain (45). All reported brain regions were examined at a threshold 
corrected for multiple comparisons (FWE-corrected at cluster-level, p<0.05). All coordinates are 
reported in Montreal Neurological Institute (MNI) format. Using the tool Talairach Applet 
(http://www.talairach.org/applet.html) the anatomic location of significant clusters was detected. 
We used SPM to perform group structural differences and to perform exploratory whole brain 
correlation analyses with PANSS positive and negative symptoms. 
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Automatic Linear Modeling (ALM)  
We further conducted a prediction model using the Automatic Linear Modeling (ALM) in 
SPSS21. We fitted an ALM for GMD and WMD separately with covariates as age, sex, duration 
of illness, age of onset, medications, cognitive scale measures (Raven percentile, Wechsler Adult 
Intelligence Scale (WAIS), all positive PANSS symptoms and all negative PANSS symptoms. 
Separate regression analyses of total GMD and WMD were performed on the best linear unbiased 
predictors. To that end, we used the forward stepwise approach combined with the Akaike’s 
Information Criterion Corrected (AICC) (46). We applied the best subset that checks "all possible" 
models, or at least a larger subset of the possible models than forward stepwise, to choose the best 
according to the best subsets criterion. The model with the greatest value of the criterion is chosen 
as the best model. Then, we applied the adjusted R-squared so that any effects in the model that 
correspond to a decrease in the prediction model are removed (i.e., p<0.05). 
 
Results 
Imaging results 
SZ showed lower gray matter densities in the anterior cingulate cortex and left middle 
temporal region, and higher GMD in the left posterior cingulate, relative to NC. Moreover, SZ had 
significantly lower WMD in the left inferior frontal rectal and the left posterior parietal regions in 
comparison to NC (Table 2). 
 
--------Insert table 2 and Figure 1 about here------- 
 
We observed significant positive correlations (p<0.05) between positive symptoms and 
GMD in the left insula and right caudate; and between negative symptoms, the right middle frontal, 
and the posterior lobe of right cerebellum (uvula) (Table 3, Figure 2).  
Inversed significant correlations were found between positive symptoms and GMD both 
the right parietal (precuneus), and the posterior lobe of left cerebellum (uvula). Additionally, 
inversed correlations were found between negative symptoms and the anterior lobe of the left 
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cerebellum. Concerning WMD, positive correlations were found with positive symptoms in the 
right middle frontal region, while negative symptoms were positively correlated with WMD in the 
right superior frontal region. Negative correlations were found between positive symptoms, the 
right inferior occipital, and the right occipital cuneus. Negative symptoms correlated negatively 
with the left superior frontal (Table 4, 3). 
 
--------Insert Table 3 and 4 and Figure 2 and 3 about here------- 
 
Comparison between male groups revealed decreased total GMD (F=.126 t=2.217 df =40 
p=.32) while no differences were observed in female groups. SZ-F showed no correlation between 
total GMD, WMD, CSF, or total brain volume and schizophrenia symptoms. SZ-M showed inverse 
correlations between ideas of grandiosity and WMD (r=-.551, r2=.303, t=-2.639, p=.018, df=38). 
Additionally, SZ-M showed positive correlation between disorientation and WMD (r=.545, 
r2=.297, t=2.598, p=.019, df=38), attention deficits and GMD (r=.466, r2=.217, t=2.108, p=.05) 
and attention deficits and WMD (r=.463, r2=.214, t=2.089, p=.05, df=38) (Figure 4). 
 
-------Insert Figure 4 around here------ 
 
We further conducted an exploratory prediction model of the linear regression relationship 
between GMD and WMD with the PANSS symptoms respectively in all patients. We note that 
they share the conceptual disorganization symptom, which is positively correlated with both 
structures (GMD: coefficient=38.99; F=5.43; p<0.026 and WMD: coefficient=41.69; F=7.53; 
p<0.010). Conversely, we note that GMD was negatively correlated with lack of spontaneity 
(F=6.10; t=-2.50; p<0.020) and hallucinations (F=5.89; t=-2.43; p<0.021). WMD was negatively 
correlated with hostility (F=5.80; t=-3.12; p<0.01) and grandiosity (F=7.82; t=-2.80; p<0.01) 
(Figure 5 and 7). 
 
-------Insert Figures 5 and 7 around here------ 
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 The intensity of lack of spontaneity (p=0.019) and hallucination (p=0.021) symptoms 
predicted the degree of GMD loss, while increased hostility (p=0.007) and grandiosity (p=0.008) 
symptoms predicted decreased WMD. Interestingly, the intensity of conceptual disorganization 
was a predictor factor of increased GMD (p=0.026) and WMD (p=0.10) in SZ (Figure 6 and 8).. 
 
-------Insert Figure 6 and 8 around here------ 
 
Results of clinical assessments: 
No differences were found between SZ-M and SZ-F when using the total PANSS scores of: 
negative, positive, or general items. When analyses were performed by individual item, no 
differences were found between SZ-M and SZ-F except on item “Guilt feeling” of the PANSS 
general, where SZ-F had higher scores (SZ-M: mean=1.67, SD=0.69, SZ-F: mean=2.38, SD=0.96, 
p=0.018, df=38). 
 
----------Insert Table 5 around here------- 
 
Cognitive behavioral assessments:  
Significant differences were found between NC and SZ groups in terms of years of 
education and cognitive performance (Table 6). 
 
--------Insert Table 6 around here------- 
 
Discussion 
 The main purpose of the present study was to investigate the relation between schizophrenia 
symptoms and gray and white matter densities and the effect of sex-specific differences on this 
relationship. As hypothesized, males with schizophrenia showed lower GMD compared to same-
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sex normal controls, while no difference were observed in female groups. Females with 
schizophrenia showed no correlations between brain densities and symptoms, while male patients 
showed several correlations, specifically between WMD and disorientation, and between both 
GMD and WMD and attention deficits. In addition, inverse correlation were observed between 
WMD and ideas of grandiosity. In addition to our findings on sex differences, the analyses revealed 
several correlations between symptoms and GMD in schizophrenia patients regardless of sex: 
between positive symptoms and GMD in the left insula and right caudate; between negative 
symptoms and GMD in the right middle frontal and the posterior lobe of right cerebellum (uvula). 
Inverse correlation were also observed between positive symptoms and GMD in the right parietal 
(precuneus), the posterior lobe of left cerebellum (uvula) and between negative symptoms and 
GMD in the anterior lobe of the left cerebellum. We also observed correlation between WMD and 
symptoms: between positive symptoms and WMD in the right middle frontal region and between 
negative symptoms and WMD in the right superior frontal region. Inverse correlation between 
positive symptoms and WMD were observed in both right inferior occipital and right occipital 
cuneus regions. Additionally, patients showed inverse correlations between negative symptoms 
and WMD in the left superior frontal region. Individual symptoms such as conceptual 
disorganization were also found to correlate with both GMD and WMD. Inverse correlations were 
observed between lack of spontaneity and hallucinations and GMD. Hostility and grandiosity 
inversely correlated with WMD. 
The finding regarding group main effect differences between NC and SZ is consistent with 
the literature (47). The anterior cingulate finding is of particular interest since a recent study 
showed that “at risk” subjects who actually develop psychosis had significantly smaller anterior 
cingulate volumes (48). Furthermore, in a recent meta-analysis, Sepede and colleagues (2014) 
argued that alterations of the anterior cingulate cortex seemed to be more common in schizophrenia 
than in bipolar disorder (8). The increased GMD of the posterior cingulate in the schizophrenia 
group may indicate a compensatory mechanism in response to the anterior cingulate deficit. 
We have also found decreased GMD in the left middle temporal, which represents one of 
the most consistent findings in patients with schizophrenia (49, 50). 
 Our significant finding of the positive relationship between PANSS positive symptoms and 
the insula and the caudate density is also consistent with some previous studies. The insula has 
been involved in emotional interoceptive representations (51) and positive symptoms were shown 
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to correlate with reward anticipation signal in the insula in individuals at high risk to develop 
psychosis (52). A recent study by Rolland et al., (2015) demonstrated that patients with acoustico-
verbal hallucinations show bilaterally greater resting state functional connectivity in the insula (53). 
Similarly, Sepede and colleagues (2014) demonstrated that significantly altered functioning of the 
insula was found in schizophrenia, and proposed it as a candidate trait marker for psychosis (8). 
We postulate that due to its location at the interface of frontal, parietal and temporal lobes, the 
insula is involved in cognitive, emotional, and somato-sensorial processes, hence providing a hub 
that integrates salient stimuli with somatosensory and autonomic information (54-57). The 
increased GMD could be associated with the over stimulation of cognitive, emotional and somato-
sensorial processes regulated by the insula resulting in delusions and hallucinations, which are 
characterized by amplification of emotional and sensory motor perception and processing. A strong 
functional connectivity has been reported between the insula and caudate. The caudate have been 
reported be functionally connected with emotive and cognitive regions including the amygdala and 
portions of the anterior and posterior cingulate and has been involved in the neurobiology of 
schizophrenia positive symptoms in relation to dopamine dysfunction (58-60). We should note 
however, that it might be related to medication (61). 
The parietal cortex was negatively correlated with the PANSS positive symptoms. 
Conversely, the frontal cortex was positively correlated with the PANSS negative symptoms. In 
accordance with these results, a study by Dazzan and colleagues (2012) demonstrated that subjects 
who develop affective psychosis had reductions in the frontal cortex. Subjects who developed 
schizophrenia had smaller volumes in the parietal cortex (48). The positive correlation in the 
middle frontal with negative symptoms is of particular interest. Several studies point out the 
importance of this region in emotion regulation (62-64), and in down-regulation of emotional 
processing (65) in normal population. A meta-analysis by Kohn et al. (2014) concludes that the 
middle frontal region (dorsolateral frontal cortex-DLPFC) plays a key role in action inhibition and 
proposes that it modulates “higher order ‘cold’ regulatory processes” (66). Of specific relevance to 
our results are findings by Smith et al., (2013) showing that a decrease in volume of the DLPFC is 
associated with improvement of depression symptoms in patients with depression (67). In view of 
these findings, it is reasonable to say that negative symptoms, which share several characteristics 
with major depression, are associated with over engagement of the DLPFC in affective inhibitory 
processes in schizophrenia patients. 
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Present findings point to the importance of the cerebellum in mediation of positive and 
negative symptoms and brain. Historically, the cerebellum was largely ignored in schizophrenia 
research. In 1979, Heath and colleagues were among the first groups to pinpoint gross pathology 
of the cerebellum in psychotic patients (68). In 1995, Martin and Albers concluded that 
morphological and functional data support the role of the cerebellar dysfunction in the pathogenesis 
of schizophrenia (69). In their review, Andreasen & Pierson (2008) argued that the cerebellum 
plays a role in higher cognitive and emotional cortical functions (70). The cerebellum with its 
cortical connections (the limbic system, the frontal, parietal, prefrontal, occipital, and temporal 
cortex) opens a pathway for explaining the diversity of schizophrenia symptoms (71). Based on 
our results, the cerebellum is mainly correlated with the PANSS negative symptoms. This may be 
in agreement with previous research findings asserting the cerebellum as an emotional pacemaker 
(72). In their review, Stoodley et al. (2010) specified that the posterior cerebellum was linked to 
cognition and the posterior vermis with emotion and cognitive affective syndromes such as 
passivity, blunted affect and withdrawal (72). Our results point out to the involvement of the vermis 
(affective) and the posterior cerebellum (cognitive) in regulation of negative symptoms such that 
increased cognitive regulation/inhibition is associated with decreased emotional processes, which 
may play a role in negative symptoms. The negative relation between the cognitive part of the 
cerebellum and positive symptoms is intriguing. Symptoms such as hallucinations and delusions 
were found to be associated with deficits in several cognitive processes (73), perception and 
correction errors (72), source and self-monitoring (75), stimulus recognition (76), and reality 
monitoring (77, 78). The relation between these cognitive processes and the cerebellum are not 
fully understood. 
Regarding WM abnormalities, we observed a strong relationship between the superior 
frontal region and negative symptoms. This finding is coherent with the fact that male patients 
showed an inverse correlation between WMD and ideas of grandiosity, and a positive correlation 
with conceptual disorientation and attention deficits. This is in agreement with previous studies 
concluding that abnormalities in the superior frontal executive region could explain negative 
symptoms (47, 79). 
 The abnormalities in GMD and WMD in our group of schizophrenia patients in comparison 
to normal controls were not in the same regions that correlated with schizophrenia clinical 
symptoms as measured by the PANSS. This is relevant and we postulate that cognitive deficits 
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play a role in such discrepancy. We reviewed neuropsychological cognitive data collected (the 
WAIS-III and Raven percentile tests) from the patients and normal group. Significant deficits were 
observed in the schizophrenia groups in all measures when compared to healthy subjects (Table 6). 
Abnormalities in the left middle temporal, the left inferior frontal and the left posterior parietal 
regions were found to be correlated with deficits in emotional memory accuracy in another study 
performed by our group (paper submitted), and several studies have shown abnormalities is these 
regions in relation with deficits in mental rotation abilities (80), IQ performance (81), language 
processing (82), and face recognition (83). 
 When examining sex-dependent differences, we noted that male patients had decreased 
total GMD when compared to normal control males, while no differences were observed in female 
groups. Several studies show that males with schizophrenia have more GM abnormalities than 
females with schizophrenia. Such abnormalities include: reduced prefrontal volumes; reduced 
anterior temporal horn and medial temporal lobe volumes, more specifically amygdala, 
hippocampus, superior temporal and larger ventricular-brain ratios (VBR); or females have more 
preserved cerebral morphology (28-37). Several authors have suggested that these differences are 
due to the neuroprotective effects of estrogen in females (84-86). In terms of correlation, females 
revealed no specific correlation between total GMD, WMD, CSF, or total brain volume and 
schizophrenia symptoms. In contrast, WMD in males inversely correlated with ideas of grandiosity, 
and positively with conceptual disorientation and attention deficits. To our knowledge, this is the 
first study to report a direct relation between white matter volume and these symptoms. 
Interestingly a study by Sallet et al., (2003) found correlations between cortical gyrification index 
and grandiosity (87). Gyrification index measures cortical folding, a feature that is hypothesized to 
represent underlying white matter (88). The white matter abnormalities are in support of 
neurodevelopmental disturbance that is more evident in males than females with schizophrenia. 
Regardless of sex of patients, our exploratory prediction model of the linear regression 
relationship between GMD and WMD with the PANSS symptoms has produced stimulating 
results. The negative correlation between WMD and ideas of grandiosity remained significant after 
grouping male and female patients together. This in itself gives further support to the important 
role of sex differences in schizophrenia. Here we report for the first time the relation between 
WMD and hostility, where increased WMD is correlated with less hostility. Only two related 
studies by Hoptman et al., (2002, 2010) have found white matter microstructure abnormalities of 
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the inferior frontal, in particular higher trace, i.e. the average diffusion coefficient of white matter 
tracts over 3D directions. The authors also found reduced functional connectivity in white matter 
between the amygdala and ventral prefrontal cortex regions to be correlated with increased 
aggression in patients with schizophrenia (89, 90). 
 Of particular interest is the association between greater WMD and more severe symptom 
scores of conceptual disorganization and attention deficits. To our knowledge, no other study has 
reported such findings in schizophrenia. To make sense of this finding, we seek support from other 
psychopathologies. Similar findings have been reported in autism, where increased white matter 
volume was associated with language and communication deficits (91), which are fundamental 
elements in the construction of conceptual disorganization. However, further studies are needed in 
schizophrenia to support this view. 
In our study GMD was inversely correlated with hallucinations, in concordance with several 
studies showing a similar association with gray matter in the left superior temporal gyrus (92-94), 
left thalamus, left and right cerebellum (93) middle/inferior right prefrontal gyri (94), bilateral 
insula and left amygdala (92) (also see review by Aguilar et al., 2008) (95). 
The intensity of lack of spontaneity and hallucination symptoms predicted the degree of 
GMD loss, while increased hostility and grandiosity symptoms predicted decreased WMD. 
Interestingly, the intensity of conceptual disorganization was a predicting factor of increased GMD 
and WMD in schizophrenia patients. To this end, future studies investigating the correlation 
between individual symptoms and specific cerebral regions are needed. 
We should consider the limitations of the present study such as potential effects of 
antipsychotic medication (past and current). We specify that all our patients were receiving 
consistent doses of first- or second-generation antipsychotic medication. All patients were in a 
stable phase of their illness (defined as no relapse within the last two months and no change in their 
antipsychotic treatment within the last month). All patients received at least one atypical 
antipsychotic (chlorpromazine equivalence was calculated) (42). The second limitation is that our 
clinical assessment was not exhaustive. We used only one scale to assess the positive and negative 
symptoms (i.e., the PANSS). Hence, we anticipate in our future research to investigate the 
association of the regions within each of the positive and negative symptoms using further scales. 
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Conclusion 
Considerable heterogeneity remains across studies investigating changes in GM and WM 
volume structures in schizophrenia. Despite the diligent efforts to control for age, sex, medications, 
and disease onset, heterogeneous symptoms could contribute to inconsistent findings. Our group 
previously advocated that future studies should group large number of patients by symptom 
dimensions. (96-99). Taking into account the importance of sex differences in schizophrenia, 
studies using the symptoms’ dimensional approach in schizophrenia may be important for 
elucidating the core pathophysiology of this illness. 
We should note that despite significant findings in this domain, neuroanatomical 
abnormalities are insufficiently sensitive to be individually or collectively diagnostic of the disease 
(or its prognosis/etiology). Hence, the abnormalities have yet to be integrated into a clinically 
validated model, which would permit a coherent approach towards early detection, prevention, and 
treatments. 
Our results shed further light on the neuroanatomical underpinnings of psychosis, providing 
insights into the physiological nature of positive versus negative symptoms. In essence, our study 
provides neurobiological evidence on the validity of a combination of overlapping and differing 
brain structural neuropsychopathology assessed by the PANSS. More importantly, our results 
reject the notion that all patients might share a core network of neuropathology. To this end, future 
studies should investigate the correlation between individual symptoms and specific cerebral 
regions. 
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Table 1. Demographics of schizophrenia patients 
 
 SZ-M SZ-F P value 
 Mean (SD) Mean (SD) df=38 
Age 31.50 (7.55) 32.65 (6.46) 0.608 
Years of education 11.20 (2.06) 12.25 (3.47) 0.253 
Age of onset 19.89 (2.97) 24.40 (7.75) 0.007 
Duration of illness (years) 11.57 (7.74) 8.25 (5.70) 0.136 
Parental socio-educational status 2.82 (.612) 2.62 (1.06) 0.470 
Chlorpromazine equivalence 722.50 (383.74) 443.33 (280.94) 0.012 
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Table 2. Regions of gray and white density differences between the schizophrenia group and 
healthy controls based on voxel-based morphometry analyses 
 
 Brain region K (voxels) t (p<0.05 PFDR- corr) 
MNI coordinates  
GMD  
NC > SZ 
anterior cingulate cortex (BA32) 336 6.02 (0, 44, 10) 
 Middle temporal cortex (BA21) 373 5.97 (-59, -1, -21) 
GMD 
SZ > NC 
Posterior cingulate 230 4.02 (-30, -63, 16) 
WMD 
NC > SZ 
Inferior frontal rectal  130 4.12 (-6, 21, -23) 
 Posterior parietal  138 3.72 (-9, -48, 66) 
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Table 3. Positive correlations between GMD and WMD regression analysis based on 
symptoms (all results are p<0.05, PFWE- corr).  
 
  
GMD Region K T MNI 
PANSS positive L Insula 523 4.68 -42, -42, 18 
 R Caudate 195 4.21 35, -16, -9 
PANSS negative R Middle Frontal 467 5.03 38, 36, 42 
 R Cerebellum posterior lobe Uvula 206 4.57 39, -84, -21 
WMD Region K T MNI 
PANSS positive R Middle frontal 240 3.82 27, 57, -8 
PANSS negative R superior frontal 72 4.32 14, 56, 24 
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Table 4. Negative correlations between GMD and WMD regression analysis based on 
symptoms (all results are p<0.05, PFWE- corr).  
 
GMD Region K T MNI 
PANSS positive R Parietal lobe precuneus 125 -3.04 6, -72, 52 
 L Cerebellum posterior lobe Uvula 219 -3.45 -9, -88, -21 
PANSS negative L Cerebellum anterior lobe 106 -3.87 -5, -52, -23 
WMD Region K T MNI 
PANSS positive R Inferior occipital  124 -4.03 44, -82, -8 
 R Cuneus occipital 145 -3.88 21, -94, -2 
PANSS negative L superior frontal 311 -4.97 -8, 18, 60 
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Table 5. Clinical assessments in schizophrenia patients 
 SZ-M SZ-F P value 
 Mean (SD) Mean (SD) df=38 
PANSS positive 17.95 (5.33) 19.65 (8.03) 0.435 
Delusions 3.39 (1.09) 3.31 (1.35) 0.857 
Conceptual disorganization  3.06 (0.87) 3.31 (1.30) 0.500 
Hallucinations 2.06 (1.23) 3.31 (1.49) 0.941 
Excitation/Hyperactivity 2.06 (0.87) 2.25 (1.13) 0.575 
Grandiosity 2.11 (1.23) 2.50 (1.59) 0.429 
Suspiciousness/persecution 2.28 (1.23) 3.25 (1.73) 0.066 
Hostility 1.56 (0.86) 2.21 (1.15) 0.108 
PANSS negative 19.50 (5.36) 21.25 (8.30) 0.434 
Blunted affect 3.11 (1.02) 3.29 (1.26) 0.868 
Emotional withdrawal 3.00 (1.28) 3.38 (0.31) 0.397 
Poor rapport 2.72 (1.02) 3.19 (1.52) 0.296 
Passive/apathetic 2.61 (1.09) 2.88 (1.15) 0.497 
Difficulty in abstract thinking 2.50 (0.99) 3.19 (1.42) 0.108 
Lack of spontaneity and flow of conversation 2.50 (1.15) 3.12 (1.59) 0.194 
Stereotyped thinking 2.61 (0.92) 3.06 (1.29) 0.244 
PANSS general 38.75 (5.27) 43.10 (12.92) 0.171 
Somatic concern 2.44 (1.20) 2.62 (0.96) 0.634 
Anxiety 2.61 (0.92) 3.31 (1.30) 0.076 
Guilt feelings 1.67 (0.69) 2.38 (0.96) 0.018* 
Tension 2.44 (0.78) 2.93 (1.29) 0.182 
Mannerisms and posturing 2.67 (0.84) 2.93 (1.57) 0.528 
Depression 2.23 (0.67) 2.69 (0.87) 0.132 
Motor retardation 2.22 (1.11) 2.56 (1.21) 0.400 
Uncooperativeness 1.56 (0.86) 2.19 (1.47) 0.130 
Unusual thought content 3.11 (1.13) 3.00 (1.32) 0.793 
Disorientation 1.93 (0.79) 2.31 (1.45) 0.232 
Poor attention 2.89 (0.83) 3.19 (1.64) 0.501 
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Lack of judgment and insight 2.83 (0.79) 2.93 (1.73) 0.819 
Disturbance of volition 2.44 (1.10) 2.88 (1.15) 0.272 
Poor impulse control 2.44 (0.92) 2.75 (1.34) 0.440 
Preoccupation 2.17 (0.86) 2.62 (0.96) 0.151 
Active social avoidance 2.94 (1.21) 3.19 (1.47) 0.601 
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Table 6. Cognitive behavioral assessments in schizophrenia patients and healthy controls 
 NC SZ P value 
df=77 
 Mean SD Mean SD  
Block design from WAIS-III 12.03 3.289 9.12 3.198 0.001 
Similitudes from WAIS-III 11.36 2.653 7.27 2.293 0.001 
Vocabulary from WAIS-III 10.44 2.259 6.24 2.465 0.001 
Raven percentile 80.56 18.320 50.99 24.827 0.001 
Years of education 18.41 3.88 11.72 2.87 0.001 
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Table and figure legends 
Figure 4. Regression analyses in males with schizophrenia and symptoms 
In SZ-M inverse correlation between ideas of grandiosity and WMD (r=.551, r2=.303, t=-2.639, 
p=.018) were found. Positive correlations were also found between disorientation and WMD 
(r=.545, r2=.297, t=2.598, p=.019), and attention deficits and GMD (r=.466, r2=.217, t=2.108, 
p=.05) and WMD (r=.463, r2=.214, t=2.089, p=.05). 
Figure 5. Model prediction by importance: ALM results 
The ALM predicted the continuous target (GMD) based on linear relationships between the target 
and all included predictors by importance. The results reveal three important predictors of gray 
matter densities: lack of spontaneity and hallucination, and conceptual disorganization. Lack of 
spontaneity and hallucination predicted lower GMD. Conceptual disorganization predicted 
increased GMD. 
Figure 7. Model prediction by importance: ALM results 
The ALM predicted the continuous target (WMD) based on linear relationships between the target 
and all included predictors by importance. The results reveal three predictors by level of important 
of WMD: hostility, grandiosity, and conceptual disorganization. Increased hostility and grandiosity 
scores predicted lower WMD. Increased conceptual disorganization scores predicted increased in 
WMD.  
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7 Article 3 
The following work has been submitted and accepted provided revision in Schizophrenia 
Research. Resubmission of revised version will before the end of September 2016 under the title: 
“The basis of memory accuracy in schizophrenia: a combined gray and white matter DARTEL 
voxel-based morphometry”. 
 
The third paper shifts away from symptoms to other core aspects of schizophrenia: 
cognition and emotion. Our group has extensively investigated sex differences in cognition and 
emotion in schizophrenia using functional imaging. Sex differences were consistently found. It was 
of interest to further investigate if such functional brain differences are also present on a 
morphological level. From a neurodevelopmental point of view, morphological brain changes 
require more time to manifest alterations. Brain functionality may be influenced by transient 
changes (e.g. stress). Here, sex differences reappear significantly. In this study, total white matter 
density in schizophrenia males correlated negatively with memory accuracy of positive and 
negative images. These correlations were observed only in male patients but not in females.  
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Abstract 
Introduction: There is robust evidence of the influence of emotion on cognition and vice versa. In 
addition, schizophrenia positive and negative symptoms are hypothesized to be related to abnormal 
threat-processing affecting cognitive domains. This study investigated cerebral structures 
associated with cognitive-memory accuracy for positive (PMA), negative (NMA) and neutral 
(ZMA) emotions.  
Methods: Patients with schizophrenia (SZ) (N=40) and normal controls (NC) (N=40) matched for 
age and sex were assessed for memory accuracy using the IAPS images. Results were correlated 
with cerebral gray matter densities (GMD) and white matter densities (WMD) using voxel-based 
morphometry (VBM) on T1-3T MRI. 
Results: Compared to NC, patients had decreased correlations with memory performance in a 
number of areas: GMD of the posterior/postcentral parietal, lentiform/putamen/caudate and inferior 
frontal/orbital cortex and WMD of the postcentral parietal and performance on the NMA; GMD of 
the temporal lobe/fusiform and WMD of the inferior temporal, precuneus parietal and frontal lobe 
and performance on the PMA; GMD of the cerebellum (anterior lobe) and WMD of the middle 
temporal and performance on the ZMA. In addition, SZ had increased correlations in the GMD and 
WMD of the inferior occipital cortex and the lingual occipital region respectively with performance 
on the NMA; increased correlation in WMD of the angular parietal region with performance on 
PMA; and WMD of the superior temporal region with performance on ZMA. Sex differences were 
observed, such that male patients’ total WMD inversely correlated with performance on NMA and 
PMA, and no significant correlations were found in females. 
Conclusion: Findings support the fronto-temporal regional atrophy hypothesis in schizophrenia. 
Relatively increased occipito-parietal WMD in patients advances the hypothesis that the core 
pathophysiological problem underlying recall memory in SZ may be related to disruptive 
coordination of large-scale brain networks. This may be affected by structural deficits more evident 
in male patients. This latter result implies that most of the significant findings in the entire group 
of schizophrenia patients might be driven by males, but more participants would have to be tested 
to verify this supposition. 
 
Keywords: Schizophrenia, memory, positive emotion, negative emotion, neutral emotion, gray 
matter, white matter, voxel based morphometry. 
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1. Introduction 
 
Schizophrenia is a term created by Bleuler in 1911 to describe the fragmentation and 
disintegration of the mind and behavior as the essence of this devastating disorder (1). Since then, 
research has intensively investigated the splitting of thoughts, feelings, and actions in schizophrenia 
(2-6). Specifically, studies addressed how and why these functions are dissociated (7-9). Although 
there is robust evidence of the influence of emotion on cognition and vice versa, the nature of these 
interactions and their role in psychotic symptoms are not yet clearly explained. Neurocognitive 
research indicates that emotion affects memory processes (10-12). Moreover, it has long been 
known that schizophrenia is associated with chronic presence of negative and positive symptoms, 
hypothesized to relate to abnormal threat processing affecting cognitive domains (13-16). Memory 
deficits are among the most common in schizophrenia and have widespread impact on cognition in 
general. This being said, we note that the neurobiological underpinnings of the relationship 
between emotion processing and cognition merit more attention than it has received. 
Recently, an elegant review argued that alteration of the basic sense of self-awareness might 
be an essential distortion of schizophrenia (17). The authors placed further stress on the role of 
distortion of social skills and proposed what they referred to as the “triple brain network model of 
the dysfunctional switching between default mode and central executive network related to the 
aberrant activity of the salience network”. Schizophrenia has also been proposed to result from a 
dysfunction in context processing and self-processing (18, 19). Clearly, memory dysfunction and 
its interaction with emotion processing, plays an important role in these models. Additionally, 
schizophrenia patients display deficits in memory processes known as retrospection and 
imagination (20). They may construct unusual beliefs or illusions (confabulation) when a stimulus 
has not been presented previously but recalled incorrectly or falsely (21). For example, in 
prediction-error-related brain responses patients show cortical activation in frontal lobe during 
disrupted prediction-error processing and construction of delusions, suggesting that patients with 
schizophrenia have an inappropriate representation of the world using extraneous information (22). 
Overall, according to these theories, schizophrenia patients have major difficulties in 
projecting themselves into past and future events, probably because of difficulties in retrieving 
circumstantial information from previous events. Hence, constructing strategic representations and 
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experiencing a continuity of subjective time becomes essentially very difficult. Such 
neurocognitive malfunction renders memory accuracy inefficient (18-20). Corlett et al., (2009) 
argue that certain experiences are inappropriately surprising and require an explanation. When the 
surprising experience is repeated, that explanation develops into an unusual or inappropriate belief 
(21). 
Neuroimaging studies have extensively investigated memory accuracy in schizophrenia 
(23-31). In a functional neuroimaging study, Sergerie and colleagues (2010) compared emotional 
memory recognition in schizophrenia patients with healthy subjects. The researchers observed that 
despite an overall lower memory accuracy, emotional memory was intact in schizophrenia. This 
pattern was present despite the fact that emotion-specific differences in brain activation exist 
between patients and controls, possibly reflecting different strategies (32). Wolf and colleagues 
(2011) compared accurate responses during a working memory task for emotional faces between a 
homogeneous group of high-performing patients and a control group. The authors confirmed 
previous findings showing a correlation between WM performance with alternating activity in the 
left and right prefrontal cortex. Furthermore, they found enhanced activity in higher visual areas of 
patients during encoding and maintenance (33). Another study argued that the precuneus and 
cerebellum function contribute to a better performance on working memory and preserved insight 
in schizophrenia via compensatory neural activity in the frontal cortex and cerebellum (34). More 
recently, a study on working memory in schizophrenia concluded that the draining of interference-
control processes results in reduced behavioral performance (35) Specifically, proactive inhibitory 
deficits and impaired control over memory was present in schizophrenia patients who were relying 
on reactive interference-control processes and manifested reduced behavioral performance (35). 
When considering structural gray and white matter neuroimaging studies, temporal lobe 
neuroanatomical abnormalities remain among the most robust findings in schizophrenia (36-40). 
The temporal lobe, in turn plays a critical role in memory (15, 27, 41) 
Overall, it is well established that memory deficits in schizophrenia represent core 
endophenotypes because they are common, relatively stable across the course of the illness, are 
present regardless of the presence of fluctuating psychotic symptoms, and are found to a lesser 
degree in unaffected relatives (42). Importantly, lack of responsiveness of memory deficits to 
current typical and/or atypical antipsychotic medication call for further investigation to elucidate 
these deficits and their relation to brain morphology in schizophrenia. 
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Several studies have reported sex differences in cognitive performances in normal 
populations (43-47). These sex differences seem to be more prominent in schizophrenia patients. 
Several studies show that males and females with schizophrenia both have cognitive impairments 
but in different cognitive domains (48-54). For example, males with schizophrenia had 
significantly more serious cognitive deficits than female patients in immediate and delayed 
memory, but not in language, attention, or visuo-spatial processing (55). Neural substrates during 
cognitive tasks also show sex-dependent difference in patients with schizophrenia. Our group 
found that female patients had decreased brain activations in the middle cingulate gyrus and 
amygdala during recognition of negative images and decreased activations during the positive 
condition in the middle and inferior frontal gyrus. Conversely, male patients had increased 
activations compared to the same-sex controls in the medial prefrontal gyrus during recognition of 
negative stimuli and in the parietal, temporal and limbic structures during the recognition of 
positive pictures (56). 
Taking previous studies into consideration, the purpose of the present study was to 
characterize the association between memory accuracy and anatomical GMD and WMD in 
schizophrenia patients. In addition, we examined potential sex-dependent differences using 
optimized voxel-based morphometry. We hypothesized that patients would show performance 
deficits in relation to abnormalities in their structural GM and WM in several regions underlying 
memory recall in schizophrenia. 
 
2. Methods 
 
2.1 Participants 
Eighty-one subjects were included in this study: 41 (22 males [NC-M] and 19 females [NC-
F]) normal controls (NC) and 40 DSM-IV schizophrenia patients (SZ) (20 males [SZ-M] and 20 
females [SZ-F]) (57). All patients were in a stable phase of their illness (defined as no relapse 
within the last two months and no change in their antipsychotic treatment within the last month). 
The groups were matched for age, sex, handedness (Edinburgh Inventory) (58) and parental 
socioeconomic status (National Occupational Classification (NOC). 
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There was no significant difference in age between NC (Mean age=31.51, SD=7.88) and 
SZ (Mean age=32.08, SD=6.96) p=0.735. In addition, no significant differences were found 
between male groups or female group. NC-M had a mean age of 30.50, SD=7.85 (p=0.677), NC-F 
aged 32.68 SD=7.96 (p=0.988). 
All patients were re-evaluated by experienced psychiatrists before being assigned to the 
research group. Affective, schizoaffective, and schizophreniform psychoses were excluded. 
Control participants were screened with the non-patients edition of the Clinical Interview for DSM-
IV (SCID) (59). Symptom severity was rated according to the positive and negative syndrome scale 
(PANSS) (60). The date of illness onset was defined as the date of 1st psychiatric consultation, for 
lack of reliable information from family members and patients. Schizophrenia has common 
symptoms with other psychiatric disorders as bipolar disorder, personality disorder, etc., therefore 
a psychiatric consultation favors a better diagnosis. All the patients received at least one atypical 
antipsychotic (chlorpromazine equivalence was calculated) (61) (Table 1.). 
 
----------Insert Table 1 around here--------- 
 
General exclusion criteria included: age below 18 or above 45 years, past or present 
neurological or Axis-I psychiatric disorder, alcoholism or drug abuse, noncompliance with testing 
procedures, abnormal uncorrected vision, or any contra-indication for MRI such as a cardiac 
pacemaker, an aneurysm clip, a metal prostheses or cardiac valve replacement, the presence of 
metal in an eye or any part of the body, certain dental work, or claustrophobia. 
 In agreement with the Declaration of Helsinki, written informed consent was obtained prior 
to participation in the experiment. The ability of schizophrenia patients to give informed consent 
was established using the guidelines of the Canadian Psychiatric Association. The ethics 
committees of the Fernand-Seguin Research Center of the Louis-H Lafontaine Hospital and the 
Regroupement Neuroimagerie Québec approved the study. Full details of subject characteristics 
are given in Table 1. All healthy participants are medication naïve, with no history of neurological 
or psychiatric disease. No abnormalities were observed on their brain structural MRIs. 
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2.2 Behavioral memory task  
First, participants passively viewed negative, positive, and neutral pictures taken from the 
International Affective Picture System (IAPS) while in the scanner (62). Although participants 
were aware that a memory task would follow, they were not explicitly told to remember the images. 
After a 15-min delay, participants performed the memory task, consisting of viewing blocks of 
positive, negative, and neutral pictures similarly to the incidental encoding task. Half of the stimuli 
in each block originated from the incidental-encoding task while the other half were never seen 
before. During this memory task, participants were asked to determine, by pressing the correct 
button, which of the stimuli were previously seen. To assess the participants’ subjective emotional 
responses, immediately at the end of the session, participants were again presented with the image 
blocks and were asked to rate them as a whole on a scale ranging from zero (absence of any 
emotional reaction) to eight (strongest emotion ever felt in one's lifetime) the intensity of 
experienced emotion. For fMRI results please refer to Bourque et al., (2013), Lakis et al., (2012) 
and Lakis et al., (2013) (63-65). 
Additional neuropsychological Cognitive evaluations were performed on patients and 
controls using WAIS-III and Raven percentile tests. Neuropsychological tests were analyzed using 
SPSS21 version to perform ANOVA and Bonferroni multiple group comparisons (p<0.05) for the 
WAISS-III and Raven percentile tests. 
 
2.3 Image acquisition  
Eighty-one individual high-resolution co-planar anatomical images were acquired using an 
12-channel headcoil (three-dimensional, spoiled gradient echo sequence; sagittal orientation, 
slices=176, scan time 9:38 min, slice thickness=0.98 mm, TR=19 ms, TE=4.92ms, flip angle=25°; 
matrix 256x256 voxels, FOV:  256x256 mm, isotropic voxels 1.0 x 1.0 x 1.0mm) on a MRI 
Siemens TRIO-TIM system (Total Imaging Matrix) at 3.0 Tesla operating at the University of 
Montreal Geriatric Institute.  
 
2.4 Image analyses 
Statistical Parametric Mapping (SPM8, Wellcome Department of Cognitive Neurology) 
implemented in MATLAB R2010a (Mathworks, Sherborn, MA) was used for image analyses. 
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Images were converted to NIFTI format and processed using the latest version of SPM8. All 
participants passed the SPM8 data quality control. Images were analyzed using the Diffeomorphic 
Anatomical Registration Through Exponentiated Lie Algebra (DARTEL) toolbox in the latest 
version of SPM8 used for voxel-based morphometry (VBM). We used VBM to assess the voxel-
wise comparison of the local concentration of gray and white matter between NC and SZ. 
 DARTEL toolbox uses a high dimensional warping process that increases the registration 
between individuals, which results in improved localization and increased sensitivity in analyses 
(66). Processing begins with the “import” step. This involves taking the parameter files produced 
by the segmentation, and writing out rigidly transformed versions of the tissue class images, such 
that they are in as close alignment as possible with the tissue probability maps. The second step is 
the registration itself. It involves the simultaneous registration of GM with GM, and WM with 
WM. This procedure begins by creating a mean of all the images, which is used as an initial 
template. Deformations from this template to each of the individual images are computed, and the 
template is then re-generated by applying the inverses of the deformations to the images and then 
taking their average. Following this, warped versions of the images can be generated. These steps 
improve computational anatomy providing more easily interpreted voxel-based morphometry 
(VBM), and better parameterization of brain shapes. Following these steps, the normalized gray 
matter (GM) and white matter (WM) maps were modulated with the resulting Jacobian determinant 
maps and smoothed with an 8-mm FWHM Gaussian kernel. Total GMD, WMD and brain volumes 
were obtained using ‘calculate raw volumes’ in the VBM8 toolbox. The segmented images were 
visually inspected, then, imported to DARTEL for the warping procedure, and finally iteratively 
aligned to the average template. During DARTEL warping, the segmented images were modulated 
with Jacobian determinates to preserve volume changes. Expert users carefully evaluated each step 
to check for normalization or segmentation errors. For more details please refer to Ashburner et 
al., (2007, 2009) (66, 67) and: 
http://www.fil.ion.ucl.ac.uk/spm/software/spm8/SPM8_Release_Notes.pdf. 
 In SPM8 VBM, all statistical analyses used the general linear model (GLM), which is used 
to identify regions of GM and WM concentration that are significantly related to a specific variable 
(68). VBM is not biased to one particular structure, which permits an even-handed and 
comprehensive assessment of anatomical differences throughout the brain (68). Using the tool 
Thèse de doctorat Adham Mancini Marïe August 2016 
125 
 
Talairach Applet http://www.talairach.org/applet.html the anatomic location of significant clusters 
was detected. The resulting sets of voxels from each contrast represent a statistical parametric map 
of the t-statistic (SPM-t). We excluded all voxels with gray matter values of less than 0.01 (absolute 
threshold masking). For all statistical analyses of VBM data, we used a uniform threshold of p < 
0.001 (uncorrected) and a minimum cluster size threshold of 100 voxels has been introduced for 
each contrast. This threshold is equivalent to a map-wise false positive rate of alpha < 0.0001 using 
a Monte Carlo procedure as implemented in the AlphaSim program in the Analysis of Functional 
Neuroimages software package (69, 70). Using SPM DARTEL factorial design specification we 
conducted an ANCOVA analysis between SZ and NC considering memory accuracy for negative, 
positive, and neutral recall scores as covariates. 
 
2.5 Group comparisons 
ANCOVA was applied to investigate differences in memory accuracy between groups. This 
analysis considered diagnostic group (SZ vs NC) by memory condition (positive, negative, neutral) 
interaction, as well as the main effect of group and condition. 
The primary focus of the analyses was the relationship between GMD and WMD (as derived 
from VBM) with memory accuracy. As SZ differed from NC in total GMD and duration of 
education, we calculated contrasts between SZ and NC with whole brain ANCOVAs, including 
total and regional GMD and WMD and duration of education as covariates. 
 
3. Results 
 
3.1 Neuropsychological tests 
ANOVA revealed significant group differences in all sub categories of the WAIS-III test 
where NC-M significantly out-performed SZ-M on all subcategories of the WAIS-III and Raven 
percentile tests. In female groups, NC-F out performed SZ-F on the Raven percentile and only two 
categories of the WAIS-III (Similitudes from WAIS-III and Vocabulary from WAIS-III). No 
differences were found on Block design when comparing female groups. No significant sex 
differences were found between normal control groups, while in patients, females out performed 
Thèse de doctorat Adham Mancini Marïe August 2016 
126 
 
males on the Raven percentile task (males=42.18, SD=22.54; females=60.23, SD=24.27, p=0.024, 
df=38) (Table 2). 
 
----------Insert Table 2 around here--------- 
 
3.2 Structural and Behavioral results as assessed by VBM8 
The analysis probing relationship between VBM and task performance showed correlations 
significant correlations in NC between NMA and GMD in the right posterior parietal cortex, 
lentiform, putamen, and caudate; and the left inferior orbitofrontal cortex. In SZ, correlations were 
observed between NMA and GMD in the left inferior occipital cortex. NC also showed significant 
correlations between PMA and GMD in the left temporal and fusiform gyrus, as well as between 
ZMA and the left anterior cerebellum. SZ did not show any correlation between GMD and PMA 
or ZMA. Correlation between Compared to SZ, WMD were higher in NC in the left postcentral 
parietal region for NMA, the left inferior temporal, left precuneus parietal, and left frontal regions 
for PMA, and left middle temporal region for ZMA. SZ had more correlations between WMD in 
left lingual occipital region and NMA; the left angular parietal region and PMA and the right 
superior temporal region for ZMA (please see Table 3, Figure 1 and 2). 
 
----------Insert Table 3 and Figure 1 and 2 around here--------- 
 
3.3 Structural, behavioral and demographic results as assessed by SPSS21 
Behaviorally we found no significant (two-tailed) differences between SZ and NC in respect 
to age (F=0.31; t=-0.34; p<0.74, df=77), sex (F=0.21; t=-0.32; p<0.75, df=77), WMD (F=0.19; t=-
0.58; p<0.56) or total brain volume (F=0.01; t=0.52; p<0.60, df=77). We found a significant (two-
tailed) group difference where NC had higher GMD than SZ (F=2.17; t=2.13; p<0.03). ANCOVA 
also revealed significant group differences where NC had better NMA (F=7.10; t=4.06; p<0.001, 
df=77), PMA (F=15.62; t=5.75; p<0.001, df=77) and ZMA (F=9.03; t=6.56; p<0.001, df=77) 
(Figure 4 and 5). 
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----------Insert Figure 4 and 5 around here--------- 
 
3.4 Sex differences 
3.4.1 Memory performance 
Behaviorally, NC-M performed better on memory accuracy than SZ-M and NC-F 
performed between than SZ-F on all conditions (positive, negative, and neutral) (Table 4). There 
were no significant sex differences in performance on any of the three memory conditions (positive, 
negative or neutral) in controls or in patients. 
 
----------Insert Table 4 around here--------- 
 
3.4.2 Subjective rating  
Subjective rating of images showed intriguing results. NC-M had lower subjective scores 
for negative and positive images compared to NC-F (respectively NC-M=5.04, SD=1.06, NC-
F=5.83, SD=0.60, p=0.007, df=77 and NC-M=4.38, SD=1.14, NC-F=5.12, SD=0.92, p=0.032, 
df=77). Significant differences were observed between NC-F and SZ-F, where SZ-F were less 
emotionally affected by negative images (SZ-F=5.14, SD=1.24, NC-F=5.83, SD=0.60, p=0.035, 
df=77). There were no significant differences is subjective rating between male groups, however 
SZ-M showed a trend, such that they had higher subjective scores for neutral images (NC-M=1.13, 
SD=1.11, SZ-M=2.10, SD=1.60, p=0.066, df=77). In addition, SZ-M had significantly higher 
rating scores for neutral images compared to NC-F (SZ-M=2.10, SD=1.60, NC-F=1.07, SD=0.80, 
p=0.037, df=77). No significant differences in ratings were found between females with 
schizophrenia and normal control males. 
 
3.4.3 Correlations 
Sex differences were observed. Specifically in SZ-M inverse correlations were found in 
WMD and NMA (r=.470, r2=.221, t=-2.258, p=.037, df=40) and PMA (r=.439, r2=.193, t=-2.074, 
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p=.05, df=40). In NC-M, GMD positively correlated with NMA (r=.444, r2=.198, t=2.219, p=.038, 
df=40). No correlations were observed in female groups (Figure 6). 
 
----------Insert Figure 6 around here--------- 
 
4. Discussion 
 
The current study aimed to test whether patients with schizophrenia would differ in terms 
of behavioral results, as well as GMD and WMD, from normal controls as assessed by memory 
accuracy and voxel-based morphometry. As hypothesized, SZ patients performed significantly 
worse on the memory accuracy task and had significantly decreased GMD and WMD in brain 
regions associated with the behavioral task, relative to NC. Memory accuracy scores for the 
negative, positive and neutral IAPS images were used as covariates in the structural brain analyses 
to identify brain regions within which GMD and WMD correlated with behavioral performance. 
Overall, the findings broadly implicated abnormalities of association between memory accuracy 
and brain GMD and WMD in schizophrenia. 
Normal controls showed significant correlations with memory accuracy in the GMD of 
several regions: posterior parietal, putamen, caudate, frontal, temporal and cerebellum, compared 
to patients. Several studies show structural and functional abnormalities in these regions in patients 
with schizophrenia (71-76). Patients showed correlation in GMD in the inferior occipital cortex 
specifically for memory accuracy of negative images. Special attention to the GMD and WMD in 
the posterior parietal region is warranted, as this region strongly differentiated NC from SZ in 
relation to the memory recall scores. The posterior parietal region is particularly engaged in 
visuospatial attention and memory (77), and several studies have reported gray matter 
abnormalities as reversed asymmetry (78), reduced gray matter density (79), and impaired activity 
during memory retrieval tasks (80, 81) in schizophrenia. We observed that SZ displayed a 
relationship between the memory score accuracy recall and the WMD of the angular region, which 
is also situated in the parietal lobe. The angular region is a heteromodal region involved in verbal 
retrieval, language and semantic processing (82) and spatial attention and orienting (83). According 
to Pearlson et al., (1996) (84), schizophrenia is associated with disturbance in the heteromodal 
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cortex which is considered as “higher-order parallel distributed networks of circuits, mediating 
complex representationally guided behaviors”.  
Compared to schizophrenia patients, Normal controls showed significant correlations 
between the temporal lobe and memory accuracy. This finding is in accordance with the literature 
showing that abnormalities in this region are associated with cognitive deficits (85). Unlike normal 
controls in this study, patients did not show any significant correlations between the cerebellum 
and memory accuracy. It has been reported that a structural deficit in the cerebellum may be 
involved in disorganization in schizophrenia, which consequently may relate to cognitive 
dysfunction (86). 
The most significant result is the increased GMD and WMD in parieto-occipital regions in 
SZ compared to NC in relation to performance on the memory task. This finding is in agreement 
with previous studies showing that patients with schizophrenia engage both higher visual and 
sensory functions to a much greater extent than controls during memory performance (33). Along 
with our results, in their review, Crossley and colleagues (2014) stated that lesions in schizophrenia 
were concentrated in both frontal and temporal cortical hubs (87). 
The evidence points to significantly more correlations with GMD in NC than SZ, which is 
in accordance with the broad body of literature we presented in the introduction. We did not find 
the same result regarding WMD. Additionally, SZ displayed stronger correlations between WMD 
regions (i.e., parietal and occipital) and memory accuracy. We posit that the relatively late WM 
myelination and neuronal pruning of brain regions in schizophrenia might play a role in our 
findings (88-90). In addition, it has also been suggested that schizophrenia is a consequence of a 
neurodevelopmental process of synaptic overpruning (91). 
Most neuroimaging studies on memory in schizophrenia have focused on working memory 
during a functional magnetic resonance imaging. Considering a strong relationship between brain 
function and structure (92) we attempted to investigate the core GM and WM structures in relation 
to the memory deficits, which are among the core endophenotypes in schizophrenia (93). 
Interpreting reality mostly involves remembering relative information about a situation. Therefore, 
understanding recall and overall memory dysfunction in schizophrenia is fundamental. For 
example, when remembering that “I was in my friends’ house yesterday”, a firm grounding in 
reality requires that I know the context in which that memory was formed 
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As hypothesized, sex differences were observed in the correlation between structural 
abnormalities and memory performance. Behaviorally, normal control males significantly out-
performed male patients on all subcategories of the WAIS-III and Raven percentile tests, while 
female patients showed fewer deficits when compared to same-sex controls, such that no 
differences were found between female groups on the block design task. When direct comparisons 
were performed between females and males with schizophrenia, females outperformed males on 
the Raven percentile task. These findings are of particular interest since both these tasks test visual 
and perceptive reasoning. These findings are consistent with studies by our groups showing no 
differences between female schizophrenia patients and female controls during mental rotation 
tasks, while male patient had worse performance on the same task compared to the same-sex 
controls (94, 95). Studies on healthy population show better performances in males compared to 
females on spacio-visual tasks (96, 97). Together these findings support the presence of an inverse 
sexual dimorphism in schizophrenia patients (98-100). 
Behaviorally, both females and males with schizophrenia performed worse than same-sex 
control groups on all conditions of the memory task, but no sex differences were observed in 
controls or in patients. This was an unexpected finding, since we anticipated that females and males 
with schizophrenia would perform differently; specifically that male patients would show greater 
deficits. We propose that the emotional component of this task played a role in decreasing the 
anticipated performance in female patients. We can find support for this postulation when analysing 
the subjective rating results. Here clearly we observe that females with schizophrenia expressed 
less subjective experience to negative images compared to the same-sex controls. Additionally, 
difference in subjective rating disappeared when we compared females with schizophrenia and 
normal control males. Most studies show no sex differences in emotional experience (101-103). 
Thus, our finding that female patients report less subjective experience with negative images is 
relatively novel. Here, we observe again an inverse sexual dimorphism in female patients with 
schizophrenia. In our study, males with schizophrenia subjectively rate negative images similarly 
to normal control males, but rated neutral images greater than both males and females controls. A 
meta-analyses by Cohen and Minor (2010) revealed that schizophrenia patients had preserved 
emotional experience but may experience strong aversive emotions when processing stimuli 
considered by healthy population as pleasant or neutral (101).  
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To explain our findings, we postulate that as a way of coping with the disorder, females 
with schizophrenia use stress avoidance strategies to prevent exacerbation of symptoms. Studies 
demonstrate that patients who manage stressful events and internal stress are less likely to present 
sever symptoms (104). Emotion-focused and inhibitory coping styles against stress have been 
reported in healthy females more than males who use more operative coping styles (105, 106). 
Interestingly, male patients in our study over experienced neutral images. 
 In this study, total WMD in males with schizophrenia correlated negatively with memory 
accuracy of positive and negative images. These correlations were observed only in male patients 
but not in females. We did not perform regions of interest analysis, which is a subject of a future 
study. Highly et al., (2003) has reported distinct sex difference in schizophrenia patients, where 
female patients had reduced white matter volumes in the occipito-parietal region, while male 
patients had increased density in the same region (107). Of interest, in our study we found 
abnormalities in white matter densities in the same region in our group of schizophrenia patients. 
Further investigation is needed to find out if these differences are sex specific. 
Despite diligence in matching our groups for sex and age, other potential confounds 
including age at onset, length of medication exposure and progressive GM changes in 
schizophrenia may have affected our results. Another shortcoming is that the DARTEL VBM study 
cannot be used to directly infer GM-WM connectivity and projections, and thus our data does not 
immediately address the question of whether schizophrenia patients alternatively use occipito-
parietal network instead of fronto-parietal network (i.e., rearranged connections). Hence, future 
studies are needed to differentiate network dysfunction from previously observed GM and WM 
abnormalities of the fronto-temporal, occipito-parietal and cerebellar-fronto hubs, and to link such 
disturbed connectivity patterns with specific clinical and cognitivo-behavioral phenotypes of 
schizophrenia.  
Overall, our findings may help to elucidate key cortical regions implicating loss of GM/WM 
volume/density, which may play a role in the disturbed cerebral connectivity network needed for 
efficient memory recall in schizophrenia. In agreement with Wang et al., (2010) (108), our findings 
suggest that the core pathophysiological problem underlying symptom presentation and cognitivo-
emotional processes are related to disruptive coordination of large scale brain networks and this 
may be affected by structural deficits. These structural deficits are strongly differentiated by sex.  
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Figure and table legends: 
 
Table 1. Clinical assessments in schizophrenia patients 
Table 2. ANOVA results displaying regions of GMD and WMD differences between the SZ and 
NC with memory accuracy in voxel-based morphometry. The values given are the stereotactic 
(MNI) coordinates and the T values of each anatomical region. SPM maps were thresholded at p < 
0.05 (corrected, voxel-level); minimum cluster size threshold of 100 voxels.  
Table 3. Regional GMD and WMD differences between the SZ and NC associated with memory 
accuracy  
Table 4. Post hoc multiple comparison show sex differences in performance in the three condition: 
positive, negative and neutral condition. 
Figure 1. Figure presenting GMD correlating with PMA, NMA and ZMA.  
Figure 2. Figure presenting WMD correlating with PMA, NMA and ZMA 
Figure 3. Boxplot representing mean GMD and WMD values between SZ and NC. Note the 
variation between GMD and WMD in NC. When we consider the variation between GMD and 
WMD we note that it is relatively diminished in the SZ. 
Figure 4. Bar graphic representing the mean PMA, NMA and ZMA between NC and SZ (bars 
represent error bars with a p<0.05). 
Figure 5. Scatter plot representing regression analyses between GMD, WMD and behavioral 
memory accuracy scores. Note that NC are clustered together with no visually noted variability. 
We note that SZ are disordered reflecting the schizophrenia disorder heterogeneity and variability 
within subjects. The plots show the curvilinear (quadratic) relationships between GMD and WMD 
respectively and memory accuracy scores. Both the linear and quadratic effects are significant.  
Figure 6. Scatter plot showing total WMD inversely correlating with NMA and PMA only in SZ-
M. GMD were positively correlated with NMA in only NC-M. 
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Table 1. Clinical assessments in schizophrenia patients 
 SZ-M SZ-F P value 
 Mean (SD) Mean (SD) df=38 
Age 31.50 (7.55) 32.65 (6.46) 0.608 
Years of education 11.20 (2.06) 12.25 (3.47) 0.253 
PANSS positive 17.95 (5.33) 19.65 (8.03) 0.435 
PANSS negative 19.50 (5.36) 21.25 (8.30) 0.434 
PANSS general 38.75 (5.27) 43.10 (12.92) 0.171 
Chlorpromazine equivalence 722.50 (383.74) 443.33 (280.94) 0.012 
Age of onset 19.89 (2.97) 24.40 (7.75) 0.007 
Duration of illness 11.57 (7.74) 8.25 (5.7) 0.136 
Parental socioeducational status 2.82 (.612 ) 2.62 (1.06) 0.470 
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Table 2. Cognitive behavioral assessments in schizophrenia patients and normal controls 
df=77 
 NC-M SZ-M p NC-F SZ-F p F 
 Mean SD Mean SD  Mean SD Mean SD   
Block design from WAIS-III 12.86 2.851 8.79 2.820 0.001 10.69 3.615 9.53 3.681 0.410 6.096 
Similitudes from WAIS-III 11.67 3.022 7.05 2.392 0.001 10.93 2.052 7.50 2.229 0.001 16.721 
Vocabulary from WAIS-III 11.05 2.312 6.16 2.672 0.001 9.46 1.854 6.32 2.311 0.001 20.527 
Raven percentile 78.24 19.98 42.18 22.54 0.001 83.80 15.79 60.28 24.27 0.003 14.451 
df=77 
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Table 3. Regional gray and white matter density differences between the schizophrenia group 
and normal controls associated with memory accuracy  
 Brain region, K (voxels), t 
(p<0.05 PFWE- corr) MNI 
coordinates 
Brain region, K (voxels), t 
(p<0.05 PFWE- corr) MNI 
coordinates 
Brain region, K (voxels), t 
(p<0.05 PFWE- corr) MNI 
coordinates 
 Negative IAPS images Positive IAPS images Neutral IAPS images 
GMD  
NC > SZ 
Posterior parietal cortex 
(k=486), (t=4.24), (-45, -19, 
27) 
Lentiform/putamen/caudate 
(k=819), (t=4.01), (18, 6, 13 
and 12, 3 53) 
Inferior frontal/orbital cortex 
(k=236), (t=3.86), (-39, 18, -6) 
Temporal lobe, fusiform gyrus 
(k=153), (t=3.63), (-34, -36, -9) 
Cerebellum anterior lobe 
(k=174), (t=4.21), (-50, -49, -
27) 
GMD 
SZ > NC 
Inferior occipital cortex 
(k=100), (t=4.48), (-27, -87, -
9) 
- - 
WMD 
NC > SZ 
Postcentral parietal cortex 
(k=288), (t=4.57), (-63, -16, 
28) 
Inferior temporal (k=156), 
(t=4.24), (-50, -18, -15) 
Precuneus parietal (k=106), 
(t=4.13), (-42, -60, 31) 
Frontal lobe (k=159), (t=3.76), (-
12, 24, 1)  
Middle temporal (k=297), 
(t=3.27) (-54, -6, -6) 
WMD 
SZ > NC 
Lingual occipital (k=352), 
(4.51), (-36, -88, -4) 
Angular parietal (k=261), 
(t=4.10), (-42, -60, 31) 
Superior temporal (k=153), 
(t=3.54), (53, -42, 15) 
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Table 4. Memory accuracy performance between groups (Post hoc multiple comparison - 
ANOVA) 
 
 NC-M SZ-M p NC-F SZ-F p F 
Condition Mean SD Mean SD df=77 Mean SD Mean SD df=77  
NMA 0.84 0.18 0.61 0.22  0.003 0.83 0.10 0.65 0.28  0.02  7.473 
PMA 0.85 0.15 0.59 0.23  0.001 0.84 0.11 0.57 0.29  0.001  12.291 
ZMA 0.79 0.15 0.50 0.21  0.001 0.75 0.13 0.52 0.23  0.001  14.189 
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Figure and table legends: 
Table 2. ANOVA results displaying regions of GMD and WMD differences between the SZ and 
NC with memory accuracy using voxel-based morphometry. The values given are the stereotactic 
(MNI) coordinates and the T values of each anatomical region. SPM maps were thresholded at p < 
0.05 (corrected, voxel-level); minimum cluster size threshold of 100 voxels, df=77.  
Legend Figure 3. Boxplot representing mean GMD and WMD values between SZ and NC. Note 
the variation between GMD and WMD in NC. When we consider the variation between GMD and 
WMD we note that it is relatively diminished in the SZ. 
Legend Figure 4. Bar graphic representing the mean behavioral accuracy recall of negative, 
positive and neutral IAPS images between NC and SZ (bars represent error bars with a p<0.05). 
Legend Figure 5. Scatter plot representing regression analyses between GMD, WMD and 
behavioral memory accuracy scores. Note that NC are clustered together with no visually noted 
variability. We note that SZ are disordered reflecting the schizophrenia disorder heterogeneity and 
variability within subjects. The plots show the curvilinear (quadratic) relationships between GMD 
and WMD respectively and memory accuracy scores. Both the linear and quadratic effects are 
significant.  
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8  Discussion  
 
We hypothesized that schizophrenia patients would exhibit sex-dependent abnormalities in their 
brain morphology, and that these abnormalities would be related to main aspects of the disorder, 
including symptoms, cognition, and emotion. To test these hypotheses, we measured cortical 
gyrification and its relationship with schizophrenia symptoms, we examined gray and white matter 
densities and their relationship with symptoms, and lastly we investigated grey and white matter 
densities and their relationship with cognitive performance. In addition to testing these hypotheses, 
a complete review of the literature was undertaken. Findings related to schizophrenia in general 
were presented, and revealed some inconsistencies in results. A specific review of the literature in 
relation to sex differences in schizophrenia concluded that differences between males and females 
are present in almost all aspects of the disorder, including incidence, prevalence, risk, age of onset, 
premorbid deficits, course of the illness and prognosis, comorbidities, psychosocial functioning 
and adjustment, clinical expression, severity of symptoms, resilience to the disorder, cognitive and 
emotional deficits, treatment response, medication efficacy and side effects, cortical and 
subcortical brain morphology. Our literature review demonstrates that all these aspects seem to be 
more severe in male patients with schizophrenia. 
 This work presented in the first paper is considered one of the first to investigate sex 
differences using gyrification index. Firstly, using cortical thickness measurements we investigated 
differences in GI between schizophrenia patients and control participants, as well as sex-specific 
differences. Secondly, we correlated cortical gyrification findings with schizophrenia symptoms 
and probed if sex differences were present in these associations. This work is, to the best of our 
knowledge, the first report of sex differences interacting with the duration of illness. Another 
important and unanticipated finding was that very few correlations were found between GI 
abnormalities and symptoms in the schizophrenia group as a whole and when analyzed separately 
sexing males and females. In addition, abnormalities in gyrification index in our group of 
schizophrenia patients in comparison to healthy controls, were not the same regions that correlated 
with schizophrenia clinical symptoms as measured by the PANSS. These intriguing findings led to 
the work presented in the second paper. Here we postulated that deeper structures and white matter 
are associated with symptoms of schizophrenia, and that this relation differs in male and female 
patients. We used voxel-based morphometry to investigate deeper structures and white matter 
Thèse de doctorat Adham Mancini Marïe August 2016 
156 
 
densities. Of particular interest is the association between greater WMD and more severe symptom 
scores of conceptual disorganization and attention deficits. In terms of correlations, while females 
revealed no specific correlation between total GMD, WMD, CSF, or total brain volume and 
schizophrenia symptoms, WMD in male patients correlated negatively with ideas of grandiosity, 
and positively with conceptual disorientation and attention deficits. To our knowledge, this is the 
first study to report a direct relationship between white matter density and these symptoms. This 
study demonstrated that even though gyrification measures were not markedly correlated with 
symptoms, differences in gray and white matter densities were. The third paper investigates another 
core aspect of schizophrenia: cognition and emotion. We investigated regional abnormalities in 
gray and white matter using VBM in relation to cognitive and emotional functioning -a sphere 
severely impaired in schizophrenia- and their relation to sex differences. Here, sex difference 
reappear significantly such that total white matter density in males with schizophrenia correlated 
negatively with memory accuracy of positive and negative images and no such associations were 
found in female patients. 
8.1  Summary of main findings 
Findings related to sex differences in schizophrenia: 
Study 1. 
1. SZ-M had significantly lower values of the GI in the right hemisphere in SZ-M relative to 
the same-sex controls (no difference between female groups).  
2. GI values decrease with age in healthy controls (with no sex difference) and in patients 
(greater in SZ-M than SZ-F) with a more progressive deterioration in the right hemisphere 
in schizophrenia. 
3. GI values decrease with the duration of illness in SZ-M but not in SZ-F. 
4. SZ-M had a significantly higher GI relative to the same-sex controls in the right temporal 
lobe. 
5. SZ-F had significant lower GI in left frontal, bilateral temporal and left parietal lobes 
relative to the same-sex controls. 
6. Positive correlation between negative symptoms and the right occipital GI in patients 
regardless of sex. 
7. SZ-M had an inverse correlation in the left occipital GI with negative symptoms. 
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8. SZ-F had positive correlations between negative symptoms and the right occipital GI. 
Study 2. 
9- SZ-M revealed decreased total GMD compared to NC-M. 
10- No differences in GMD, WMD, CSF or total brain volume were observed in female 
groups.  
11- SZ-F showed no correlations between total GMD, WMD, CSF, or total brain volume and 
schizophrenia symptoms.  
12- SZ-M showed inverse correlation between WMD and ideas of grandiosity. 
13- SZ-M showed correlations between WMD and disorientation. 
14- SZ-M showed correlations between both GMD and WMD and attention deficits. 
Study 3 
15. NC-M significantly out-performed SZ-M on all subcategories of the WAIS-III and Raven 
percentile tests.  
16. SZ-F when compare to NC-F showed fewer deficits than SZ-M: in the Raven percentile 
and only two categories of the WAIS-III (Similitudes from WAIS-III and Vocabulary from 
WAIS-III).  
17. SZ-M showed inverse correlations between WMD and NMA and PMA. 
18. NC-M, total GMD correlated with NMA; in female groups, no correlations were found. 
 
Findings related to differences between SZ and NC: 
Study 1. 
1. Significantly lower values of the overall GI in SZ relative to NC.  
2. SZ had lower GI in bilateral frontal, temporal and parietal lobes. 
Study 2. 
3. SZ had lower GMD in the anterior cingulate cortex, left middle temporal in comparison to 
NC.  
4. SZ had higher GMD in the left posterior cingulate compared to NC.  
5. SZ had lower WMD in the left inferior frontal rectal region and the left posterior parietal 
region in comparison to NC. 
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6. SZ showed correlations between positive symptoms and GMD in the left insula and right 
caudate.  
7. SZ showed correlations between negative symptoms and GMD in the right middle frontal 
and the posterior lobe of right cerebellum (Uvula).  
8. SZ showed inverse correlations between positive symptoms and GMD in the right parietal 
(precuneus), the posterior lobe of left cerebellum (Uvula). 
9. SZ showed inverse correlations between negative symptoms and GMD in the anterior 
lobe of the left cerebellum.  
10. SZ showed correlations between positive symptoms and WMD in the right middle frontal 
region. 
11. SZ showed correlation between negative symptoms were and WMD in the right superior 
frontal region.  
12. SZ showed inverse correlations between positive symptoms and WMD in both right 
inferior occipital and right occipital cuneus regions.  
13. SZ showed inverse correlations between negative symptoms and WMD in the left 
superior frontal region.  
14. SZ showed correlations between the conceptual disorganization symptom and both GMD 
and WMD.  
15. SZ showed inverse correlations between GMD and lack of spontaneity and hallucinations.  
16. SZ showed inverse correlations between WMD and hostility and grandiosity. 
Study 3. 
17. No significant difference was found between SZ and NC in total brain volume or total 
WMD. NC had higher GMD than SZ. 
18. NC performed better that SZ on all memory accuracy tasks (NMA, PMA ZMA).  
19. NC showed higher GMD correlation with NMA in the right posterior parietal cortex, lentiform, 
putamen, and caudate; the left inferior orbitofrontal cortex. 
20. NC showed higher GMD correlation with ZMA in the left anterior cerebellum.  
21. NC showed higher WMD correlation with NMA in the left postcentral parietal region.  
22. NC showed higher WMD correlation with PMA in the left inferior temporal, left 
precuneus parietal, and left frontal regions. 
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23. NC showed higher WMD correlation with ZMA in the left middle temporal region for 
ZMA.  
24. NC showed higher GMD correlation with PMA in the left temporal and fusiform region.  
25. SZ showed higher GMD correlation with NMA in the left inferior occipital cortex.  
26. SZ did not show any GMD correlation with PMA or ZMA. 
27. SZ showed higher WMD correlation with NMA in left lingual occipital region.  
28. SZ showed higher WMD correlation with PMA in the left angular parietal region. 
29. SZ showed higher WMD correlation with NMA in the right superior temporal region. 
Findings in schizophrenia patients 
 
Structural findings: 
The results obtained in our study were overall congruent with previous findings of 
decreased volume, density and cortical thickness in patients with schizophrenia relative to controls 
(191, 266-268, 271-275, 575). As reported in numerous other studies (270, 278, 576-580) our 
sample of schizophrenia patients had lower gray matter densities in the anterior cingulate cortex 
and left middle temporal gyrus in comparison with healthy controls. It is of particular interest that 
decreases in gray matter densities were not necessarily related to abnormalities in gyrification index 
in patients in our study. A recent study by Kong et al., (2014) similarly found discordance between 
gray matter volume and cortical thickness such that patients had reduced gray matter while cortical 
thickness remained relatively preserved. The authors suggested that differences between gray 
matter volume and thickness could be jointly driven by surface area, gray/white matter intensity 
contrast, and curvature (580). Consistently with our results, a review by Crossley and colleagues 
(2014) stated that lesions in schizophrenia were concentrated in both frontal and temporal cortical 
hubs (581). 
In addition to frontal and temporal anomalies, patients had higher gray matter densities in 
the left posterior cingulate compared to healthy controls. This region seems to be more preserved 
in the early stages of illness and increased GMD may indicate a compensatory mechanism in 
response to the anterior cingulate deficits (18, 19).  
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Symptom related findings 
The positive correlation between the PANSS positive and the caudate and insula in 
schizophrenia patients is intriguing. The caudate has been reportedly involved in the neurobiology 
of schizophrenia positive symptoms in relation to dopamine dysfunction (90, 91, 582), although 
caudate abnormalities may be related to medication exposure (583). The insula is involved in 
emotional interoceptive representations (584), and in acoustico-verbal hallucinations (585). We 
postulate that due to its location at the interface of frontal, parietal and temporal lobes, the insula 
is involved in cognitive, emotional and somato-sensory processes, hence providing a hub that 
integrates salient stimuli with somatosensory and autonomic information (586-589). The increased 
GMD could be associated with the over stimulation of cognitive, emotional and somato-sensorial 
processes regulated by the insula resulting in symptoms such as delusions and hallucinations which 
are characterized by amplification of emotional and sensory motor perception and processing. 
Of particular interest were the positive correlations in the GMD in the middle frontal and 
WMD of the superior frontal with negative symptoms. These findings are similar to those of 
Nesvag et al (2009) who demonstrated that the severity of negative symptoms was mainly related 
to larger gray matter volumes of the frontal lobe (590). Several studies point out at the importance 
of this region in emotion regulation (591-593), and in down-regulation of emotional processing 
(594) in normal population. Negative symptoms have been attributed to overinhibition of affective 
processes and maladaptive cognitive emotion regulation strategies (595). These processes were 
associated with increased frontal activation and volume (590, 596), while disinhibition and 
emotional lability have been associated with frontal lesions (597, 598). For example, Smith et al., 
(2013) showings that a decrease in volume of the DLPFC is associated with improvement of 
depression symptoms in patients with depression (599). WM connectivity abnormalities in the 
superior frontal executive region have been proposed to explain negative symptoms in 
schizophrenia (578, 600). In accordance with these results, a study by Dazzan and colleagues 
(2012), demonstrated that subjects who develop affective psychosis had reductions in the frontal 
cortex (579). In view of these findings, it would be reasonable to say that negative symptoms that 
share several characteristic of depression are associated with over-engagement of the frontal cortex 
in affective inhibitory processes in schizophrenia patients.  
Another important finding was the fact that the parietal cortex was inversely correlated with 
the positive symptoms. Several studies show that positive symptoms were related to deficits of 
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logical reasoning processes (601). Such processes are mediated by the parietal cortex (602). In 
accordance with these results Dazzan and colleagues (2012), found that subjects who eventually 
developed schizophrenia had smaller volumes in the parietal cortex (579) 
According to our results, the cerebellum played an important role in positive and negative 
symptoms and was a major region differentiating memory accuracy between healthy controls and 
schizophrenia patients. These latter results are discussed in a subsequent section. The cerebellum 
with its cortical connections (the limbic system, the frontal, parietal, prefrontal, occipital, and 
temporal cortex), opens a new pathways for explaining the diversity of symptoms of schizophrenia 
(603) In addition, it plays a role in higher cognitive and emotional cortical functions (604). Based 
on our results, the cerebellum is more correlated with negative symptoms. Stoodley et al. (2010) 
postulated that the posterior cerebellum was linked to cognition and the posterior vermis with 
emotion and cognitive affective syndromes such as passivity, blunted affect, and withdrawal (605). 
Our results point to the involvement of the vermis (affective) and the posterior cerebellum 
(cognitive) in regulation of negative symptoms such that increased cognitive regulation/inhibition 
is associated with decreased emotional processes, which may play a role in negative symptoms. 
The negative relation between the cognitive part of the cerebellum and positive symptoms is 
intriguing. Hallucinations and delusions were found to be associated with deficits in several 
cognitive processes (606) including perception and correction errors (607), source and self-
monitoring (608), stimulus recognition (609), reality monitoring (610, 611). 
Exploratory prediction model of the linear regression relationship between GMD and WMD 
with the PANSS symptoms has also produced noteworthy results. In broad lines, WMD increases 
were related with less hostility scores and more sever conceptual disorganization and attention 
deficits. Additionally, increased hostility and grandiosity symptoms in our patients predicted 
decreased WMD. Several studies showed that reduced functional connectivity in white matter 
between the amygdala and ventral prefrontal cortex regions has been associated with increased 
aggression in patients with schizophrenia (612, 613). Interestingly, the intensity of conceptual 
disorganization was a predicting factor of increased GMD and WMD in schizophrenia patients in 
our study. To our knowledge, no other study has reported such findings in schizophrenia. Similar 
findings have been reported in autism, where increased white matter volume was associated with 
language and communication deficits (614), which are fundamental elements in the construction 
of conceptual disorganization, however further studies are needed in schizophrenia to support this 
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view. In accordance with existing literature, GMD was inversely correlated with hallucinations. In 
addition, the intensity of lack of spontaneity and hallucination symptoms predicted the degree of 
GMD loss. This is in concordance with several studies showing a similar association with gray 
matter in the left superior temporal gyrus (276, 615, 616), left thalamus, and left and right 
cerebellum (276) middle/inferior right prefrontal gyri (615), bilateral insula and left amygdala (616, 
617). 
We expected that GI values in several brain regions would be significantly correlated with 
the severity of symptoms, but we found only one association between occipital GI and negative 
symptoms. Given that overt clinical expression of some psychiatric and neurodevelopmental 
disorders may be a reflection of an underlying abnormality in growth of cortical convolutions 
(618), it is plausible that the significant decrease in the GI observed in schizophrenia is not directly 
related to symptoms but to the disease itself. Our findings point to abnormalities in the 
morphological development of the cortical layer in schizophrenia. Neurodevelopmental brain 
changes may be present at the onset of the illness (20, 562, 619-624), with further changes 
occurring during progression of schizophrenia (619, 625-629). In addition, we found that the 
abnormalities in GI, GMD and WMD in our group of schizophrenia patients in comparison to 
healthy controls were not the same regions that correlated with schizophrenia clinical symptoms. 
It is possible that decreases in cortical gyrification are related to other illness deficits as 
neurocognitive measures, and are not necessarily associated with clinical symptoms. We postulate 
that cognitive deficits play a role in such discrepancy. Several studies have shown abnormalities in 
these regions in relation with deficits in mental rotation abilities (630), IQ performance (631), 
language processing (632), and face recognition (633). In addition, abnormalities in the left middle 
temporal, the left inferior frontal and the left posterior parietal regions were found in be correlated 
with deficits in emotional memory accuracy in another study performed by our group (634, 635). 
 
Behavioral findings 
Schizophrenia patients showed significant deficits in all neuropsychological measures when 
compared to normal controls subjects including WAIS, Raven percentile, and memory recall tasks. 
This is consistent with numerous previous reports (137, 463, 636-641). In terms of performance on 
the memory task specifically, it was associated with GMD and WMD abnormalities in 
schizophrenia patients. As expected, patients has significantly worse at the memory accuracy task 
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and had significantly decreased GMD and WMD in major brain regions involved in the behavioral 
task. The most significant result we should first note however is the increased correlations between 
memory performance and the GMD and WMD in the parieto-occipital regions in schizophrenia 
patients compared to healthy controls. Previous work report enhanced function in higher visual 
areas combined with enhanced recruitment of sensory areas in schizophrenia patients during 
memory performance (642).  
Within the regions that showed structural abnormalities in schizophrenia patients, the 
posterior parietal GMD and WMD especially differentiated healthy controls from schizophrenia 
patients in relation to the memory recall scores. This region sub-serves visuospatial attention and 
memory (643), and several studies have reported gray matter abnormalities including reversed 
asymmetry (644), reduced gray matter density (272), and impaired activity during memory retrieval 
tasks (645, 646) in schizophrenia. However, we observed that schizophrenia patients displayed a 
relationship between the memory score accuracy recall and the WM of the angular region, which 
is also situated in the parietal lobe. The angular gyrus is a heteromodal region involving verbal 
retrieval, language and semantic processing (647) as well as spatial attention and orienting (648). 
This makes its relation to schizophrenia particularly interesting. According to Pearlson et al., 
(1996), schizophrenia is associated with disturbance in the heteromodal cortex, which is considered 
as “higher-order parallel distributed networks of circuits, mediating complex representationally 
guided behaviors” (649). 
When we specifically considered the temporal lobe, we observed increased correlations 
with the behavioral task in the GMD and WMD in healthy controls compared to schizophrenia. 
This is in accordance with the existing literature. For example, Rametti and colleagues (2007) have 
shown significant correlation between forgetting and density of the anterior hippocampus. They 
argued that these findings support the hypothesis of a regional atrophy within the hippocampus in 
schizophrenia patients (650).  
Most neuroimaging studies investigating memory in schizophrenia have focused on 
working memory during fMRI. Significant interaction between brain function and structure has 
been postulated (651), however few studies have attempted to investigate the core GM and WM 
structures in relation to memory deficits, which are among the core endophenotypes in 
schizophrenia (652). Interpreting reality mostly involves remembering relative information about 
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a situation; therefore, understanding recall of memory dysfunction in schizophrenia is fundamental. 
For example, when remembering that “I was in my friend’s house yesterday”, a firm grounding in 
reality requires that I know the context in which that memory was formed. 
Overall, the results of the present thesis demonstrate the presence of cortical and subcortical 
abnormalities in patients with schizophrenia. These abnormalities were related to schizophrenia 
symptoms and to cognitive and behavioral deficits.  
Our results shed further light on the neuroanatomical underpinnings of psychosis, providing 
advanced insights into the physiological nature of positive versus negative symptoms and memory 
performance. In essence, our study provides neurobiological evidence on the validity of a 
combination of overlapping and differing brain structural neuropsychopathology in schizophrenia 
More importantly, our results reject the notion that all patients might share a core network of 
neuropathology. 
 
Findings concerning sex differences 
 
Structural findings 
Hemispheric and regional decreases in frontal lobes in patients have been frequently 
reported in the literature, however only few have reported sex differences (556-558). We found 
that male patients had significantly lower values of the GI in the right hemisphere relative to same-
sex controls, but no differences were found between female groups. It is well documented that GI 
decreases with age in the general population (653), and our results support these findings. However, 
such decreases were more severe in patients with schizophrenia, especially in males and 
particularly in the right hemisphere. Furthermore, only males had significant decreases associated 
with the duration of illness. Several studies have shown an association between severity of illness 
and disturbances in cerebral structure and connectivity in the right hemisphere (654).in frontal 
lobes (654-656), and temporal and parietal lobes (654, 656, 657) Such disturbances tend to 
deteriorate with duration of illness (658-662) and are worse in patients who have earlier age of 
onset (20, 562, 619-624). Our findings may help explain why the course of illness, prognosis, and 
social outcomes are often worse in males relative to females with schizophrenia.  
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Additional sex differences in patients included the fact that male patients had global 
hemispheric decreases not confined to any specific region, whereas female patients had 
significantly lower GI in the left frontal, bilateral temporal and left parietal lobes. These findings 
may reflect a more defused and generalized cortical loss in males. In comparison, females might 
compensate by preserving cortical gyrification in other cerebral regions. For example, Abbs et al, 
(2011), found that female patients with schizophrenia showed decreases in anterior cingulate 
volume that were compensated in the inferior parietal lobe. Relatively normalized parietal volumes 
correlated with preservation of verbal memory processing (553). This task correlated with the 
anterior cingulated volumes in same-sex healthy controls. Male patients seem to present less 
structural compensation. A review by Salem and Kring (1998) attribute structural and neural lack 
of compensation in male patient to several factors, including: a) the central nervous system in males 
takes longer time to develop and thus the risk to neurological insults is higher (303, 663, 664) b) 
there is a greater hemispheric lateralization in males, thus damage to one hemisphere at early stages 
of development are more difficult to compensate; c) there is overall presence of more prenatal 
abnormalities of neuronal migration in males relative to females (663). 
Findings by Niu et al, (2004) support these theories. They found a significant left-smaller-
than-right volumetric asymmetry of the amygdala in male patients with schizophrenia. In addition 
male patients had reduced volumes in the bilateral amygdala while female patients had reductions 
only in right amygdala compared to same-sex controls (544). 
Consistently with the GI findings of sex differences in schizophrenia, examination of total 
GMD revealed that male patients had decreased total GMD compared to healthy males, while no 
differences were observed in female groups. Several studies have shown that males have more GM 
abnormalities than females with schizophrenia: reduced prefrontal volumes, reduced anterior 
temporal horn and medial temporal lobe volumes, more specifically amygdala, hippocampus, 
superior temporal and larger ventricular-brain ratios (VBR) or that females have more preserved 
cerebral morphology (292, 301, 517-524). Several authors have suggested that these differences 
are due to the neuroprotective effects of estrogen in females (339-341). The lack of differences in 
white matter densities between males with schizophrenia and same-sex controls was of particular 
interest. Recent findings show that abnormalities in white matter in patients with schizophrenia are 
related to disturbed sexual dimorphism rather than decreased white matter densities (512, 665). 
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Correlations between structures and clinical symptoms 
Our findings revealed that female patients with more negative symptoms also had greater 
GI in the right occipital cortex, whereas male patients who had greater negative symptoms had 
lower GI in the left occipital cortex. As mentioned previously, few correlations where found 
between GI abnormalities and symptoms. Jou et al. (2005) demonstrated abnormalities in cortical 
gyrification in individuals at increased genetic risk of schizophrenia who are not presenting the full 
schizophrenia symptomatology (666). To explain these findings, a study by Onitsuka et al., (2007) 
showed a relation between reduced volumes in the visual association areas and hallucinations. 
Their study included only male schizophrenia patients (667). Bijanki et al., (2015) reported an 
association between increased white matter fractional anisotropy in the occipital lobe and increased 
score of Scale for the Assessment of Negative Symptoms (SANS) in schizophrenia patients. The 
authors did not report any sex differences (668). Mitelman et al., (2003) found that patients with 
negative symptoms and poorer outcome had significantly lower gray matter volumes in the 
temporal and occipital lobes compared to better outcome patients and healthy controls (669). 
Of particular interest is that female patients in our study had significantly more symptoms 
compared to male patients, but it was males who exhibited more diffuse cortical abnormalities. In 
addition, females with schizophrenia had no association between total GMD, WMD, CSF, or total 
brain volume with any of the individual schizophrenia symptoms. Only males with schizophrenia 
showed an inverse correlation between ideas of grandiosity and WMD. Additionally, correlations 
between disorientation and WMD and attention deficits and GMD and WMD were observed only 
in males with schizophrenia. Savadjiev et al., (2014) found that disturbances of normal sexual 
dimorphism in white matter were correlated with the degree of negative symptoms. The authors 
demonstrated negative symptom strength increased with the reduction in connection asymmetry in 
males with schizophrenia, while stronger negative symptoms were correlated with increase in 
asymmetry in females with schizophrenia (512). Correlation between increased WMD and 
attention deficits has been reported in patients with ADHD (670). However, to our knowledge this 
is the first study to report such finding only in males with schizophrenia. Studies show that males 
with schizophrenia show more attention deficits compared to female patients (454). These findings 
suggest that females with schizophrenia may be less vulnerable to particular cognitive deficits 
compared to males with schizophrenia (455). 
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In support of our findings is that females with schizophrenia tend to present less ideas of 
grandiosity in comparison with males with schizophrenia. A study on psychotic experiences in 
adolescence found that boys reported more grandiosity and anhedonia and had more parent-rated 
negative symptoms than girls (671). Furthermore, prevalence of grandiosity was reported to be 
higher in males than females with early episode psychosis (672). These findings support that males 
with schizophrenia seem to have a greater biological vulnerability to worse symptoms, consequent 
social disability in the face of psychosis and poorer prognosis, while females have either a 
biological or a psychosocial resilience to the illness (390). 
To our knowledge, this is the first study to report a direct relation between white matter 
density and these symptoms. Interestingly a study by Sallet et al., (2003) found correlations 
between cortical gyrification index and grandiosity (673). Gyrification index is a marker of degree 
of cortical folding which is hypothesized to represent underlying white matter volume (674). Sex 
difference in functional connectivity has been reported in patients with schizophrenia. Lei et al 
(2015), found that male and female patients have disturbed functional integration in two separate 
networks: the sensorimotor network and the default mode network. The authors suggest that sex-
specific patterns of functional aberration existed in schizophrenia, and these patterns were 
associated with the clinical features both in male and female patients (675). The white matter 
abnormalities are in support of neurodevelopmental disturbance that is more evident in males than 
females with schizophrenia. 
In our study, the negative correlation between WMD and ideas of grandiosity observed in 
males with schizophrenia remained significant after grouping male and female patients together. 
Thus, significant results in schizophrenia research might be biased and related to only males but 
not females and vice versa giving further support to the important role of sex differences in 
schizophrenia. 
 
Correlations between structures and cognitive performance 
Importantly for the present thesis, sex differences were also observed in the third study. We 
used a memory task based on photos from the International Affective Picture System (IAPS) 
database. IAPS provides a standardized set of pictures for studying emotion and attention (676). 
Male patients showed inverse correlations between WMD and memory accuracy of negative and 
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positive pictures. Healthy males had GMD that positively correlated with negative pictures. 
Interestingly, in female groups no correlations were found.  
The relatively late WM myelination and neuronal pruning of brain regions in schizophrenia 
might play a role in the current findings (677-679). It has been suggested that schizophrenia is a 
consequence of a neurodevelopmental process of synaptic overpruning (680). Highly et al., (2003) 
has reported distinct sex difference in schizophrenia patients, where female patients had reduced 
white matter volumes in the occipito-parietal region, while male patients had increased density in 
the same region (565). Of interest, in our study we found abnormalities in white matter densities in 
the occipito-parietal region in our group of schizophrenia patients. Further investigation is needed 
to find out if these abnormalities are sex specific. 
 
Behavioral findings 
Sex differences in our second study emerged in patients with schizophrenia, where normal 
control males significantly outperformed male patients on all subcategories of the WAIS-III and 
Raven percentile tests, while female patients showed fewer deficits when compared to same-sex 
controls, such that no differences were found between female groups on the block design task. 
When direct comparisons were performed between females and males with schizophrenia, females 
outperformed males on the Raven percentile task. These findings are of particular interest since 
both these tasks test visual and perceptive reasoning. These findings are consistent with studies by 
our groups showing no differences between female schizophrenia patients and female controls 
during mental rotation tasks, while male patient had worse performance on the same task compared 
to the same-sex controls (94, 95). Studies on healthy population show better performances in males 
compared to females on spacio-visual tasks (96, 97). Together these findings support the presence 
of an inverse sexual dimorphism in schizophrenia patients (98-100). Sex differences observed 
support existing literature showing males with schizophrenia have worse cognitive performance 
compared females with schizophrenia. Female schizophrenia have preserved language, verbal 
memory and visuospatial memory (455) and have better performances in processing speed and 
episodic memory compared to males with schizophrenia (455, 461, 462). Reasoning tasks have 
been closely related to the posterior parietal cortex (602). Abnormalities in this region has been 
reported particularly in male patients with schizophrenia (547, 553). Perturbation of normal gray 
matter volume asymmetry, has been observed in the left inferior parietal lobes in male patients, but 
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not female patients (547). In our first study, only male schizophrenia patients showed more rapid 
decreased GI values in the right parietal lobe in relation to duration of illness. It is proposed that 
females with schizophrenia compensate volumetric loss in the anterior cingulate by engaging 
alternative patterns between the inferior parietal and the prefrontal cortex (553). These differences 
in cognitive impairments may be a result of sex differences in age of onset or illness severity (37, 
403, 464-471). 
On the memory accuracy task, both females and males with schizophrenia performed worse 
than same-sex control groups on all conditions of the memory task, but no sex differences were 
observed in controls or in patients. This was an unexpected finding, since we anticipated that 
females and males with schizophrenia would perform differently; specifically that male patients 
would show greater deficits. We propose that the emotional component of this task played a role 
in decreasing the anticipated performance in female patients. We can find support for this 
postulation when analyzing the subjective rating results. Here clearly we observe that females with 
schizophrenia expressed less subjective experience to negative images compared to the same-sex 
controls. Additionally, difference in subjective rating disappeared when we compared females with 
schizophrenia and normal control males. Most studies show no sex differences in emotional 
experience (681, 682). Thus, our finding that female patients report less subjective experience with 
negative images is relatively novel. Here, we observe again an inverse sexual dimorphism in female 
patients with schizophrenia. In our study, males with schizophrenia subjectively rated negative 
images similarly to normal control males, but rated neutral images greater than both males and 
females controls. A meta-analyses by Cohen and Minor (2010) revealed that schizophrenia patients 
had preserved emotional experience but may experience strong aversive emotions when processing 
stimuli considered by healthy population as pleasant or neutral (681). To explain our findings, we 
postulate that as a way of coping with the disorder, females with schizophrenia use stress avoidance 
strategies to prevent exacerbation of symptoms. Studies demonstrate that patients who manage 
stressful events and internal stress are less likely to present sever symptoms (595, 683, 684). 
Emotion-focused and inhibitory coping styles against stress have been reported in healthy females 
more than males who use more operative coping styles (685-687). Interestingly, male patients in 
our study over experienced neutral images. 
Overall, present studies support existing literature about abnormalities in key cortical 
regions implicated in schizophrenia. Sex differences in schizophrenia patients were demonstrated 
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throughout the three studies. Morphological differences in gyrification and in grey and white matter 
densities, differences in correlations between gyrification, GMD, WMD and symptoms, and 
differences in correlations between GMD and WMD and memory acuity. We conclude from our 
findings two important things. First, that sex differences in schizophrenia are present and affect the 
morphology, the clinical presentation of the disease and cognitive functions in patients. Secondly, 
that males with schizophrenia have more structural and functional abnormalities that worsen with 
the duration of illness compared to females with schizophrenia. 
In agreement with Wang et al., (2010) our findings suggest that the core pathophysiological 
problem underlying symptom presentation and cognitivo-emotional processes are related to 
disruptive coordination of large scale brain networks and this may be affected by structural deficits. 
These structural deficits are strongly sex related (688). 
Several elegant hypotheses have been proposed to explain sex differences in the 
schizophrenia brain. Crow (2008) suggested that sex differences related to psychosis are attributed 
to a genetic species-specific variation related to a locus on the X and Y chromosomes. Gene 
expression in this region is influenced by the degree of X and Y chromosomes pairing in male 
meiosis. This process is referred to as MSUC “meiotic suppression of unpaired chromosomes" 
which normally would lead to a more rapid mean rate of lateralization in females than in males 
(this in turn relates to the higher incidence rate of language delays and dyslexias in males). This 
complex theory posits that language disturbances are integral to psychosis. Lateralization or 
cerebral torque (where the right frontal lobe is larger than the left, while the left occipito-temporo-
parietal is larger than the right) is due to the development of neural connections associated with 
language: from right to left in relation to the motor speech output and from left to right in relation 
to speech perception. Disturbance in this neural development was proposed as the basis of the 
genetic predisposition to psychosis, i.e. the authors suggest that schizophrenia is a result of an 
abnormal cerebral lateralization associated with the emergence of language in humans (571). When 
this hypothesis is considered in the context of brain structures, it may explain the higher levels of 
anomalies found in males compared to female patients in our study and the differences in the 
development of schizophrenia in males and females in general (572). 
The influence of sex steroid hormones has also been considered (573, 574). These studies 
strongly suggest that the neuroprotective effects of estrogen (which influences sexual 
characteristics, development of the brain aminergic networks, and the ability to adapt to stressful 
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events) enhance the vulnerability threshold for psychosis by the downward regulation of dopamine. 
For example, Riecher-Rossler et al., (1994) and Hafner (2003) found that increased levels of 
estrogen in females with schizophrenia with normal menstrual cycles were significantly associated 
with lower severity of schizophrenia symptoms suggesting that that estrogen had: "a weak 
neuroleptic-like effect on schizophrenia symptoms" (325, 689, 690). The estrogen neuro-protective 
hypothesis is one of the most widely accepted explanations. Estrogens, directly or indirectly, 
modulates symptom expression in males and females with schizophrenia. Organizational and 
activational effects have been attributed to sex hormones. Organizational effects occur in the brain 
during the prenatal fetal phase and are stable, while activational effects are related to the level of 
circulating hormones (311, 312, 315, 414-421). Seeman and Lang (1990) put forward several 
arguments in favor of the estrogen neuro-protective hypothesis. The modulatory relation between 
the dopaminergic system and estrogen have been proposed to delay the onset of illness by 4-6 years 
is females and to cause an additional onset peak at age 40 to 45 years, when estrogen levels 
decrease. Males exhibit one main peak of schizophrenia onset in their late teens and early twenties. 
Females present with less debilitating symptoms during the first decade following onset, in 
thereafter their symptoms approximates that of males, particularly after menopause. Lower doses 
of antipsychotic treatment are effective premenopausally, perhaps due to the potentiating effect of 
the antidopaminergic action of estrogen, while higher doses are needed postmenopausally (417). 
Rendering further support to this hypothesis is the effectiveness of estrogen therapy in improving 
symptoms of schizophrenia (422, 423). The observed worsening of symptoms when estrogen levels 
drop sharply after pregnancy or during the follicular phase of the menstrual cycle (424, 425), and 
symptom improvement during mid-luteal phase when estrogen levels are high in females with 
schizophrenia directly supports this hypothesis (426-429). 
In short, evidence based medicine may be fundamentally flawed because there is an ongoing 
failure of research tools to include sex differences in study design and analysis (691, 692). The US 
National Institutes of Health (NIH) issued study guidelines for the evaluation of gender differences. 
Their aim was to ensure that drug safety and efficacy of are adequately investigated (691-693). 
Over the past decade sex differences in schizophrenia are more widely acknowledged and females 
are more frequently studied or at least included in the protocols (694). For example, it is recognized 
that females might require lower doses of antipsychotic medications during their reproductive years 
due to antipsychotic-estradiol interactions (340-342). 
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Our findings support the hypothesis that possible factors contributing to the development 
of schizophrenia and related psychosis are slightly different in males and females and that these 
factors interact differently with the sexes (694). 
We advocate the need to include female and male subjects in research designs in an equal 
manner and performing analyses and interpreting results in males and females separately. 
  
Thèse de doctorat Adham Mancini Marïe August 2016 
173 
 
8.2 Limitation 
 
Even though several studies show similar results using cortical thickness and gray matter 
density. GI along with cortical thickness seem to be more sensitive to genetic and phenotypic 
differences than grey matter volume (695). Density mapping may be influenced by diagnostic 
differences in extra-cortical CSF and surface curvature/complexity (554). 
Even though patients with past or present diagnosis of drug and alcohol abuse were 
excluded from the study, chronic substance and alcohol misuse is reported more frequently in male 
than female schizophrenia patients, and may contribute to the greater changes observed in male 
patients. 
Finally, as gyrification decreases in both healthy controls and patients were observed, 
gyrification is a more ambiguous marker as it is difficult to isolate factors of gyrification decline 
related to healthy aging from those related to disease (confounded by disease progression, different 
behavioral factors, and substance/medication exposure). However, sex differences in patients with 
schizophrenia remained consistent after controlling for these variables. 
Since our DARTEL VBM study cannot be used to directly infer GM-WM connectivity and 
projections, our data do not immediately address the question of whether schizophrenia patients 
alternatively use occipito-parietal network instead of fronto-parietal network (i.e., re-arranged 
connections). Future studies are needed to differentiate network dysfunction from previously 
observed GM and WM abnormalities of the fronto-temporal, occipito-parietal and cerebellar-fronto 
hubs, and to link such disturbed connectivity patterns with specific clinical and cognitivo-
behavioral phenotypes of schizophrenia. Overall, our findings may help to elucidate key cortical 
regions implicating loss of GM/WM volume/density, which may play a role in disturbed cerebral 
connectivity network fundamental to memory recall and modulation of symptoms. By taking into 
account the patients’ sex in our studies; we demonstrated that sex differences influence results and 
that separating males from females in experimental designs may help a better understanding of the 
illness 
 Another limitation of the presented studies is a potential effect of antipsychotic medication 
(past and current). We specify that all our patients were in a stable phase of their illness defined as 
no relapse within the last two months and no change in their antipsychotic treatment within the last 
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month. All the patients received at least one atypical antipsychotic (chlorpromazine equivalence 
was calculated) (696). 
Another limitation is that our list of assessments was by no means exhaustive. We used only 
one scale to assess the positive and negative symptoms (i.e., the PANSS). We anticipate in our 
future research the need to investigate that regions correlating with positive and negative symptoms 
assessed by PANSS remain consistent using other symptom assessment scales such as “Symptom 
rating scales and outcome in schizophrenia” (697) 
Considerable heterogeneity remains across studies investigating changes in GM and WM 
volume structures in schizophrenia. Heterogeneous symptoms may contribute to inconsistent 
findings. In future studies, we advocate to group large number of patients by symptom dimensions, 
which map on the emotional, cognitive, and psychomotor dimensions. Studies using the symptoms’ 
dimensional approach in schizophrenia may be useful for elucidating the core pathophysiology of 
this illness and in reducing heterogeneity of brain morphological endophenotypes in schizophrenia. 
We emphasize the importance of sex differences here. As seen in our first and second studies, same 
symptoms seem to be related differently to the brain in males and females with schizophrenia. 
Thus, studies need to investigate symptom dimensions in males and females separately. 
 We should note that despite significant findings in this domain, neuroanatomical 
abnormalities are insufficiently sensitive to be individually or collectively diagnostic of the disease 
(or its prognosis/etiology). Hence, the abnormalities have yet to be integrated into a clinically 
validated model, which would permit a coherent approach towards early detection, prevention, and 
treatments. 
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9 Conclusion 
 
Structure abnormalities in patients with schizophrenia were detected in the cerebral cortex and 
white and gray matter densities when compared to healthy controls. These abnormalities were more 
robust in male patients, and worsened with the progress of the disease. Females with schizophrenia 
had fewer deviations from healthy females, and even when important abnormalities were detected, 
females with schizophrenia seemed to recruit/compensate by the preservation of alternative 
cerebral regions. Furthermore, we emphasize that age of onset and duration of illness seems to 
influence cerebral structures to a greater extent in males than in females with schizophrenia. We 
suggest that the core pathophysiological problem underlying symptom presentation and cognitivo-
emotional processes are related to disruptive coordination of large-scale brain networks (688), and 
this may be affected by structural deficits. These structural deficits are strongly sex related. 
Accordingly, we advocate that future studies should include large samples of males and females 
with schizophrenia. Using connectomes or brain networks approaches to investigate the 
relationship between sex and brain function in schizophrenia is encouraged. Despite the diligent 
efforts to control for age, sex, medications, disease onset, the heterogeneity of symptoms, might 
have influenced our findings. As previously advocated by our group (178, 179, 698, 699), future 
studies should examine large number of patients by symptom clusters, including emotional, 
cognitive and psychomotor dimensions. In this work, we advocate that considering sex of patients 
in schizophrenia is a crucial factor to be considered in the design of research studies. 
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10  Clinical and research implications 
 
Our overall findings point out to the importance of sex in modulating the clinical and functional 
presentation of schizophrenia. Controlling for covariates such as age, duration of illness, social 
status, etc. is insufficient thus future studies in schizophrenia should systematically separate 
between males and females, if we wish to understand this complex and devastating mental illness. 
As emphasized in his visionary paper Vive la Difference Shon Lewis (1992) advanced that using 
sex for subtyping schizophrenia, is a - reliable, stable and valid - an immutable sociodemographic 
variable (360). Clinically, we advance that therapeutic approaches need to be customized to the sex 
of the patient. Therapy type, treatment dose, and duration need to be reviewed in light of the 
significant and morphological sex differences in schizophrenia. Knowing the sex of the patient, 
may help determine the therapeutic approach and disease trajectory. We can adapt health care 
according to her or his needs, understand risks, and improve prognosis. This work puts forward the 
following major conclusions: 1- Sex differences in schizophrenia are present in the major aspects 
of the disease, and these differences remain while using different methods. 2- Sex in schizophrenia 
is a crucial factor to be considered in the design of schizophrenia studies. 3- Results from studies 
grouping both males and females with schizophrenia should be interpreted with caution. 4- On a 
clinical level, taking sex differences in consideration is important if we wish to address the 
individuality of each of our patients and help improve their quality of life. 
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12 Appendix 
 Fourth article: Adrianna Mendrek and Adham Mancini-Marïe. Sex/gender differences in 
the brain and cognition in schizophrenia. Neuroscience and Biobehavioral Reviews 2016 
Aug; 67:57-78. 
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   Table X. The summary of studies investigating sex differences in brain structure of schizophrenia patients 
Study ref Diagnosis (N) Patients 
M:F 
Age (Mean) Healthy N= 
M:F 
Age (Mean) region approach findings 
Lang et al 2006 29 FEP 
26 SZ 
2 SZA 
1 psychosis 
not otherwise 
specified 
21:8  22.0 (5.1) N=22  
12:10 
24.7 (6.4) Thalamus MRI  
A single rater manual volumetric 
measures 
Male FEP but not females  
subjects showed significantly 
smaller right Anterior 
internal capsule volumes 
compared to healthy volunteers 
Andreasen et al 1994. SZ (52) 36:16 30.1 (9.6) 
 
N=90 
48:42 
27.43 (10.33) Total brain 
volume 
cerebrospinal 
fluid (CSF), and 
CSF within the 
ventricular 
system.  
 
Regional 
measures:  
frontal, temporal, 
parietal, and 
occipital 
lobes and the 
cerebellum 
MRI 
Automated volumetric measures 
using locally developed software 
 
Men have brain tissue deficit in 
all four of the cortical brain 
tissue regions. 
 
Women have a deficit only in 
frontal tissue.  
 
Andreasen et al 1990. SZ (54) 36:18 M=32.46 (8.59) 
F=35.39 (10.75) 
N=47  
28:19 
M 32.93 (9.25) 
F 36.63 (12.67) 
Ventricular 
volume 
MRI 
Manual measurement 
Most of the increased 
ventricular size was found in the 
male patients.  
 
Significantly smaller thalamus 
in the male patients,  
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Reite et al 1997. SZP (20) 11:9 M 37.1 (4.7) 
F 38.2 (5.6) 
 
N=20 
10:10 
M 38.2 (9.3) 
F 3.1 (6.5) 
 
Total brain 
volume, left and 
right 
hemisphere, and 
left and right 
superior 
temporal gyri. 
 
MRI  
Combined automated and 
manual segmentation 
 
Male patients showed less 
asymmetry than the control 
group, while the female patient 
showed significantly more 
asymmetry.  
 
The male patient had smaller 
superior temporal gyri than the 
control group.  
 
No evidence of total brain 
volume differences was 
observed. 
Gur et al., 2000 SZ (70) 40:30  28.7 (6.9) N=81  
34:47 
26.4 (6.7) Gray and 
white matter 
volumes of the 
dorsolateral, 
dorsomedial, 
orbitolateral, and 
orbitomedial 
prefrontal cortex 
MRI 
Manual segmentation  
 
 
Reduction in the dorsolateral 
area in men (9%) and women 
(11%), for the dorsomedial 
area only in men (9%), and for 
orbital regions only in women 
(23% and 10% for lateral and 
medial, 
respectively).  
 
Schizophrenia is associated 
with reduced gray 
matter volume in prefrontal 
cortex, which affects men and 
women in the dorsolateral 
sector.  
 
The effects are moderated 
by sex for dorsomedial and 
orbital regions and are related 
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to symptom severity and 
cognitive function.  
Gur et al., 2000 SZ (100) 58:42  
 
29.2 (7.3) N=110 51:59 
 
26.1 (6.3) Gray and white 
matter volumes 
of temporolimbic 
(hippocampus 
and amygdala) 
and 
neocortical 
regions (superior 
temporal gyrus 
and temporal 
pole) were 
examined 
MRI Hippocampal: volume was 
reduced more in men (7%) than 
women (8.5%). 
 
Amygdala: more decreased 
volume in men while women 
had increased volume.  
 
temporal pole: more decreased 
gray matter in men (10%) than 
women 
(8.5%).  
 
Superior temporal gyrus, 
decrease only in men. 
Lewine et al. 1995. SZ (108),  
SZA (20), MDD 
(27), BPD (20) 
SZ (82:26) 
SZA (7:13) 
MDD (7:20)  
BPD (5:15)  
 
M 32.4 F 33.9  
M 39.4 F 39.6  
M 39.3 F41.4  
M 32.6 F 39.7  
N=150   
59:91 
 
M 31.5  
F 35.2 
Global MRI  
Brain images evaluated by 
neuroradiologiste blind to 
diagnosis 
SZ males had Significantly 
more morphologic anomalies 
especially of the lateral 
ventricles than healthy male 
volunteers.  No difference in SZ 
women  
Nopoulos et al. 1997 SZ (80) 40:40 M 28.8 (7.3)  
F 27.4 (7.8)  
80 matched 
for age and 
sex 
M 28.4 (7.1) F 
27.8 (7.6) 
Ventricles, CSF 
and whole brain 
volumes 
MRI  
Automated volumetric measures 
of major brain regions. 
Male patients having 
significantly larger ventricles 
than male controls, female 
patients showing no significant 
enlargement in comparison with 
female controls.  
 
Other structures:  
Male and female patients with 
schizophrenia have the same 
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pattern of structural brain 
abnormalities, but male patients 
appear to manifest greater 
severity, especially 
with regard to ventricular 
enlargement. 
Bryant et al. 1999. SZ 59 (36:23) M 32.66 (5.53) 
F37.31 (5.09) 
37 (19:18) M 34.26 (6.65) 
F 33.33 (8.02)  
 
temporal lobe: 
superior 
temporal gyrus, 
the 
amygdala/hippoc
ampal complex, 
and the temporal 
lobe  
the prefrontal 
cortex and 
caudate 
 
MRI 
Automated volumetric measure 
 
Left temporal lobe volume on 
the left was significantly smaller 
in male patients than in male 
comparison subjects. 
Female patients and female 
comparison subjects 
demonstrated no significant 
difference in temporal lobe 
volume.  
 
There were no statistically 
significant gender interactions 
for the superior  
temporal gyrus, the 
amygdala/hippocampal 
complex, or the comparison 
regions. 
Flaum et al. 1995. SZ 102 (70:32)  87  Lateral and third 
ventricles, 
thalamus, 
hippocampus, 
and superior 
temporal,  
caudate nuclei 
MRI  
Regions of interest volume were 
outlined manually by an 
experienced technician on all 
slices in which they were 
visualized.  
no significant Gender by 
Diagnosis effects for any of the 
regions of interest 
Lauriello et al. 1997 SZ (23) 18:19 M 37.9 (9.2) 
F  39.8 (10.2) 
N=23 
18:19 
M 38.4 (9.5) 
F 37.9 (9.2) 
measures of 
head 
MRI 
Volumetric semiautomated image 
analysis technique 
There were no group-by-sex 
interactions. 
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size, cortical 
gray matter, 
white matter and 
sulci, and lateral 
and third 
ventricles  
 
No difference in ventricular 
enlargements and relation with 
age at symptom onset or length 
of illness in either men or 
women with schizophrenia 
 
Narr et al.2004. FES (50) 33:17 25.5 (4.5) N=50  
33: 17 
27.8 (7.3) Superior frontal 
(dorsolateral), 
inferior frontal 
(orbitofrontal), 
temporal, 
parietal and 
occipital. 
MRI  
3D gyral complexity 
Semi-automated and manual 
outlining 
Significant increases in cortical 
folding in the right superior 
frontal cortex in male patients 
compared to controls, while no 
differences were observed in 
women 
Narr et al.  2006 FES 72 51:21 25.1 (4.7) N=78 
37:41 
27.3 (6.6) Regional CSF 
volume 
Measuring volumes of lateral 
ventricle horn and regional 
differences identified by 
comparing the distances from the 
ventricular surfaces to the central 
core at anatomically matched 
locations. 
Dorsal superior horn 
expansions in female patients 
compared with same-sex 
controls. 
 
Narr et al. 2003.  SZ (25) 15:10 M 32.4 (7.9) 
F 39.9 (10.2) 
N=28 
15:13 
M 33.0 (10.1) 
F 35.2 (9.0) 
Grey matter, 
white matter and 
CSF 
MRI manual and automated 
measures  
Greater abnormalities in male 
patients compared to female 
patients where specific 
increases in the sulcal and 
subarachnoid CSF that 
appeared prematurely in men 
diagnosed with schizophrenia, 
while women patients showed 
normal aging effects 
Narr et al. 2000.  SZ (25) 15:10 31.1 (5.6) N=28 
15:13 
30.5 (8.7) Corpus callusum MRI Abnormalities in men patients 
compared to women patients. 
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Manual contouring by diagnosis 
blind technician, and automated 
surface measure 
Significant increases in 
maximum width in anterior and 
posterior regions in male 
patients compared to control 
men.  
 
Increased patterns of callosal 
variability in female patients but 
no effect of diagnosis between 
female groups. 
Narr et al. 2005. FES (72) 51:21 25.1 (4.7) N=78  
37:41 
27.3 (6.6) Whole brain and 
ROI 
MRI 
Manual derived sulcal/gyral 
curves as landmarks 
Automated cortical pattern and 
grey matter thickness measures  
Greater Loss of superior 
temporal sulcal slope 
asymmetry in the right 
hemisphere in male patients   
  
Female patients showed 
cortical thinning in 
cingulate and occipital regions 
bilaterally compared to healthy 
females, more widespread in 
right cingulate and left occipital 
cortex.  
Male patients showed thinning 
more prominently in the left 
hemisphere in caudal anterior 
cingulate cortices, within the 
paracentral lobule and posterior 
occipital regions bilaterally 
compared to healthy males. 
 
Male patients showed small 
regional thickness increases in 
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the vicinity of the gyrus rectus 
compared to male controls. 
 
Cortical thinning in caudal 
anterior and posterior cingulate 
cortices (right hemisphere 
pronounced) and the cuneus 
was observed in female 
patients compared to same sex 
controls.  
 
Male patients showed thinning 
in the paracentral lobule and 
caudal anterior cingulate (left 
hemisphere pronounced) and 
posterior occipital cortices 
Narr et al 2001. SZ (25) 15:10 31.1 (5.6) 28 15:13 30.5 (8.7) superior frontal 
(dorsolateral), 
parieto-occipital,  
temporal, and 
inferior frontal 
(orbitofrontal 
MRI 
Manual and automated measures 
Schizophrenia males show 
greater loss of superior 
temporal sulcal slope 
asymmetry (normally found 
healthy males) in the right 
hemisphere relative to 
schizophrenia females 
 
Greater variability in the 
longitudinal fissure, reflecting 
both larger sulci and larger 
cerebrospinal fluid (CSF) 
volume in males relative to 
female patients. 
Molina et al 2005. SZ (85)  
M:  
SZP N=51  
59:29 M 27.2 (8.9) 
F  31.1 (10.3) 
N=45  
24: 21 
M 31.2 (10.1) 
F 32.7 (13.0) 
cortical 
prefrontal, 
MRI  
Automated calculation of CSF 
Men showed significantly more 
CSF in the left prefrontal area, 
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SZU N=8   
 
Females N=24 
SZ paranoid 
N= SZ 
undifferentiate
d 
 
temporal, and 
hemispheric 
CSF values 
due to probable grey matter 
loss.  
 
CFS values in the prefrontal 
and temporal regions were 
positively correlated with illness 
duration in men, but not in 
women. 
Yotsutsuji et al 2003. SZ (40) 20:20 
 
26.1 (5.0) N=40 (20:20) 25.1 (5.8) Perigenual 
cingulate gyrus 
MRI 
Volumetric measure of both gray 
and white matter. 
Semi-automatic segmentation 
into gray matter, white matter, 
and cerebrospinal fluid. 
 
Perigenual cingulate gyrus 
volume done by one rater who 
was blinded to subjects’ identity, 
gender, and diagnosis 
Total (left and right) perigenual 
cingulate gray matter volume 
was significantly reduced in 
female schizophrenia patients 
compared with female controls.  
 
There was no significant 
difference in the gray matter 
volume of the perigenual 
cingulate gyrus between male 
groups.  
 
Significant gender 
differences were found in the 
total gray and white matter 
volume of the perigenual 
cingulate gyrus in control 
subjects (women _ men), 
although these gender 
differences were not significant 
in the patient group. 
 
Male patients had significantly 
increase volumes in the left 
temporal horn, bilateral anterior 
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horns, the right body, as well as 
the third ventricle. Women 
patients showed similar, but 
less pronounced ventricular 
enlargements 
Frederikse et al. 2000. SZ (30) 15:15 M 39.00 (9.26) 
F 40.00 (10.51) 
N=30 
15:15 
M 39.67 (11.06) 
F 38.40 (9.80) 
inferior parietal 
lobule 
MRI  
GM volume 
Semiautomatic into gray matter, 
white matter, and cerebrospinal 
fluid manual measure of inferior 
parietal lobule 
Men with schizophrenia had a 
reversal of the normal 
asymmetry (i.e., they had right-
greater-than-left IPL), as well as 
significantly decreased left IPL 
volume compared to control 
men.  
 
No significant differences in 
asymmetry or volume were 
observed in women patient 
relative to the same-sex 
controls 
 
Male patients exhibited a 
reversal 
 of the normal left-greater-than-
right male asymmetry in this 
region and had left inferior 
parietal  lobule gray matter 
volumes that were significantly 
smaller than those of healthy 
male subjects.  
 
Female patients did not differ 
significantly from healthy 
female subjects in left or right 
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inferior parietal lobule volume or 
in asymmetry. 
Collinson et al. 2003. EOSZ (33) 22:11 Total 16.8 (1.4) 
M 16.8 (1.3)  
F 16.8 (1.5) 
 
 
N=30  
18:12 
Total=16.4 (1.7) 
M 16.3 (1.6) 
F 16.4 (1.9) 
Left and right 
hemisphere 
volume 
MRI 
Automated and manual 
segmentation 
Male, but not female, patients 
had reduced left hemisphere 
volume and a trend to reduced 
temporal lobe volume.  
 
Reversal of normal rightward 
asymmetry in the female 
control group was reversed to a 
leftward asymmetry in females 
with schizophrenia. 
Savadjiev et al. 2014. AOSZ (39) 
 
22:17 M 16.5 (0.97)  
F16.0 (1.0) 
N=33  
16:17 
M 15.7 (1.5)  
F 15.2 (1.1) 
the geometry of 
interhemispheric 
white matter 
connections 
MRI  
DTI automated measures 
Reversal of normal asymmetry 
where female patients showed 
asymmetry. These 
abnormalities were correlated 
with negative symptom severity 
in a sex-specific manner 
Vogeley et al., 2000. SZ (24) 11:13 M 51.27 5.44 
F 55.85 8.90 
 
N=24 
11:13 
Age at death 
M 54.18 (9.10) 
F  52.23 (13.56) 
prefrontal 
regions 
Post mortem planimetric analysis 
Gyrification index  
A gray-to-white-matter ratio and 
an asymmetry coefficient 
computation 
 
Significant diagnosis-by-sex 
interaction in the right prefrontal 
cortex, where male patients had 
higher gyrification index (GI) in 
comparison to healthy men, 
while no significant differences 
were observed between two 
female groups 
Mancini-Marïe et al., 
2015 
SZ (48) 24:24 M 31.25 (7.96) 
F 33.04 (8.38) 
N=48 
24:24  
M 33.50 (8.69) 
F 29.92 (7.15) 
Left and right 
hemispheres. 
Frontal, 
temporal, 
parietal, occipital 
cortex 
MRI  
Automated gyrification index 
significantly lower values of the 
GI in the right hemisphere in 
men with schizophrenia 
compared to the same-sex 
controls and no differences 
between women groups 
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Greater decrease in 
hemispheric GI values in men 
patients  
 
Significant GI values decrease 
with the duration of illness in 
schizophrenia men but not in 
schizophrenia women 
 
Sex-by-illness duration 
interaction, such that men 
patients showed more rapid 
decrease in the right parietal 
and occipital GI, while women 
showed more rapid decrease in 
the left frontal and right 
temporal GI 
Gur et al., 2002. SZ (100) 58:42 29.2 (7.3) N=110 
51:59 
26.1 (6.3) Temporolimbic 
(hippocampus 
and amygdala) 
and 
neocortical 
regions (superior 
temporal gyrus 
and temporal 
pole)  
MRI 
Grey and white matter volumes 
Hippocampal gray matter 
volume was reduced 
in men (7%) and women (8.5%) 
with schizophrenia. 
Amygdala showed decreased 
volume was evident for men 
(8%) whereas women (10.5%) 
had increased 
volume.  
 
Temporal pole 
showed decreased gray matter 
in men (10%) and women 
(8.5%).  
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Superior temporal gyrus, the 
decrease exceeded 
that of whole-brain only in men 
(11.5%).  
 
Cortical volumes 
were associated with better 
memory performance 
in healthy women. 
Niu et al. 2004 SZ (40)  20:20 M 26.4 (5.1) 
F  25.9 (5.19) 
N=40 
20:20 
M 25.5(5.6) 
F 24.8 (6.2) 
Amygdala and 
the temporal 
lobe 
MRI  
Semi-automated and manual 
volumetric measure  
Only male patients had 
significantly reduced volumes in 
the bilateral amygdala relative 
to the same-sex controls.  
Significant left-smaller-than-
right volumetric asymmetry of 
the amygdala was detected 
only in men and not in women 
with schizophrenia 
Takayanagi et al. 2011 FES (52) 29:23 M 27.8 (6.0) 
F 28.1 (5.8) 
N=40  
(22:18) 
M 29.9 (5.6) 
F 27.5 (4.8) 
All regions 
ROI: 
hippocampus 
and amygdala 
MRI  
Multiple brain measures (volume 
and cortical thickness)  
Fully automated procedure 
 
Sex differences were found in 
the bilateral amygdala, with 
more reductions in men than 
women with schizophrenia 
Irle et al. 2011. SZ (46) 23:23 M 32.8(8.9) 
F33.4 (8.2) 
N=46 
23:23 
M 33.22 (8.4) 
F  34.0 (8.6) 
hippocampus MRI 
Automated and manual tracing 
Only men with schizophrenia 
had hippocampal volume 
reductions relative to the same-
sex controls at the illness onset, 
but with longer illness duration 
women had similarly reduced 
hippocampal size as male 
patients.  
 
Thèse de doctorat Adham Mancini Marïe August 2016 
249 
 
Only women patients showed 
an inverse relationship between 
the hippocampal volume and 
illness duration. 
Goldstein et al. 2002 SZ (40) 27:13 M 46.6 (11.4) 
F 41.4 (7.0) 
N=48 
27:21 
M 41.6 (11.6 
F 39.0 (9.9) 
Middle frontal 
gyrus, 
frontomedial and 
fronto-orbital 
cortices; basal 
forebrain, 
anterior, 
posterior and 
paracentral gyri, 
insula, 
parahippocampu
s gyrus, posterior 
parietal, primary 
auditory cortex, 
amygdala, 
hippocampus, 
dorsal medial 
thalamic nuclei, 
caudate, 
putamen, globus 
pallidum 
MRI 
Semi-automated and manual 
volume measure  
Volume reductions in ACC in 
women but not in men with 
schizophrenia, relative to the 
same-sex control 
 
Reversed sexual dimorphism 
where male patients showed 
greater grey matter volume of 
ACC than men. 
Takahashi, et al. 2002 SZ (40) 20:20 M 26.4 (5.1) 
F 25.9 (5.1) 
N=40 
20:20 
M 25.5 (5.9) 
F 24.8 (6.2) 
Anterior 
cingulate gyrus 
MRI  
Volume of the whole brain and 
both grey and white matter.  
 
All measurements were carried 
out by one rater, blinded to 
gender and diagnosis. 
Volume reductions in ACC in 
women but not in men with 
schizophrenia, relative to the 
same-sex controls 
 
The right anterior cingulate was 
significantly reduced only in 
women with schizophrenia.   
Thèse de doctorat Adham Mancini Marïe August 2016 
250 
 
 
Women patients lacked the 
normal structural asymmetry - 
right larger than left ACC.  
 
Contrary to prediction that men 
with schizophrenia would show 
more laterality disruption, they 
did not differ from the same-sex 
control group on any measure 
Takahashi et al. 2004 SZT (26) 
SZ (58)  
SZT 14:12 
SZ 31:27 
SZT  
M 23.6 (5.4) 
F 26.3 (4.6) 
SZ   
M 25.5 (4.9) 
F 26.2 (4.8) 
N=61 
31:31 
M 24.9 (5.1) 
F 24.2 (5.9) 
perigenual 
cingulate gyrus 
MRI  
Volume of the gray and white 
matter 
 
All measurements were carried 
out by one rater, blinded to 
gender and diagnosis. 
Schizophrenia patients showed 
a lack of normal gender 
differences of the perigenual 
cingulate 
gray matter seen in the healthy 
controls 
(females>males).  
Takahashi et al. 2003 SZ (40) 20:20 26.1 (5.0) N=40 
20:20 
25.1 (5.8) perigenual 
cingulate gyrus 
MRI  
Volume of both gray and 
white matter of the perigenual 
cingulate gyrus 
 
All measurements were carried 
out by one rater, blinded to 
gender and diagnosis. 
Significant sex difference in the 
perigenual cingulate gyrus in 
control subjects where women 
had larger grey matter volumes 
than men.  
This difference was not 
significant in schizophrenia due 
to reduction in bilateral 
perigenual cingulate gray 
matter in female patients 
compared with female controls 
and no differences between the 
men groups. 
Goldstein et al. 2007 SZ (88) M 67.1%  
F 32.9% 
44.6 (9.7) N=48 
M 56% F44% 
40.5 (10.8) Hypothalamus MRI 
Segmentation hypothalamus 
Contrary to expectations, 
hypothalamic volumes in 
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M: males, F: females, SZ: schizophrenia, FES: First episode schizophrenia, MRI: magnetic resonance imaging, SZT: schizotypal disorder, BPD: Bipolar disorder, SZA: schizoaffective 
disorder, FEP: first episode psychosis, SZP: paranoid schizophrenia, MDD: major depressive disorder, ROI: region of interest, SZU: schizophrenia undifferentiated, AOSZ: adolescent 
onset schizophrenia, EOSZ: early onset schizophrenia
schizophrenia patients were 
significantly larger than those in 
normal controls.  These 
abnormalities were also present 
in nonpsychotic relatives of 
schizophrenia patients; they 
were positively correlated with 
anxiety and were more 
pronounced in women 
Duggal et al. 2005 FES (30) 15:15 
 
M 31.4 (5.5) 
F 25.9 (8.7) 
N=30 
 
M 33.5 (7.0)  
F 26.5 (11.4) 
Insula MRI 
Manual tracing of insular volumes 
Women with schizophrenia had 
significantly reduced right 
insular volume relative to 
healthy women, while there was 
no effect in men 
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 Table Y. Differences between ICD-10 and DSM-IV in schizophrenia 
 ICD-10 DSM-IV 
Diagnoses 1 symptom from Schneiderian 
first rank or 2 from a second list 
of psychotic symptoms 
1 symptom from Schneiderian first 
rank or 2 from a second list of 
psychotic symptoms 
Symptoms  List 1) thought echo, thought 
insertion or withdrawal or thought 
broadcasting; delusions of 
control, influence or passivity; 
hallucinatory voices giving a 
running commentary or 
discussing the patient among 
themselves or persistent delusions 
of other kinds that are 
“completely impossible.” 
List 2) hallucinations 
accompanied by delusions or 
overvalued ideas; incoherence 
or irrelevant speech; catatonic 
behavior; and “negative” 
symptoms. 
List 1) bizarre delusions (which 
would cover the three delusional 
symptoms in the ICD-10 list) and 
auditory hallucinations  
 
 
 
 
 
 
 
List 2) 5 symptoms: delusions of 
any type; hallucinations of any 
type; disorganized speech; catatonic 
or grossly disorganized behavior, 
and negative symptoms. 
Duration Minimum 1 month Minimum 1 month and at least 6 
months for a diagnosis  
Functioning  No specification Since the onset of the illness 
functioning is markedly below that 
achieved prior to the onset. 
Between episodes Negative symptoms (or no 
symptoms) between episodes.  
These are further subtyped based 
on whether the negative 
symptoms are progressive or 
stable.  
Characterized by the presence or 
absence of interepisode residuel 
symptoms which may be either 
negative symptoms or attenuated 
forms of the defining psychotic 
symptoms.  
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First onset of psychotic 
symptoms lasting for at 
least 1 month but less 
than 6 
Diagnosed as Schizophrenia  Diagnosed as Schizophreniform 
Disorder.  
 
F20.0 Paranoid 
Schizophrenia  
 
Requires that the delusions or 
hallucinations be prominent 
whereas other specific symptoms 
(i.e., flattening or incongruity of 
affect, catatonic symptoms, or 
incoherent speech) must not 
“dominate the clinical picture.” 
Requires that the individual be 
preoccupied with one or more 
delusions or frequent hallucinations 
and that none of a list of different 
specific symptoms (i.e., 
disorganized speech, disorganized 
or catatonic behavior, or flat or 
inappropriate affect) be also 
prominent. 
F20.1 Hebephrenic 
Schizophrenia 
(Disorganized 
Schizophrenia in DSM-
IV)  
Flat or inappropriate affect and 
either disorganized speech or 
disorganized behavior 
Disorganized speech, disorganized 
behavior and flat or inappropriate 
affect are all required. 
F20.2 Catatonic 
Schizophrenia  
 
 
The lists of catatonic 
symptoms share most 
features in common 
except for : 
ICD-10 requires only one 
catatonic symptom lasting at least 
2 weeks.  
 
 
 
Command automatism 
The DSM-IV definition is more 
severe in that a minimum of two 
catatonic features must be present.  
 
Echolalia and echopraxia 
F20.3 Undifferentiated 
Schizophrenia  
Either having “insufficient 
symptoms” to meet the criteria 
for one of the other subtypes  
or “so many symptoms that the 
criteria for more than one of the 
other subtypes is met.”  
 
Only for cases that do not meet 
criteria for any of the other 
subtypes. 
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F20.5 Residual 
Schizophrenia  
 
 
The ICD-10 definition requires 
that there be at least 12 months of 
negative symptoms (four drawn 
from a possible list of six) in an 
individual for whom the general 
criteria for Schizophrenia are not 
currently met. 
The DSM-IV definition is more 
broadly defined in that the criteria 
also allow for two or more active 
phase symptoms to be present in an 
attenuated form (e.g., odd beliefs, 
unusual perceptual experiences). 
DSM-IV also does not specify a 
duration. 
F20.6 Simple 
Schizophrenia (Simple 
Deteriorative Disorder in 
DSM-IV)  
 
Requires that there be a significant 
change “in the overall quality of 
some aspects of speech or personal 
behavior manifest as loss of drive 
or interests, aimlessness, idleness, 
a self-absorbed attitude and social 
withdrawal.”  
 
Not is DSM-IV, but under Simple 
Deteriorative Disorder  
 
Requires “poor interpersonal 
rapport, social isolation, or social 
withdrawal.”  
 
Exclusion of Personality, Mood, or 
Anxiety Disorder. 
 Adapted from First MB (2009a, 2009b & 2007)(700, 701) 
 
